<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "journalpublishing3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xml:lang="en" article-type="review-article">
<?release-delay 0|0?>
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">IJO</journal-id>
<journal-title-group>
<journal-title>International Journal of Oncology</journal-title></journal-title-group>
<issn pub-type="ppub">1019-6439</issn>
<issn pub-type="epub">1791-2423</issn>
<publisher>
<publisher-name>D.A. Spandidos</publisher-name></publisher></journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3892/ijo.2025.5766</article-id>
<article-id pub-id-type="publisher-id">ijo-67-01-05766</article-id>
<article-categories>
<subj-group>
<subject>Review</subject></subj-group></article-categories>
<title-group>
<article-title>Advancements in the therapeutic potential of sesquiterpenoids for the treatment of hepatocellular carcinoma (Review)</article-title></title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Li</surname><given-names>Yan</given-names></name><xref rid="af1-ijo-67-01-05766" ref-type="aff">1</xref><xref rid="af2-ijo-67-01-05766" ref-type="aff">2</xref><xref rid="fn1-ijo-67-01-05766" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Du</surname><given-names>Xin</given-names></name><xref rid="af1-ijo-67-01-05766" ref-type="aff">1</xref><xref rid="af2-ijo-67-01-05766" ref-type="aff">2</xref><xref rid="fn1-ijo-67-01-05766" ref-type="author-notes">&#x0002A;</xref></contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mao</surname><given-names>Jingxin</given-names></name><xref rid="af1-ijo-67-01-05766" ref-type="aff">1</xref><xref rid="af3-ijo-67-01-05766" ref-type="aff">3</xref><xref ref-type="corresp" rid="c1-ijo-67-01-05766"/></contrib></contrib-group>
<aff id="af1-ijo-67-01-05766">
<label>1</label>Chongqing Medical and Pharmaceutical College, Chongqing 400030, P.R. China</aff>
<aff id="af2-ijo-67-01-05766">
<label>2</label>Chongqing Municipal Key Laboratory for High Active Traditional Chinese Drug Delivery System, Chongqing 401331, P.R. China</aff>
<aff id="af3-ijo-67-01-05766">
<label>3</label>College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, P.R. China</aff>
<author-notes>
<corresp id="c1-ijo-67-01-05766">Correspondence to: Professor Jingxin Mao, Chongqing Medical and Pharmaceutical College, 82 Middle University Town Road, Shapingba, Chongqing 400030, P.R. China, E-mail: <email>mmm518@163.com</email></corresp>
<fn id="fn1-ijo-67-01-05766" fn-type="equal">
<label>&#x0002A;</label>
<p>Contributed equally</p></fn></author-notes>
<pub-date pub-type="collection">
<month>07</month>
<year>2025</year></pub-date>
<pub-date pub-type="epub">
<day>19</day>
<month>06</month>
<year>2025</year></pub-date>
<volume>67</volume>
<issue>1</issue>
<elocation-id>60</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>04</month>
<year>2025</year></date>
<date date-type="accepted">
<day>27</day>
<month>05</month>
<year>2025</year></date></history>
<permissions>
<copyright-statement>Copyright: &#x000A9; 2025 Li et al.</copyright-statement>
<copyright-year>2025</copyright-year>
<license license-type="open-access">
<license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions>
<abstract>
<p>Sesquiterpenoids are widely distributed in plants, animals, marine organisms and microorganisms, particularly in <italic>Asteraceae</italic> plants, and they exhibit various biological activities, including anti-tumor, anti-bacterial, anti-inflammatory, antiviral and antioxidant properties. They also have the effects of protecting the liver, protecting the nerves, preventing and treating diabetes and improving immunosuppressive function. Hepatocellular carcinoma (HCC) is the main type of primary liver cancer and the third leading cause of cancer-related death worldwide. There is accumulating evidence that HCC is an increasingly serious threat to human health and the incidence of primary liver cancer is also still increasing. For the present review, literature on sesquiterpenoids in the treatment of liver cancer from 2003 to 2024 was searched through electronic databases. A total of 46 sesquiterpenoids were identified for HCC treatment. It was found that sesquiterpenoids play a therapeutic role in HCC by inhibiting proliferation, inducing apoptosis, inhibiting invasion and metastasis of HCC cells, regulating the body's immune function and decreasing the resistance of tumor cells. Sesquiterpenoids are promising drugs, which may create more opportunities for the treatment of liver cancer. However, research on how sesquiterpenoids act on HCC is not systematic and most reports are also limited to mixtures, while there is only a small number of reports of new sesquiterpene monomers for treating HCC. Therefore, it is necessary to further discover new components and study their biological activities, and to gradually conduct in-depth <italic>in vivo</italic> studies and clinical application in the future. The present study reviewed the research progress of sesquiterpene-rich natural products in the treatment of HCC in the past two decades.</p></abstract>
<kwd-group>
<title>Key words</title>
<kwd>sesquiterpenoids</kwd>
<kwd>anti-hepatoma</kwd>
<kwd>pharmacological action</kwd>
<kwd>treatment</kwd>
<kwd>mechanism</kwd></kwd-group>
<funding-group>
<award-group>
<funding-source>Chongqing Municipal Education Commission Youth Project</funding-source>
<award-id>KJQN202402816</award-id></award-group>
<award-group>
<funding-source>Chongqing Natural Science Foundation General Project</funding-source>
<award-id>2023NSCQ-MSX1632</award-id></award-group>
<funding-statement>This research was funded by the Chongqing Municipal Education Commission Youth Project (grant no. KJQN202402816) and Chongqing Natural Science Foundation General Project (grant no. 2023NSCQ-MSX1632).</funding-statement></funding-group></article-meta></front>
<body>
<sec sec-type="intro">
<label>1.</label>
<title>Introduction</title>
<p>Liver cancer is a malignant tumor that poses a serious threat to human health. According to statistics, there are ~700,000 new cases of liver cancer worldwide every year. Data released by the International Agency for Research on Cancer of the World Health Organization show that in 2022, there were an estimated 900,000 new cases of liver cancer worldwide. The incidence rate of liver cancer ranks sixth among malignant tumors and has become the third leading cause of death in the world, with 830,000 deaths per year (<xref rid="b1-ijo-67-01-05766" ref-type="bibr">1</xref>). Among them, the number of new cases and deaths of liver cancer in China is close to half of the total. Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor and the second leading cause of cancer death in China. In 2022, there were 316,500 deaths due to primary liver cancer, ranking second in both the number of deaths and mortality rate. The etiology of liver cancer is diverse and complex and it is currently thought to be related to hepatitis virus infection, alcohol, nitrosamine substances, aflatoxin and certain chemical carcinogens (<xref rid="b2-ijo-67-01-05766" ref-type="bibr">2</xref>). In addition to traditional liver tumor resection, further treatment methods for liver cancer, including interventional therapy, radiofrequency ablation, immunotherapy, targeted therapy, hyperthermic perfusion therapy and liver transplantation, have developed rapidly in recent years (<xref rid="b3-ijo-67-01-05766" ref-type="bibr">3</xref>). Due to its difficult initial diagnosis, rapid progress, significant risk factors after surgery and poor prognosis (<xref rid="b4-ijo-67-01-05766" ref-type="bibr">4</xref>), most patients with liver cancer have missed the opportunity for radical surgery at the time of clinical diagnosis and liver cancer still has the possibility of further development, recurrence and metastasis after palliative surgery. Immunotherapy and targeted therapy are expensive and have not been popularized to date.</p>
<p>Primary prevention of liver cancer and the search for new therapeutic drugs are the current research hotspots. Although aspirin, sorafenib, regorafenib, lenvatinib and other anti-liver cancer drugs are effective therapeutic drugs in clinical practice, they still have shortcomings such as low efficacy, serious side effects and drug resistance (<xref rid="b5-ijo-67-01-05766" ref-type="bibr">5</xref>-<xref rid="b7-ijo-67-01-05766" ref-type="bibr">7</xref>). Although chemotherapy and immunotherapy are conventional options for treatment, they have large toxic and side effects, while natural products have lower systemic toxicity and fewer side effects, which can provide better treatment options for patients (<xref rid="b8-ijo-67-01-05766" ref-type="bibr">8</xref>,<xref rid="b9-ijo-67-01-05766" ref-type="bibr">9</xref>) and have unique advantages in the treatment of liver cancer.</p>
<p>Natural products have played an important role in medicine, particularly in the treatment of chronic and metabolic diseases, and are the basis of most early drugs (<xref rid="b10-ijo-67-01-05766" ref-type="bibr">10</xref>). Some of the world's best-known drugs, including artemisinin, berberine, paclitaxel and elemene, are compounds of natural origin (<xref rid="b11-ijo-67-01-05766" ref-type="bibr">11</xref>). With the development of natural medicinal chemistry technology, the determination of phytochemical compositions and its application in drug development have become possible. In the nearly 20 years, natural products still exist as sources of new drugs and have a large share in new drug discovery (<xref rid="b12-ijo-67-01-05766" ref-type="bibr">12</xref>). Terpenoids are a class of active natural products with a wide range of pharmacological effects and represent a rich library of candidate compounds for drug discovery (<xref rid="b13-ijo-67-01-05766" ref-type="bibr">13</xref>). Terpenoids can be divided into several subclasses according to their chemical structures, including semi-terpenoids, monoterpenoids, sesquiterpenoids, diterpenoids, ester terpenoids and triterpenoids. Among them, the most distributed class of sesquiterpenoids is mainly divided into acyclic, monocyclic, bicyclic, tricyclic and tetracyclic sesquiterpenoids. They can also be divided into five-membered ring, six-membered ring and seven-membered ring sesquiterpenoids by the number of carbon atoms. Furthermore, it can be divided into sesquiterpene alcohols, sesquiterpene ketones and sesquiterpene lactones according to different oxygen-containing groups (<xref rid="b14-ijo-67-01-05766" ref-type="bibr">14</xref>). Various studies have shown that sesquiterpenoid exhibits potential therapeutic effects in anti-tumor, anti-inflammatory, antibacterial and anti-cardiovascular diseases (<xref rid="b15-ijo-67-01-05766" ref-type="bibr">15</xref>-<xref rid="b22-ijo-67-01-05766" ref-type="bibr">22</xref>), and there are more new components and physiological activities to be explored. There have been numerous studies on the application of sesquiterpenoids in HCC, but there is still a lack of systematic analysis of their therapeutic applications. In the present review, the research progress of natural products in the treatment of liver cancer in the past two decades was summarized.</p></sec>
<sec sec-type="methods">
<label>2.</label>
<title>Methods</title>
<p>Prior to 2003, due to technical limitations, the literature records were incomplete or difficult to obtain. A 20-year span is sufficient to present the development process of this field from initial exploration to in-depth research, facilitating the sorting of trends and key nodes; balancing research resources and energy constraints, with a moderate duration for detailed analysis of literature, to avoid an overly broad or narrow scope. Adapting to the changes in liver cancer treatment concepts, technologies and drugs, it is conducive to study the effects of sesquiterpenes in combination with disease characteristics. At the same time, it complies with the standards and regulations of the medical research industry, making it easy to compare and communicate with similar studies. Due to the above reasons, the PubMed (<ext-link xlink:href="https://pubmed.ncbi.nlm.nih.gov/" ext-link-type="uri">https://pubmed.ncbi.nlm.nih.gov/</ext-link>), Web of Science (<ext-link xlink:href="https://www.webofscience.com/" ext-link-type="uri">https://www.webofscience.com/</ext-link>), Science Direct (<ext-link xlink:href="https://www.sciencedirect.com" ext-link-type="uri">https://www.sciencedirect.com</ext-link>) and Springer databases (<ext-link xlink:href="https://link.springer.com/" ext-link-type="uri">https://link.springer.com/</ext-link>) were searched for information on sesquiterpenes for the treatment of HCC from 2003 to 2024. The search terms were 'sesquiterpenoid compound', 'sesquiterpene lactone', 'sesquiterpene', 'turmeric', 'curcuma zedoary', '<italic>Artemisia</italic>', 'atractylodes rhizome' and 'liver cancer', 'hepatocellular carcinoma' and 'HCC'. The keyword combinations 'liver cancer AND natural sesquiterpenes' and 'hepatocellular carcinoma and natural sesquiterpenes' were used to find relevant articles. The inclusion criteria were as follows: i) Studies with <italic>in vivo</italic> animal experiments showing the anticancer efficacy of natural sesquiterpenes against HCC; ii) clinical trials concerning the therapeutic benefit of HCC; and iii) original research papers written in English. Review articles, meta-analyses, cross-sectional studies, descriptive studies, studies that did not provide sample data of cancer patients and projects that used secondary data were excluded from this review.</p>
<p>Previous studies were excluded from the review if they were found to have major methodologic errors or lack scientific merit. To aid in classification efforts, studies on mixtures of different compounds or crude extracts were excluded from this study, except for chemically ambiguous sesquiterpenoids. Not all pharmacological effects of sesquiterpenoids have been described in detail in the literature. For instance, the mechanism by which artemisinin exerts its specific anti-HCC activity is still elusive, which may limit its further development in the clinic. Therefore, based on the results of the literature search, a secondary literature search was performed for certain specific medicinal plants obtained, and the search terms were the names of representative compounds, including 'artemisinin', 'elemene' and 'parthenolide'. The gaps of the first search were supplemented and the research system was markedly enriched. Those reviews also includes compounds with undescribed mechanisms that nevertheless have inhibitory effects on HCC cells, providing a more comprehensive anti-liver cancer research direction for the future. Finally, 46 sesquiterpenoids were obtained.</p></sec>
<sec sec-type="results">
<label>3.</label>
<title>Results</title>
<p>Increasing evidence has shown that sesquiterpenoids can effectively inhibit the progression of HCC and play a therapeutic role in different stages of the disease. It can effectively treat HCC by improving antioxidant capacity, enhancing specific and non-specific immune function, inhibiting cell proliferation and promoting cell apoptosis. The molecular structure of sesquiterpenoids is presented in <xref rid="f1-ijo-67-01-05766" ref-type="fig">Fig. 1</xref>. Schematics illustrating pathways included in the mechanisms of action of various sesquiterpenoids in HCC are provided in <xref rid="f2-ijo-67-01-05766" ref-type="fig">Figs. 2</xref> and <xref rid="f3-ijo-67-01-05766" ref-type="fig">3</xref>. The basic information of various natural sesquiterpenoids, including their source, molecular formula and molecular mass, was presented in <xref rid="tI-ijo-67-01-05766" ref-type="table">Table I</xref>. It summarizes the activity features of the sesquiterpenoids, including IC<sub>50</sub> and dosage, mechanism of action and effects (<xref rid="tII-ijo-67-01-05766" ref-type="table">Table II</xref>).</p>
<sec>
<title>Sesquiterpene lactones</title>
<p>Sesquiterpene lactones are the most studied sesquiterpene compounds at present. The chemical structure of sesquiterpene lactones is based on a skeleton of 15 carbon atoms and consists of three cyclic isoprene structures, one of which is a five-membered (&#x003B3;-) lactone group (cycloester) (<xref rid="b23-ijo-67-01-05766" ref-type="bibr">23</xref>). This unique structure makes sesquiterpene lactones have a variety of biological activities. Previous studies have shown that &#x003B1;-methylene-lactones of this kind of compounds have anti-tumor activity, while &#x003B1;- and &#x003B2;-unsaturated lactones have strong anti-inflammatory activity (<xref rid="b24-ijo-67-01-05766" ref-type="bibr">24</xref>-<xref rid="b26-ijo-67-01-05766" ref-type="bibr">26</xref>). Depending on the carboxy skeleton and the type and position of the substituent, sesquiterpene lactones can be divided into different subgroups, including the germacranolides, guaianolides, pseudoguaianolides, eudesmanolides and elemanolides. In recent years, it has been found that sesquiterpene lactones with anti-tumor activity are mainly derived from artemisinins, alantolides, descholinolides and parthenolides.</p></sec>
<sec>
<title>Artemisinin and its derivatives</title>
<p>Sesquiterpenoids, particularly guaiacolactone, artemisia, absinthium, sterolactone and barley fructosterol lactone, are the main chemical components of <italic>Artemisia</italic>, and some of them have shown a variety of significant biological activities, including anti-tumor, anti-malaria, anti-inflammatory, immunomodulatory, anti-ulcer, anti-parasite and anti-bacterial (<xref rid="b27-ijo-67-01-05766" ref-type="bibr">27</xref>).</p>
<p>The main component of the <italic>Artemisia</italic> and its derivatives is artemisinin, dihydroartemisinin and artesunate are derivatives of artemisinin, have strong anti-tumor activity. The anticancer properties of artemisinin result from its unique chemical structure, particularly its internal peroxide bridge structure, which is critical for its biological activity. Its mechanism of action mainly involves the generation of reactive oxygen species (ROS) after interaction with intracellular iron (<xref rid="b28-ijo-67-01-05766" ref-type="bibr">28</xref>). Cancer cells, including HCC, exhibit an abnormal iron metabolism, as indicated by elevated transferrin receptor expression and iron accumulation. This dependence makes them more vulnerable to oxidative damage caused by ROS (<xref rid="b29-ijo-67-01-05766" ref-type="bibr">29</xref>). Upon iron activation, artemisinin produces cytotoxic free radicals that target cellular macromolecules, leading to apoptosis and ferroptosis (<xref rid="b30-ijo-67-01-05766" ref-type="bibr">30</xref>). Artemisinin has been shown in studies of HCC to induce mitochondrial dysfunction, disrupting cellular respiration and energy production. In addition, it can regulate key signaling pathways, including the phosphatidylinositol-3-hydroxykinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) axis, thereby inhibiting cell proliferation and enhancing apoptosis (<xref rid="b31-ijo-67-01-05766" ref-type="bibr">31</xref>). Another key mechanism involves the regulation of angiogenesis. Artemisinin has been shown to inhibit vascular endothelial growth factor (VEGF) signaling, which is critical for tumor angiogenesis and metastasis (<xref rid="b32-ijo-67-01-05766" ref-type="bibr">32</xref>). This is particularly important in HCC, which relies heavily on neovascularization for growth and spread. In addition, artemisinin enhances the effects of conventional therapies, potentially reducing drug resistance by making cancer cells more sensitive to chemotherapeutic agents and radiotherapy (<xref rid="b33-ijo-67-01-05766" ref-type="bibr">33</xref>). It is able to reduce the production of inflammatory cytokines and reprogram immune cells, such as the anti-tumor phenotype of macrophages, in a certain direction. These immunomodulatory effects, coupled with its direct cytotoxic effects, enhance its anticancer potential (<xref rid="b34-ijo-67-01-05766" ref-type="bibr">34</xref>). Artemisinin inhibited the migration and invasion of HCC cell lines in a dose- and time-dependent manner. The inhibitory effect of artemisinin on invasion and metastasis of HCC cells is mediated by upregulation of tissue inhibitors of metalloproteinase 2 (TIMP2) and downregulation of matrix metalloproteinase 2 <italic>in vitro</italic> and <italic>in vivo</italic> (<xref rid="b35-ijo-67-01-05766" ref-type="bibr">35</xref>).</p>
<p>Dihydroartemisinin significantly inhibited the growth of HCC cells <italic>in vitro</italic> and <italic>in vivo</italic> by inducing G2/M cell cycle arrest and apoptosis in HCC cell lines. Induction of p21 and inhibition of cyclin B and cell division cycle (CDC)25C contributed to dihydroartemisinin-induced G2/M arrest. Dihydroartemisinin-induced apoptosis was found to be associated with mitochondrial membrane depolarization, cytochrome c release, caspase activation and DNA fragmentation. In addition, dihydroartemisinin was able to inhibit HCC growth in a xenograft mouse model (<xref rid="b36-ijo-67-01-05766" ref-type="bibr">36</xref>).</p>
<p>The mechanisms by which artesunate derivatives inhibit tumor growth are not fully understood, among which the most likely mechanism is that artesunate derivatives exhibit several modes of action against HCC simultaneously in a variety of specific ways. Whether artesunate drugs are used alone or synergistically in combination, the underlying mechanisms are similar and may act in a variety of specific ways, while exhibiting several modes of anti-HCC action. Artesunate is a reduced artemisinin monoester succinate that inhibits the activity of HepG2 and BWTG3 cells in a dose- and time-dependent manner (<xref rid="b37-ijo-67-01-05766" ref-type="bibr">37</xref>). It can induce apoptosis of HCC cells by specifically inhibiting signal transducers and activators of transcription (STAT3) (<xref rid="b38-ijo-67-01-05766" ref-type="bibr">38</xref>). Artesunate interfered with STAT3 dimerization <italic>in vitro</italic>, inhibited constitutive and I-6-induced STAT3 and then regulated STAT3-dependent procysteinyl aspartate-specific proteinase-3 (caspase-3), B-cell lymphoma/leukemia-2 (Bcl-2)-related X protein (Bcl-xl) and survivin. Another study found that artesunate combined with sorafenib induced apoptosis in HCC cells by inhibiting the PI3K/AKT/mTOR pathway (<xref rid="b39-ijo-67-01-05766" ref-type="bibr">39</xref>).</p></sec>
<sec>
<title>Lavandiolide H</title>
<p>Guaiacane-type sesquiterpene dimers, which contain a large amount of sesquiterpene lactone, were isolated from A<italic>rtemisia</italic> and acted on three kinds of liver cancer cells (<xref rid="b40-ijo-67-01-05766" ref-type="bibr">40</xref>-<xref rid="b42-ijo-67-01-05766" ref-type="bibr">42</xref>). The results showed that the guaiacolide dimer sesquiterpene Lavandiolide H significantly inhibited the proliferation of three different human hepatoma cell lines. The sesquiterpene also induced G2/M-phase arrest and apoptosis of HepG2 cells and downregulated the expression of the Bcl-2 oncogene and poly(ADP-ribose) polymerase 1 (PARP-1), while upregulating the expression of cleaved PARP-1 (<xref rid="b43-ijo-67-01-05766" ref-type="bibr">43</xref>). The results of this study indicated the potential of guaiactone dimer as a candidate natural small molecule compound for the treatment of HCC.</p></sec>
<sec>
<title>Isoalantolactone</title>
<p>Isoalantolactone is derived from the dried roots of elecampane, a plant of the genus <italic>Inula</italic> in Asteraceae, and has wide-ranging therapeutic potential (<xref rid="b44-ijo-67-01-05766" ref-type="bibr">44</xref>). As a promising candidate for cancer research, as well as drug discovery and design, Isoalantolactone exhibits potent anti-proliferative activity against HepG2 cells. By promoting caspase-dependent apoptosis, inducing oxidative stress to inhibit cell migration and cell invasion, and blocking Ras/Raf/MAPK kinase signaling, it induces dose-dependent inhibition of HepG2-cell proliferation (<xref rid="b45-ijo-67-01-05766" ref-type="bibr">45</xref>).</p></sec>
<sec>
<title>Dehydrocostus lactone</title>
<p>Dehydrocostus lactone is a sesquiterpene lactone with a high content in the essential oil of <italic>Inula racemosa</italic> and the main bioactive component of <italic>Inula racemosa</italic>. Dehydrocostus lactone inhibits HepG2 human hepatoblastoma cells by downregulating the PI3K/AKT signaling pathway (<xref rid="b46-ijo-67-01-05766" ref-type="bibr">46</xref>).</p></sec>
<sec>
<title>Costunolide</title>
<p>Costunolide is one of the main chemical components and quality control components of <italic>Costustoot</italic> in traditional Chinese medicine. Epidermal growth factor receptor (EGFR) amplification and abnormal activity are closely related to the occurrence and development of a variety of malignant tumors, including liver cancer. Therefore, key molecules in the EGFR signaling pathway are considered important oncogenic factors and key therapeutic targets. Costunolide can increase the ubiquitination of EGFR and reduce the distribution of EGFR recycling to the cell membrane, thereby inhibiting EGF signaling (<xref rid="b47-ijo-67-01-05766" ref-type="bibr">47</xref>). <italic>In vitro</italic> studies showed that costunolide could inhibit the proliferation and promote apoptosis of HepG2 cells, and cause cell cycle arrest in G2/M phase in a dose-dependent manner, and thus significantly induce apoptosis of HepG2 cells. The mechanism is that costunolide may promote cell apoptosis by upregulating the expression levels of Bcl-2-associated X-protein (Bax), caspase-3, caspase-8 and caspase-9 and downregulating the expression of Bcl-2 protein (<xref rid="b48-ijo-67-01-05766" ref-type="bibr">48</xref>).</p></sec>
<sec>
<title>Britannin</title>
<p>Phytosterols, flavonoids, sesquiterpene lactones and essential oils are the main chemical constituents of <italic>Inula L.</italic> Britannin, a compound isolated from <italic>Inula L.</italic>, which can induce apoptosis and autophagy by activating ROS-regulated adenosine monophosphate-activated protein kinase (AMPK) in liver cancer cells. It provides a molecular basis for the development of Britannin as an effective anti-liver cancer drug candidate (<xref rid="b49-ijo-67-01-05766" ref-type="bibr">49</xref>).</p></sec>
<sec>
<title>Bigelovin</title>
<p>Bigelovin, a sesquiterpene lactone isolated from <italic>Inula</italic>, has been shown to have apoptosis-inducing, anti-inflammatory and anti-angiogenic activities. Bigelovin was found to have potential antitumor activity against human HCC <italic>in vitro</italic> and <italic>in vivo</italic>. Bigelovin inhibited cell proliferation and colony formation. Bigelovin induces apoptosis by promoting the cleavage of caspase-3 and PARP-1. This process is also accompanied by the activation of autophagy, which is manifested as the increase of autophagosomes and the decrease of light chain I protein type 3-II, Beclin-1 and ubiquitin-binding protein p62 (<xref rid="b50-ijo-67-01-05766" ref-type="bibr">50</xref>).</p></sec>
<sec>
<title>Narjatamolide</title>
<p>Narjatamolide, isolated from rhizoma nardostachyos, exhibits an anti-proliferation effect on BEL-7402 cells in a dose-dependent manner, and the results of cell cycle analysis show that this compound can induce cell cycle arrest in G2/M phase (<xref rid="b51-ijo-67-01-05766" ref-type="bibr">51</xref>).</p></sec>
<sec>
<title>Parthenolide</title>
<p>Parthenolide is a gemmarane type sesquiterpene lactone natural product extracted from <italic>Leucanthemella</italic>, which was first isolated from the traditional herbal medicine white daisy in 1965 (<xref rid="b52-ijo-67-01-05766" ref-type="bibr">52</xref>). By inducing the generation of ROS in HepG2 cells, blocking its cell cycle and causing apoptosis and autophagy, it exerts an anti-tumor effect (<xref rid="b53-ijo-67-01-05766" ref-type="bibr">53</xref>).</p></sec>
<sec>
<title>Micheliolide</title>
<p>Micheliolide is a sesquiterpene lactone natural product isolated from <italic>Michelia L.</italic> and <italic>Michelia x alba</italic> (<xref rid="b54-ijo-67-01-05766" ref-type="bibr">54</xref>), which is a guaiacane sesquiterpene in structure. Compared with parthenolide, aconitolide has at least three advantages: High stability, low toxicity and continuous release of active drug (<xref rid="b55-ijo-67-01-05766" ref-type="bibr">55</xref>). Micheliolide as a thioredoxin reductase (TrxR) inhibitor with high potential to induce immunogenic cell death (ICD). The magnitude of ICD-related effects induced by micheliolide exposure in HCC cells was found to depend on the generation of ROS-mediated endoplasmic reticulum (ER) stress (ERS). Furthermore, ROS inhibition normalizes micheliolide-induced ERS, whereas TrxR downregulation acts synergistically with micheliolide-driven ERS, and micheliolide inhibits the development of hepatoma organoids (<xref rid="b56-ijo-67-01-05766" ref-type="bibr">56</xref>).</p></sec>
<sec>
<title>Dimethylaminomicheliolide</title>
<p>Dimethylaminomicheliolide is a pro-drug of micheliolide, and in normal cells, the former has higher stability, higher activity and lower toxicity than micheliolide. In addition to their anti-tumor effects, micheliolide and dimethylaminomicheliolide also have protective effects against inflammation, hepatic steatosis, diabetic nephropathy and rheumatoid arthritis (<xref rid="b57-ijo-67-01-05766" ref-type="bibr">57</xref>-<xref rid="b60-ijo-67-01-05766" ref-type="bibr">60</xref>). Dimethylaminomicheliolide has minimal side effects in animals and is a safe and promising drug for long-term <italic>in vivo</italic> treatment (<xref rid="b61-ijo-67-01-05766" ref-type="bibr">61</xref>). Dimethylaminomicheliolide reduced the viability of HCC cells in a dose- and time-dependent manner, and caused cell cycle arrest in G2/M phase and inhibited cell invasion and epithelial-mesenchymal transition (EMT). It also induces cell death through the intrinsic apoptotic pathway of HCC cells, which can be blocked by the caspase inhibitor zVAD-fmk, Bax/Bcl-2 antagonist/killer 1 (Bak) silencing or Bcl-2 overexpression. Dimethylaminomicheliolide inactivates the PI3K/AKT pathway, leading to ROS production, thereby regulating dimethylaminomicheliolide-induced apoptosis (<xref rid="b62-ijo-67-01-05766" ref-type="bibr">62</xref>).</p></sec>
<sec>
<title>Deoxyelephantopin</title>
<p><italic>Elephantopus scaber</italic>'s chemical composition is complex and its main components include sesquiterpene lactones, triterpenes, flavonoids, steroids and anthrones. Modern pharmacological studies have shown that it has the effects of liver protection, as well as antibacterial, anti-tumor and anti-inflammatory properties, and may be used in the treatment of diabetes (<xref rid="b63-ijo-67-01-05766" ref-type="bibr">63</xref>-<xref rid="b65-ijo-67-01-05766" ref-type="bibr">65</xref>). Deoxyelephantopin is the main component of <italic>Elephantopus scaber</italic> (<xref rid="b66-ijo-67-01-05766" ref-type="bibr">66</xref>), which has a variety of biological activities, including antibacterial, anti-diabetic, anti-inflammatory, wound healing, liver protection and anti-cancer activity (<xref rid="b67-ijo-67-01-05766" ref-type="bibr">67</xref>,<xref rid="b68-ijo-67-01-05766" ref-type="bibr">68</xref>). Deoxyelephantopin inhibits the proliferation and induces apoptosis of HepG2 cells in a dose-dependent manner, possibly related to the generation of ROS, glutathione (GSH) depletion and reduced TrxR activity, disrupting the mitochondrial membrane potential (MMP) and enhancing DNA fragmentation. Further studies have shown that deoxyelephantopin can reduce the phosphorylation of inhibitor of nuclear factor &#x003BA;B (NF-&#x003BA;B)&#x003B1; (I&#x003BA;B-&#x003B1;) to inhibit the translocation of constitutive and inducible NF-&#x003BA;B to the nucleus, and exert its anti-cancer effect through oxidative stress. Deoxyelephantopin can be used as a potential drug for effective treatment of liver cancer (<xref rid="b69-ijo-67-01-05766" ref-type="bibr">69</xref>).</p></sec>
<sec>
<title>Scabertopinolide G</title>
<p>A total of seven new compounds, Scabertopinolide A-G, were isolated from <italic>Elephantopus scaber</italic>, among which Scabertopinolide G showed the strongest inhibitory effect on the proliferation of three human tumor cell lines, HepG2, Hep3B and MCF-7 (<xref rid="b70-ijo-67-01-05766" ref-type="bibr">70</xref>). Scabertopinolide G induces autophagy in Hep3B and HepG2 cells by increasing ROS production and reducing the MMP. In addition, signaling pathways including MAPK and AKT may play an important role in the induced death of liver cancer cells (<xref rid="b71-ijo-67-01-05766" ref-type="bibr">71</xref>).</p></sec>
<sec>
<title>Santamarine</title>
<p>Santamarine is one of the effective components of <italic>Aplotaxis auriculata</italic>. The potential anticancer activity of santamarine was achieved by inhibiting cell proliferation and inducing cell apoptosis. Santamarine inhibited TNF-&#x003B1;-induced translocation of NF-&#x003BA;B to the nucleus by reducing the phosphorylation of I&#x003BA;B-&#x003B1;. In addition, santamarine inhibited STAT3 activation by reducing the phosphorylation of tyrosine 705. Pretreatment with acetylcysteine reversed the effects of santamarine-mediated cell death, NF-&#x003BA;B inhibition and STAT3 activity blockade, suggesting that oxidative stress is involved in santamarine-mediated anticancer activity. The exact molecular mechanism of santamarine-induced apoptosis needs to be further studied to make it a lead drug for the treatment of liver cancer in the future (<xref rid="b72-ijo-67-01-05766" ref-type="bibr">72</xref>).</p></sec>
<sec>
<title>Hemistepsin A</title>
<p><italic>Hemistepta lyrata</italic> is a plant of the Asteraceae family, a wild Korean biennial herb that is traditionally used to treat wounds, fever, bleeding and ulcers. Hemistepsin A, one of the compounds extracted from <italic>Hemistepta lyrata</italic>, is a potential candidate for the prevention of hepatitis, steatosis and fibrosis (<xref rid="b73-ijo-67-01-05766" ref-type="bibr">73</xref>-<xref rid="b76-ijo-67-01-05766" ref-type="bibr">76</xref>). Hemistepsin A slows down the cell cycle progression of HCC cells and induces cell senescence by activating AMP-activated AMPK (<xref rid="b77-ijo-67-01-05766" ref-type="bibr">77</xref>). Hemistepsin A induces apoptosis of HCC cells by downregulating STAT3 and sensitizing them to conventional chemotherapy drugs (<xref rid="b78-ijo-67-01-05766" ref-type="bibr">78</xref>).</p></sec>
<sec>
<title>Xanthatin</title>
<p>Xanthatin is a bicyclic sesquiterpene lactone isolated mainly from Xanthium (<xref rid="b79-ijo-67-01-05766" ref-type="bibr">79</xref>). Studies have shown that xanthatin has significant antitumor activity in a variety of cell lines of colon, breast, lung, cervical and skin cancers (<xref rid="b80-ijo-67-01-05766" ref-type="bibr">80</xref>,<xref rid="b81-ijo-67-01-05766" ref-type="bibr">81</xref>). Xanthatin can trigger an ER stress response in HCC cells and the pro-apoptotic effect is related to ER stress. By increasing activating transcription factor 4 (ATF4) in the nucleus, xanthatin promotes the PERK-eIF2&#x003B1;-ATF4 signaling pathway and its downstream target of C/EBP homology protein-mediated ER stress (<xref rid="b82-ijo-67-01-05766" ref-type="bibr">82</xref>,<xref rid="b83-ijo-67-01-05766" ref-type="bibr">83</xref>).</p></sec>
<sec>
<title>Telekin</title>
<p>Telekin is extracted from the traditional Chinese herb <italic>Carpesium divaricatum</italic>. It was reported to inhibit HepG2 cell viability and induce apoptosis in a dose-dependent manner. In addition, Telekin treatment induced cell cycle arrest at the G2/M phase, with a significant increase in CDC25A and CDC2 phosphorylation and a decrease in cyclin B1 levels. Telekin induces G2/M phase arrest in hepatoma cells by activating the p38 and mitogen-activated protein kinase activated protein kinase 2 (MAPKAPK2) pathways, and has an inhibitory effect on hepatoma cells (<xref rid="b84-ijo-67-01-05766" ref-type="bibr">84</xref>).</p></sec>
<sec>
<title>Artemiprincepsolides A</title>
<p>Artemiprincepsolides A-F were isolated from <italic>Artemisia princeps</italic>, and compounds 1-6 were evaluated for their hepatotoxicity against three hepatoma cell lines. Among them, Artemiprincepsolide A showed significant cytotoxicity against HepG2, Huh7 and SK-Hep-1 cells, which was almost comparable to the positive control sorafenib, inhibited the migration and invasion of HepG2 cells in a dose-dependent manner by downregulating phospho-CDC2 and upregulating cyclin B1 protein levels, and significantly induced G2/M-phase arrest in HepG2 cells. Apoptosis was induced by downregulating the expression of Bc1-2 and upregulating the level of Bax (<xref rid="b85-ijo-67-01-05766" ref-type="bibr">85</xref>).</p></sec>
<sec>
<title>Carpespene A</title>
<p>The main active components of Carpesium mainly include sesquiterpene lactones and monoterpenoids (<xref rid="b86-ijo-67-01-05766" ref-type="bibr">86</xref>,<xref rid="b87-ijo-67-01-05766" ref-type="bibr">87</xref>), among which sesquiterpene lactones show strong cytotoxic activity (<xref rid="b88-ijo-67-01-05766" ref-type="bibr">88</xref>). Its antitumor activity is reflected in its potent cytotoxic effect on a variety of tumor cell lines and induction of apoptosis <italic>in vitro</italic>. Among them, the &#x003B1;- and &#x003B2;-unsaturated lactone ring is the key active center (<xref rid="b89-ijo-67-01-05766" ref-type="bibr">89</xref>). A total of 10 previously undescribed sesquiterpenes, carpespenes A-J (nos. 1-10), and eight known compounds (nos. 11-18), were isolated from the whole strain of <italic>Carpesium faberi</italic>, Guizhou. Carpespene A is an eudesmanolide-type sesquiterpene lactone containing an open five-membered ring of C-2 and C-3. Mechanistically, Carpespene A induced apoptosis in HepG2 cells by triggering excessive ROS accumulation, and ROS-induced cytoprotective autophagy attenuated the cytotoxicity of Carpespene A. Carpespene A also inhibited the anti-phagocytosis and enhanced the cytotoxic effect of ROS on HepG2 cells (<xref rid="b90-ijo-67-01-05766" ref-type="bibr">90</xref>).</p></sec>
<sec>
<title>Dimethylaminomicheliolide</title>
<p>Dimethylaminomicheliolide is a pro-drug of micheliolide, in normal cells show than micheliolide higher stability.</p>
<p>The active center of sesquiterpene alcohols has a structure of 15 carbon atoms. The six most common sesquiterpene alcohols are farnesol, nerolidol, petrolatol, patchoulic alcohol, santalol and eucalyptol.</p></sec>
<sec>
<title>Linalool</title>
<p><italic>Coriandrum sativum</italic> is used as an appetiser for its flavoured leaves and seeds and is also considered a home remedy in herbal and folk medicine. In addition to its ability to reduce fertility, hyperglycemia, hyperlipidemia and oxidative stress, cilanthus has antibacterial, anxiolytic and sedative effects (<xref rid="b91-ijo-67-01-05766" ref-type="bibr">91</xref>,<xref rid="b92-ijo-67-01-05766" ref-type="bibr">92</xref>). Linalool is the main component of coriandrum sativum and one of the chemicals commonly used in the cosmetics and perfume industries. Safety evaluation studies have shown that linalool is not irritating, phototoxic or allergenic, but has low-grade acute toxicity (<xref rid="b93-ijo-67-01-05766" ref-type="bibr">93</xref>). Linalool reduced HepG2 viability by inhibiting mitochondrial complex I and II activity, increasing ROS and reducing ATP and GSH levels (<xref rid="b94-ijo-67-01-05766" ref-type="bibr">94</xref>).</p></sec>
<sec>
<title>Xanthorrhizol</title>
<p>Derived from <italic>Turmeric</italic>, Xanthorrhizol exhibits anti-cancer activity against various types of cancer, liver, lung, breast, cervical and colon cancer, by alleviating angiogenesis and metastasis, activating apoptosis and inducing cell-cycle arrest (<xref rid="b95-ijo-67-01-05766" ref-type="bibr">95</xref>). Xanthorrhizol promoted the proteolytic cleavage of PARP and inhibitor of caspase-activated deoxyribonuclease (ICAD), and concomitantly, the expression of anti-apoptotic Bcl-2 and Bcl-xl was also decreased in HepG2 cells, The above results indicate that xanthorrhizol is an effective anti-liver cancer drug, and its mechanism of action is to induce apoptosis (<xref rid="b96-ijo-67-01-05766" ref-type="bibr">96</xref>).</p></sec>
<sec>
<title>Cis-Nerolidol</title>
<p>Nerolidol, a compound found in numerous plant species, has received considerable attention in various fields of research due to its anti-inflammatory, anti-leishmaniasis and anti-fungal activities (<xref rid="b97-ijo-67-01-05766" ref-type="bibr">97</xref>,<xref rid="b98-ijo-67-01-05766" ref-type="bibr">98</xref>). Nerolidol is a sesquiterpene and exists in the form of two isomers, cis-nerolidol (C-NER) and trans-nerolidol (<xref rid="b99-ijo-67-01-05766" ref-type="bibr">99</xref>). Only C-NER showed medium cell toxic activity (HepG2/C3A); C-NER did not show genotoxic activity but altered MMP, reduced cell proliferation and induced cell death by arresting the cell cycle at G1 phase (<xref rid="b100-ijo-67-01-05766" ref-type="bibr">100</xref>).</p></sec>
<sec>
<title>&#x003B1;-Bisabolol</title>
<p>Chamomile is a commonly used medicinal herb in Europe and has historically been used in cosmetics and health foods (<xref rid="b101-ijo-67-01-05766" ref-type="bibr">101</xref>). Its main components are blue balsamol and &#x003B1;-bisabolol. &#x003B1;-Bisabolol is a low-toxicity sesquiterpene that can be used in the pharmaceutical, food and hygiene industries, particularly for topical applications. Using human hepatoma HepG2 cells as a model, higher concentrations of cleaved caspase-3, -8 and -9 were found in &#x003B1;-bisabolol-treated cells compared with untreated cells. In addition, &#x003B1;-bisabolol reduced mitochondrial cytochrome c levels, increased the cytosolic cytochrome c content and upregulated the downregulation of pro-apoptotic proteins Bax and BH3-interacting domain death agonist and the anti-apoptotic Bak and Bcl-2 proteins. After &#x003B1;-bisabolol treatment, the expression of p53, NF-&#x003BA;B and Fas was increased, suggesting that they play a role in mediating &#x003B1;-bisabolol-induced apoptosis in cancer cells (<xref rid="b102-ijo-67-01-05766" ref-type="bibr">102</xref>).</p></sec>
<sec>
<title>Sesquiterpene ketones</title>
<p>Ketones feature a carbonyl group (C=O) connected to 2 functional groups (R and R'). Sesquiterpene ketones generally contain 15 carbon atoms, and structures with a number between 10 and 15 carbon atoms are also included in this group because of their similar characteristics. Previous studies have shown that sesquiterpenes containing &#x003B1;- and &#x003B2;-unsaturated ketones exhibit significant anti-tumor activities (<xref rid="b103-ijo-67-01-05766" ref-type="bibr">103</xref>).</p></sec>
<sec>
<title>Germacrones</title>
<p>Germacarones are found in plants from different families, such as <italic>Zingeraceae</italic>, <italic>Geraniaceae</italic> and <italic>Ericaceae</italic>. Currently, germacrone is mainly obtained from <italic>Curcuma zedoary</italic>, and it can be used as a quality marker component of <italic>Curcuma zedoary</italic>. Previous studies have shown that germacarone has a significant inhibitory effect on HepG2 and BeL-7402 cells and can induce G2/M-phase arrest of the cell cycle, which is related to the significant reduction of cyclin B1 and cyclin-dependent kinase 1 protein expression and the induction of p21. Dose-related upregulation of Bax and downregulation of Bcl-2/Bcl-xl resulted in an increase in the total number of associated apoptotic cells, as well as upregulation of tumor suppressor gene p53 and increased ROS (<xref rid="b104-ijo-67-01-05766" ref-type="bibr">104</xref>). Germacarone can also reduce the expression of STAT3 and Janus kinase 2 (JAK2), and induce apoptosis of HepG2 cells through the JAK2/STAT3 signaling pathway (<xref rid="b105-ijo-67-01-05766" ref-type="bibr">105</xref>).</p></sec>
<sec>
<title>Atractylon</title>
<p>Atractylon extracted from <italic>Atractylodes Lancea (Thunb.) DC.</italic> and <italic>Atractylodes macrocephala</italic> significantly inhibited proliferation and promoted apoptosis of hepatoblastoma cell lines (<xref rid="b106-ijo-67-01-05766" ref-type="bibr">106</xref>-<xref rid="b108-ijo-67-01-05766" ref-type="bibr">108</xref>). In addition, the results showed that atractylon decreased the MMP, increased ROS levels and inhibited Bcl-2 expression. The activation of Bax and cleaved caspase-3 indicated that atractylon induced apoptosis of HCC cells through the mitochondrial apoptosis pathway. The results also showed that atractylon inhibited the migration and invasion of HCC cells by inhibiting the EMT process and downregulating the expression of matrix metalloproteinases-2 and -9, and also inhibited the growth of HCC cells. Furthermore, it has an inhibitory effect on the EMT process <italic>in vivo</italic> (<xref rid="b109-ijo-67-01-05766" ref-type="bibr">109</xref>). After atractylon treatment, the proliferation ability of hepatoblastoma cells decreased, and the apoptosis rate increased. The invasion and migration abilities of HepG2 cells were significantly decreased. In addition, atractylon was observed to regulate the expression of thymopoietin-antisense RNA 1 and CCDC18 antisense RNA 1 and inhibit the invasion and migration of liver cancer cells <italic>in vitro</italic> (<xref rid="b110-ijo-67-01-05766" ref-type="bibr">110</xref>).</p></sec>
<sec>
<title>Ar-turmerone</title>
<p>Ar-turmerone is one of the active components of <italic>Curcuma longa</italic>, and ar-turmerone induces apoptosis in HepG2 cells through ROS-mediated activation of ERK and c-Jun N-terminal kinase (JNK) and triggering endogenous and exogenous caspase activation, leading to apoptosis (<xref rid="b111-ijo-67-01-05766" ref-type="bibr">111</xref>).</p></sec>
<sec>
<title>Other types of sesquiterpenes</title>
<sec>
<title>Thapsigargin</title>
<p>Guaiane-type sesquiterpenoids are an important class of natural products in nature, and hundreds of guaiane-type sesquiterpenoids have been isolated and identified (<xref rid="b112-ijo-67-01-05766" ref-type="bibr">112</xref>). Guaiane-type sesquiterpenoids belong to the bicyclic sesquiterpenes. The basic mother nucleus is formed by three isoprene units, and generally has a 4,10-dimethyl-7-isopropyl group substitution. Due to the different position of side chains, there are also other types of sesquiterpenes, including pseudoguaiane, patchoulane, carotane, lactarane and daucane (<xref rid="b113-ijo-67-01-05766" ref-type="bibr">113</xref>). Thapsigargin, a guaiacan-type sesquicolide isolated from <italic>Thapsia garganica</italic>, is an irreversible ER calcium ATPase inhibitor (<xref rid="b114-ijo-67-01-05766" ref-type="bibr">114</xref>), which inhibits sarcoplasmic reticulum calcium pumps (SERCA-ATPase) in human HCC cells. Depleting the intracellular Ca<sup>2+</sup> pool induces apoptosis. The X-ray structure of the thapsigargin-SERCA complex provides a basis for understanding the structural conformation of the complex, as well as the surrounding environment of the binding site. It also provides detailed information for the design of targeted prodrugs with thapsigargin as the active ingredient (<xref rid="b115-ijo-67-01-05766" ref-type="bibr">115</xref>). Thapsagargin (G202) has completed phase II clinical trials for the treatment of glioblastoma multiforme and HCC, and is expected to enter the market in the near future (<xref rid="b116-ijo-67-01-05766" ref-type="bibr">116</xref>,<xref rid="b117-ijo-67-01-05766" ref-type="bibr">117</xref>).</p></sec>
<sec>
<title>(2S,7R,10S)-3-hydroxypseudotigerone-11-O-&#x003B2;-D-glucopyranoside</title>
<p>2S,7R,10S)-3-hydroxypseudotigerone-11-O-&#x003B2;-D-glucopyranoside is an eucalanes type sesquiterpene. It's one of the main chemical constituents of <italic>A. lancca</italic> (Thunb.) DC (<xref rid="b118-ijo-67-01-05766" ref-type="bibr">118</xref>-<xref rid="b120-ijo-67-01-05766" ref-type="bibr">120</xref>), which had obvious protective effects on HepG2 cells induced by N-acetyl-p-aminophenol at a concentration of 10 <italic>&#x003BC;</italic>M. The cell survival rate was 34.6%, which is higher than that with bicyclol-positive drugs, indicating that it exhibits a strong hepatoprotective effect (<xref rid="b121-ijo-67-01-05766" ref-type="bibr">121</xref>).</p></sec>
<sec>
<title>Hinesol</title>
<p>Hinesol is a vanilloid type sesquiterpene, which has been extracted from <italic>Atractylis lancea</italic>, <italic>Atractylodes chinensis</italic>, <italic>Atractylodes japonica</italic> and <italic>Atractylodes rhizome</italic> (<xref rid="b106-ijo-67-01-05766" ref-type="bibr">106</xref>,<xref rid="b122-ijo-67-01-05766" ref-type="bibr">122</xref>,<xref rid="b123-ijo-67-01-05766" ref-type="bibr">123</xref>); it was observed to inhibit cell proliferation and induce cell apoptosis by arresting the cell cycle in G1 phase of SMMC-7721 and LM3 cells. The mechanism is related to the inhibition of the phosphorylation of MAPK and ERK, and the downregulation of NF-&#x003BA;B p65 and phosphorylated p65 in the nucleus (<xref rid="b124-ijo-67-01-05766" ref-type="bibr">124</xref>).</p></sec>
<sec>
<title>Curcumenol</title>
<p><italic>Curcuma zedoary</italic>, traditionally due to its wide range of plant components, has been reported to have numerous biological activities and is used for many therapeutic effects (<xref rid="b125-ijo-67-01-05766" ref-type="bibr">125</xref>). Curcumenol, an oxidized guaiacan-type sesquiterpene, has obvious anti-tumor, liver cancer inhibition, liver protection and anti-inflammatory effects (<xref rid="b126-ijo-67-01-05766" ref-type="bibr">126</xref>). Aberrant expression of microRNAs (miRs) in HCC can regulate the occurrence and development of HCC (<xref rid="b127-ijo-67-01-05766" ref-type="bibr">127</xref>-<xref rid="b130-ijo-67-01-05766" ref-type="bibr">130</xref>). Previous studies have shown that curcumenol can inhibit the expression of oncogene miR-2l to exert anti-liver cancer effects (<xref rid="b131-ijo-67-01-05766" ref-type="bibr">131</xref>-<xref rid="b134-ijo-67-01-05766" ref-type="bibr">134</xref>). It can inhibit cell proliferation and lead to a significant increase in the apoptotic ratio by regulating the DJ-1 (Parkinsonism-associated deglycase gene encoding a member of the peptidase C56 family of proteins), phosphatase and tensin homolog and PI3K/AKT signal transduction pathways. The drug effect of curcumenol depends on the action time and dosage (<xref rid="b135-ijo-67-01-05766" ref-type="bibr">135</xref>).</p></sec>
<sec>
<title>Zerumbone</title>
<p>As a representative of humulane sesquiterpenes, zerumbone shows good anti-tumor activity, which is related to the induction of cancer cell apoptosis and anti-proliferative effects (<xref rid="b136-ijo-67-01-05766" ref-type="bibr">136</xref>). It has been shown to inhibit HCC cell proliferation by inducing apoptosis and thus G2/M cell-cycle arrest through inhibition of the PI3K/AKT/mTOR and STAT3 signaling pathways (<xref rid="b137-ijo-67-01-05766" ref-type="bibr">137</xref>), and also by significantly reducing the expression of matrix metalloproteinase-9, VEGF and VEGF receptor proteins in a dose-dependent manner. Inhibition of the proliferation and migration of the HepG2 cell line has been observed (<xref rid="b138-ijo-67-01-05766" ref-type="bibr">138</xref>). Gingerone can significantly increase the apoptosis of HepG2 cells in a certain period of time, and this apoptosis is achieved by regulating the ratio of Bax/Bcl-2 (<xref rid="b139-ijo-67-01-05766" ref-type="bibr">139</xref>-<xref rid="b141-ijo-67-01-05766" ref-type="bibr">141</xref>).</p></sec>
<sec>
<title>Artemeriopodin G7</title>
<p>Artemisia is one of the largest genera in the <italic>Asteraceae</italic> family, usually represented by 500 species of small herbs and shrubs (<xref rid="b142-ijo-67-01-05766" ref-type="bibr">142</xref>,<xref rid="b143-ijo-67-01-05766" ref-type="bibr">143</xref>). It is widely distributed in the Northern temperate zone of Asia, Europe and North America (<xref rid="b144-ijo-67-01-05766" ref-type="bibr">144</xref>). Numerous artemisia species (e.g., <italic>Artemisia annua</italic>, <italic>Artemisia atrovirens</italic>, <italic>Capillary artemisia</italic>, <italic>Artemisia mongolica</italic> and <italic>Artemisia nilagirica</italic>) have been used as traditional medicines to treat a variety of diseases (<xref rid="b145-ijo-67-01-05766" ref-type="bibr">145</xref>), such as malaria, dysmenorrhea, amenorrhea, hepatitis, inflammation, bruising, jaundice, bleeding and cancer (<xref rid="b27-ijo-67-01-05766" ref-type="bibr">27</xref>,<xref rid="b146-ijo-67-01-05766" ref-type="bibr">146</xref>). Artemeriopodin G7, extracted from <italic>Artemisia australis</italic>, can inhibit the migration and invasion of HepG2 cells and induce apoptosis. G2/M cell-cycle arrest was induced by downregulation of CDC2 and p-CDC2 levels. In addition, artemeriopodin G7 targeted platelet-derived growth factor receptor A and affected the AKT/STAT signaling pathway (<xref rid="b147-ijo-67-01-05766" ref-type="bibr">147</xref>).</p></sec>
<sec>
<title>Cryptomeridiol</title>
<p>Cryptomeridiol, a naturally occurring sesquiterpene derivative isolated from traditional Chinese medicine plant <italic>Magnolia officinalis</italic>, was effective against HCC by exacerbating the pre-activated unfolded protein response and activating the silent nerve growth factor-induced gene B NGFI-B. Mechanistically, Nur77 is induced to sense the inositol-requiring enzyme 1 &#x003B1;/apoptosis signal-regulating kinase 1/JNK signal and transduce to mitochondria, resulting in loss of MMPmitochondrial membrane potential. Cryptomeridiol-induced heightened ER stress and mitochondrial dysfunction resulted in increased cytotoxic products of ROS. The <italic>in vivo</italic> anti-HCC activity of cryptomeridiol was superior to that of sorafenib, which is currently used to treat advanced HCC. Identification of Nur77 as a molecular target of cryptomeridiol provides a basis for further development of improved anti-HCC drugs (<xref rid="b148-ijo-67-01-05766" ref-type="bibr">148</xref>).</p></sec>
<sec>
<title>Furanodiene</title>
<p>Furanodiene is a pure compound isolated from <italic>Curcuma zedoary</italic>. Furanodiene inhibits HepG2 cell growth by causing cell-cycle arrest at G2/M and inducing apoptosis. The furanodiene-mediated mitochondrial caspase apoptosis pathway also involves the activation of p38 and the inhibition of ERK and MAPK signaling (<xref rid="b149-ijo-67-01-05766" ref-type="bibr">149</xref>).</p></sec>
<sec>
<title>Hirsutanol A</title>
<p>Hirsutanol A is a novel sesquiterpenoid isolated from the endophyte of <italic>Sarcophyton tortuosum</italic>, a soft coral in the South China sea. The autophagic death of hepatoma carcinoma cells is induced by the activation of ROS (<xref rid="b150-ijo-67-01-05766" ref-type="bibr">150</xref>,<xref rid="b151-ijo-67-01-05766" ref-type="bibr">151</xref>).</p></sec>
<sec>
<title>Elemene</title>
<p>Elemene is also extracted from <italic>Curcuma zedoary</italic> as a non-cytotoxic antitumor agent with few side effects, but may inhibit tumor cell proliferation, induce apoptosis and differentiation, eliminate tumor cells, reverse multidrug resistance and inhibit tumor metastasis, particularly in HCC (<xref rid="b152-ijo-67-01-05766" ref-type="bibr">152</xref>-<xref rid="b154-ijo-67-01-05766" ref-type="bibr">154</xref>). Elemene induced apoptosis, inhibited the cell cycle and reversed GSH S-transferase P1 methylation in QGY7703 cells (<xref rid="b155-ijo-67-01-05766" ref-type="bibr">155</xref>).</p></sec>
<sec>
<title>&#x003B2;-elemene</title>
<p>&#x003B2;-elemene has been shown to have anti-cancer effects on a variety of tumor diseases, including liver cancer, by inhibiting tumor-cell growth or promoting apoptotic cell death. c-Met is a tyrosine kinase receptor, which is widely found to be overexpressed in tumor tissues and involved in cell proliferation, migration, invasion and survival. Downregulation of c-Met expression by &#x003B2;-elemene induced growth inhibition in mouse hepatoma cells (<xref rid="b156-ijo-67-01-05766" ref-type="bibr">156</xref>).</p></sec>
<sec>
<title>Sesquiterpenoids with an unspecified mechanism of action but an anti-liver cancer effect</title>
<p>One new guaiane-type sesquiterpenoid-Acorusin E, has been isolated from the rhizomes of <italic>Acorus tatarinowii</italic>. <italic>In vitro</italic> cytotoxicity was evaluated in liver cancer cells (SMMC-7721 and HepG2 cells) and showed moderate cytotoxicity with IC<sub>50</sub> values of 2.11-7.99 <italic>&#x003BC;</italic>mol (<xref rid="b157-ijo-67-01-05766" ref-type="bibr">157</xref>).</p>
<p>Senecio is an important genus in <italic>Asteraceae</italic>, with &gt;200 species in China (<xref rid="b158-ijo-67-01-05766" ref-type="bibr">158</xref>), most of which are widely used in folk medicine due to their potent biological activity. Senedensiscin G, which was isolated from Senedensiscin, showed a broad spectrum of inhibitory activity against SMMC-7721 cells (<xref rid="b159-ijo-67-01-05766" ref-type="bibr">159</xref>).</p>
<p>The roots of <italic>Scorzonera divaricata</italic> have antipyretic and detoxicant activities and are used in traditional medicine to treat toxic ulcers and malignant gastric tumors (<xref rid="b160-ijo-67-01-05766" ref-type="bibr">160</xref>). Sulfoscorzonin E isolated from the aboveground part of <italic>Scorzonera divaricata</italic> exhibited moderate cytotoxic activity against hepatoma HepG2 cells and possessed strong 2,2&#x02032;-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) and 2,2-diphenyl-1-picrylhydrazyl free radical scavenging abilities (<xref rid="b161-ijo-67-01-05766" ref-type="bibr">161</xref>).</p>
<p>Artemongolins A-K (nos. 1-11), undescribed sesquiterpenoid dimers isolated from <italic>Artemisia mongolica</italic>, comprise a rare 5/7/5/5/10 hexocyclic system; their structures were unambiguously elucidated through comprehensive spectroscopic analyses, encompassing high-resolution electrospray ionization mass spectrometry for precise molecular formula determination, infrared spectroscopy to identify functional groups, one-dimensional nuclear magnetic resonance (proton nuclear magnetic resonance, carbon-13 nuclear magnetic resonance, distortionless enhancement by polarization transfer) and two-dimensional nuclear magnetic resonance (correlation spectroscopy, heteronuclear single quantum coherence, heteronuclear multiple-bond correlation, rotating-frame Overhauser effect spectroscopy) experiments for detailed structural connectivity and stereochemical assignment, and electron capture detector calculations using the time-dependent density functional theory to establish absolute configurations. Evaluation of the anti-HCC activity of three human HCC cell lines showed that Artemongolin E had the highest activity (<xref rid="b162-ijo-67-01-05766" ref-type="bibr">162</xref>).</p>
<p>To date, 14 known compounds (nos. 12-25) and Artemyriantholides A-K (nos. 1-11) have been isolated from <italic>Artemisia lactiflora</italic>. All compounds were chemically characterized as bluish sesquiterpene dimers. The anti-liver cancer assay showed that the 11 compounds had obvious inhibitory effects on HepG2 and Huh7 cells with IC<sub>50</sub> values of 7.9-67.1 <italic>&#x003BC;</italic>M. Artemyriantholides E and H showed good inhibitory activity on HCC. A computational prediction model suggested that the target of Artemyriantholides is mitogen-activated protein kinase kinase 2 (MAP2K2) (<xref rid="b163-ijo-67-01-05766" ref-type="bibr">163</xref>).</p>
<p>At the concentration of 200 <italic>&#x003BC;</italic>g/ml, the inhibitory effect of ethanol extract of artemisia sacrorum on HepG2 cells was 65.5%, and the inhibitory effect on Huh7 cells was 28.1%, the inhibitory effect of ethyl acetate extract on HepG2 cells was 93.5%, and the inhibitory effect on Huh7 cells was 82.0%. Artemisacrolide B was prominent in three HCC cell lines, with IC<sub>50</sub> of 21.9 <italic>&#x003BC;</italic>M (HepG2), 9.0 <italic>&#x003BC;</italic>M (Huh7) and 16.9 <italic>&#x003BC;</italic>M (SK-Hep-1), respectively (<xref rid="b164-ijo-67-01-05766" ref-type="bibr">164</xref>).</p>
<p>Guaiacolide dimers are a unique class of natural products with anticancer activity, but their low content in plants limits in-depth pharmacological studies. Lavandiolide I, a guaiacolide dimer isolated from <italic>Artemisia</italic>, showed potent anti-HCC activity against the HepG2, Huh7 and SK-Hep-1 cell lines. To explore more active oligomers, 33 derivatives of Lavandiolide I were designed, synthesized and evaluated for their inhibitory activity against human hepatoma cells. Of these derivatives, 10 were more active than Lavandolide I and Sorafenib against all three cell lines. Among them, derivatives 25, 27 and 33 have 1.2-5.8 times higher anti-liver cancer activity than Lavandolide I, and have lower toxicity and better safety against human liver cells (THLE-2), with selection indices between 1.3 and 3.4, while Lavandolide I is more toxic to THLE-2 cells (<xref rid="b165-ijo-67-01-05766" ref-type="bibr">165</xref>).</p></sec>
<sec>
<title>Mechanism of action of compounds</title>
<p>The first mechanism is through the regulation of the MAPK pathway, which includes stress-activated protein kinase/JNK, ERK and MAPK14 (p38-MAPK) (<xref rid="b166-ijo-67-01-05766" ref-type="bibr">166</xref>). In HCC tissues, activated ERK in turn induces the expression of multiple genes, activates NF-&#x003BA;B and phosphorylates cellular transcription factor-1, promotes cell transition from G1 phase to S phase (<xref rid="b167-ijo-67-01-05766" ref-type="bibr">167</xref>,<xref rid="b168-ijo-67-01-05766" ref-type="bibr">168</xref>), and thus promotes the proliferation of HCC cells. Activated ERK can also upregulate the expression of genes including hypoxia-inducible factor-1&#x003B1; and VEGF-&#x003B1;, and promote the glycolysis process and angiogenesis of HCC. The use of ERK inhibitors can reduce the expression of ERK, resulting in slow cell proliferation and cell apoptosis (<xref rid="b169-ijo-67-01-05766" ref-type="bibr">169</xref>,<xref rid="b170-ijo-67-01-05766" ref-type="bibr">170</xref>). For instance, the furanodiene-mediated mitochondrial caspase apoptosis pathway also involves the activation of p38 and the inhibition of ERK and MAPK signaling.</p>
<p>The second regulatory pathway is inhibition of the PI3K/AKT/mTOR pathway. PI3K can promote the production of phosphatidylinositol-3,4,5-triphosphate, thereby promoting the phosphorylation of AKT and further activating the serine/threonine protein kinase mTOR, promoting protein synthesis and the growth and invasion of liver cancer cells (<xref rid="b170-ijo-67-01-05766" ref-type="bibr">170</xref>,<xref rid="b172-ijo-67-01-05766" ref-type="bibr">172</xref>). For instance, dimethylaminomicheliolide inactivates the PI3K/AKT pathway, leading to ROS production, thereby regulating dimethylaminomicheliolide-induced apoptosis.</p>
<p>As one of the important transcriptional regulators, the third regulatory pathway NF-&#x003BA;B can exert biological effects by regulating the transcriptional expression of a variety of genes. NF-&#x003BA;B has a key role in inflammatory response and tumor development, and plays an important regulatory role in the progression of liver injury, liver fibrosis and HCC (<xref rid="b173-ijo-67-01-05766" ref-type="bibr">173</xref>). In neutrophil-driven HCC, the NF-&#x003BA;B gene can exert negative regulatory effects on the chemokine network in neutrophils. However, NF-&#x003BA;B gene knockout can promote the occurrence of liver cancer (<xref rid="b174-ijo-67-01-05766" ref-type="bibr">174</xref>). For instance, deoxyelephantopin can reduce the phosphorylation of I&#x003BA;B-&#x003B1; to inhibit the translocation of constitutive and inducible NF-&#x003BA;B to the nucleus, and exert its anti-cancer effect through oxidative stress.</p>
<p>The fourth regulatory pathway is the JAK2/STAT3 pathway. The activation of the JAK2/STAT3 pathway is a common mechanism leading to the occurrence of liver cancer, and upregulation of STAT3 is often found in HCC (<xref rid="b113-ijo-67-01-05766" ref-type="bibr">113</xref>). The expression of STAT3, as a driver, plays a key role in the occurrence, progression, metastasis and immunosuppression of HCC, and is associated with poor prognosis (<xref rid="b175-ijo-67-01-05766" ref-type="bibr">175</xref>). For instance, germacarone can also induce apoptosis of HepG2 cells by reducing the expression of STAT3 and JAK2 signaling pathway components.</p>
<p>The last regulatory pathway is induction of mitochondrial dysfunction, the key role of mitochondria in ROS production and apoptotic signaling in tumor cells. Structural and functional differences between mitochondria in normal cells and cancer cells, result in cancer cells are more susceptible to oxidative stress compared to normal cells (<xref rid="b176-ijo-67-01-05766" ref-type="bibr">176</xref>). For instance, atractylon showed that decreased the MMP, increased ROS levels and inhibited Bcl-2 expression. The activation of Bax and cleaved caspase-3 indicated that atractylon induced apoptosis of HCC cells through the mitochondrial apoptosis pathway.</p>
<p>The &#x003B1;- and &#x003B2;-unsaturated carbonyl and &#x003B1;-methylene lactone groups and the conjugated aldehyde groups in sesquiterpene lactones are considered to be reactive partial structures (<xref rid="b25-ijo-67-01-05766" ref-type="bibr">25</xref>,<xref rid="b177-ijo-67-01-05766" ref-type="bibr">177</xref>). Both its cytotoxic and anti-inflammatory properties are partially mediated by &#x003B1;,&#x003B2;-unsaturated carbonyl functions, such as cyclopentenone and &#x003B1;-methylene &#x003B3;-lactone (<xref rid="b178-ijo-67-01-05766" ref-type="bibr">178</xref>). For instance, when cancer cells were treated with parthenolide, the ROS in tumor cells were increased due to a decrease in the cysteine group of the antioxidant non-protein molecule GSH.</p></sec>
<sec>
<title>Applications of sesquiterpenes</title>
<p>Given the high cancer-related mortality and the severe side effects of radiotherapy and chemotherapy treatments, researchers and scientists have made great efforts to extract new natural products from plants, microorganisms and other organisms to evaluate their anticancer activity and explore their mechanisms of action, as they are considered to have fewer toxic side effects compared to traditional therapies such as chemotherapy. These efforts have led to the development of anticancer drugs and the introduction of natural products into clinical applications. In 1994, elemene oral emulsion and elemene injection were approved by the China Food and Drug Administration. The drug has been on the market and has become a national second-class anticancer drug with Chinese intellectual property rights. It is used to treat various diseases and bone metastasis. It features affinity for and targeting of tumor cells, as well as sustained release, stability and safety (<xref rid="b179-ijo-67-01-05766" ref-type="bibr">179</xref>). Liposomal elemene is a non-cytotoxic antineoplastic agent with a high content of anticancer active ingredients (85% &#x003B2;-elemene) and is also called a 'green therapy' for cancer treatment. In the clinic, elemene liposome can be used alone or in combination with chemoradiotherapy, or before and after surgery (<xref rid="b180-ijo-67-01-05766" ref-type="bibr">180</xref>). After 20 years of clinical research, elemene liposomes can inhibit a variety of cancer cells through multiple targets and can improve immune function. In particular, it has obvious advantages in improving the quality of life of patients, prolonging survival time, resisting metastasis and recurrence, and reversing multi-drug resistance. At present, rimantagliene injection and oral emulsion have entered the 'National Medical Insurance Drug List' and are used in &gt;3,000 hospitals in China, reaching &gt;700,000 cancer patients, including patients in Southeast Asia, Hong Kong, Japan, South Korea, Europe and the United States (<xref rid="b181-ijo-67-01-05766" ref-type="bibr">181</xref>). However, it can cause serious adverse reactions, such as phlebitis after intravenous injection. To date, various new delivery systems, including solid lipid nanoparticles (NPs) (SLN), nanostructured lipid carriers, long-circulating liposomes, active-targeting SLN, drug-loaded liposomes and microemulsions, self-emulsified drug delivery systems and active-targeting microemulsions, have been developed. Already being actively developed, these systems have contributed to numerous advances in elemene (<xref rid="b182-ijo-67-01-05766" ref-type="bibr">182</xref>).</p>
<p>The development of drug resistance and dose-related toxicity of natural products are the main disadvantages of chemotherapeutic drugs in cancer treatment. Therefore, combination therapy has become a feasible way to improve the efficacy and reduce systemic toxicity of natural products. Although artemisinin is the first choice for anti-malarial drugs, its derivatives have shown remarkable efficacy in the treatment of laryngeal cancer, uveal melanoma and pituitary macroadenoma, and are in phase I to II clinical trials for the treatment of lupus nephritis and diseases such as breast cancer, colon cancer and non-small cell lung cancer. In the treatment of HCC, artesunate, a derivative of artemisinin, can be used to sensitize sorafenib and play a synergistic anti-tumor effect. Because artesunate is well tolerated and affordable, the combination of artesunate and sorafenib can benefit most patients with HCC. In addition, this combination therapy could reduce the potential toxicity of sorafenib by reducing its effective dose (<xref rid="b183-ijo-67-01-05766" ref-type="bibr">183</xref>,<xref rid="b184-ijo-67-01-05766" ref-type="bibr">184</xref>).</p>
<p>Numerous synthetic and herbal medicines have poor oral bioavailability due to their low water solubility or inability to cross biofilms, resulting in poor dissolution in biological fluids and poor therapeutic efficacy. A growing number of reports have highlighted the promise of phosphatidyl-based formulations as effective drug delivery systems for natural bioactive ingredients. Lipid NPs loaded with artemisinin provide a promising approach for HCC treatment, harnessing the respective advantages of artemisinin and lipid NP-based delivery systems (<xref rid="b185-ijo-67-01-05766" ref-type="bibr">185</xref>). Encapsulation of artemisinin in lipid NPs significantly reduced its systemic toxicity. By facilitating targeted drug delivery specifically to the tumor site, artemisinin's cytotoxic effects on healthy tissues can be minimized. This targeted approach reduces the common side effects of traditional chemotherapy, such as gastrointestinal discomfort, liver toxicity and bone marrow suppression. In addition, the use of biocompatible and biodegradable lipids in the formulation of NPs further contributes to the reduction of toxicity. Another study aimed to investigate the liver targeting and anti-HCC effects of artesunate (ART)-loaded, glycyrrhetinic acid (GA)-modified polyethylene glycol (PEG)-poly(lactic-acetic acid) (PLGA) (ART/GA-PEG-PLGA) NPs. ART/GA-PEG-PLGA NPs have pro-apoptotic effects on HepG2 cells, which are mainly achieved by inducing high levels of ROS, reducing MMP and inducing cell cycle arrest. Furthermore, ART/GA-PEG-PLGA NPs induced the endogenous apoptotic pathway in HepG2 cells by upregulating the activity of cleaved caspase-3/7 and the levels of cleaved PARP and phosphorylated p38-MAPK. In addition, ART/GA-PEG-PLGA NPs accumulated more in the liver and had a longer mean retention time, resulting in improved bioavailability. Finally, ART/GA-PEG-PLGA NPs facilitated the targeted distribution of ART in the liver, prolonged the retention time of ART and enhanced its anti-tumor effect <italic>in vivo</italic> (<xref rid="b183-ijo-67-01-05766" ref-type="bibr">183</xref>).</p></sec></sec></sec>
<sec sec-type="discussion">
<label>4.</label>
<title>Discussion</title>
<p>So far, a variety of sesquiterpenes have been found in numerous traditional Chinese medicine and plants, such as the <italic>Asteraceae</italic>, <italic>Gentianaceae</italic>, <italic>Zingiberaceae</italic>, <italic>Umbelliferaceae</italic>, <italic>Olivaceae</italic>, <italic>Magnoliaceae</italic> and <italic>Valeriaceae</italic>. Previous studies have shown that sesquiterpenes exhibit potential therapeutic effects on anti-tumor, anti-inflammatory, anti-bacterial and anti-cardiovascular diseases, and more new components and physiological activities need to be explored. In the present article, several types of sesquiterpenes were reviewed, revealing that the biological activity of sesquiterpene alcohols was not as good as that of sesquiterpene ketones and sesquiterpene lactones. In the future, compounds with the structure of sesquiterpene alcohols can be modified to strengthen the structure-activity relationship.</p>
<p>A variety of natural substances can inhibit liver cancer by causing growth arrest in cancer cells, inducing apoptosis and inhibiting metastasis. Its regulatory mechanisms mainly include the MAPK signaling pathway, PI3K/Akt/mTOR signaling pathway, NF-&#x003BA;B signaling pathway, JAK2/STAT3 signaling pathway and mitochondrial pathway. For instance, Hinesol has a certain inhibitory effect on the MAPK and NF-&#x003BA;B signaling pathways, and NF-&#x003BA;B is one of the downstream components of the ERK/MAPK signaling pathway. The activation of MAPK can promote the dual phosphorylation and degradation of I&#x003BA;B-&#x003B1;. The crosstalk between the MAPK signaling pathway and the NF-&#x003BA;B pathway plays a crucial role in regulating cell fate. For instance, JNK and p38-MAPK in the MAPK family can activate NF-&#x003BA;B under certain conditions, thereby cooperating to regulate cell survival and death; on the other hand, NF-&#x003BA;B can also affect MAPK activity through a feedback mechanism. The complexity of this interaction allows the two signaling pathways to have different effects on apoptosis under different physiological and pathological conditions. For instance, in the mechanistic pathway of artesunate, AKT can indirectly affect STAT3 activity by phosphorylating a variety of signaling molecules. AKT can phosphorylate and inhibit glycogen synthase kinase 3 (GSK-3), and inhibition of GSK-3 may lead to phosphorylation and activation of STAT3 (<xref rid="b187-ijo-67-01-05766" ref-type="bibr">187</xref>). mTORC1 can affect STAT3 expression and activity by regulating protein synthesis. mTORC1 activation can promote the synthesis of ribosomal proteins and translation initiation factors, which may increase STAT3 expression and phosphorylation. The PI3K/AKT/mTOR signaling pathway is regulated by multiple negative feedback signals that may also affect STAT3 phosphorylation and activity. By inhibiting the proliferation, invasion and differentiation of liver cancer cells and delaying the expression of related factors, it interferes with multiple signal transduction, so as to achieve the purpose of treating liver cancer.</p>
<p>The fatal issues of sorafenib and cisplatin are their drug resistance and severe toxicity, and natural products are considered as a safe and effective alternative for cancer treatment (<xref rid="b188-ijo-67-01-05766" ref-type="bibr">188</xref>), so the chemopreventive concept of plant-derived natural products is becoming increasingly important. The use of natural product monomers from inception to late combination and encapsulation in lipid nanoparticles minimizes toxic effects by facilitating specific, targeted delivery to the tumor site.</p></sec>
<sec sec-type="conclusions">
<label>5.</label>
<title>Conclusion</title>
<p>To date, numerous studies on sesquiterpenes from the same source have been published, but there is a lack of certain studies on the different effects of sesquiterpenes from different sources. The different or identical efficacy of compounds from various sources can be investigated in the future. Furthermore, numerous studies on the activity of sesquiterpenes are only limited to <italic>in vitro</italic> tests and animal studies, and further studies are needed to evaluate the <italic>in vivo</italic> efficacy, mechanism of action, structure-activity relationship and clinical application of these compounds, so as to provide a reasonable and reliable scientific basis for the development of a new generation of safe and effective natural small molecular compounds and promote their clinical application.</p></sec></body>
<back>
<sec sec-type="data-availability">
<title>Availability of data and materials</title>
<p>Not applicable.</p></sec>
<sec sec-type="other">
<title>Authors' contributions</title>
<p>YL and JM conceived and designed the study. YL, JM and XD carried out the analysis and wrote the manuscript. All authors have read and agreed to the final version of the manuscript. Data authentication is not applicable.</p></sec>
<sec sec-type="other">
<title>Ethics approval and consent to participate</title>
<p>Not applicable.</p></sec>
<sec sec-type="other">
<title>Patient consent for publication</title>
<p>Not applicable.</p></sec>
<sec sec-type="COI-statement">
<title>Competing interests</title>
<p>The authors declare that they have no competing interests.</p></sec>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p></ack>
<ref-list>
<title>References</title>
<ref id="b1-ijo-67-01-05766"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bray</surname><given-names>F</given-names></name><name><surname>Laversanne</surname><given-names>M</given-names></name><name><surname>Sung</surname><given-names>H</given-names></name><name><surname>Ferlay</surname><given-names>J</given-names></name><name><surname>Siegel</surname><given-names>RL</given-names></name><name><surname>Soerjomataram</surname><given-names>I</given-names></name><name><surname>Jemal</surname><given-names>A</given-names></name></person-group><article-title>Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries</article-title><source>CA Cancer J Clin</source><volume>74</volume><fpage>229</fpage><lpage>263</lpage><year>2024</year><pub-id pub-id-type="doi">10.3322/caac.21834</pub-id><pub-id pub-id-type="pmid">38572751</pub-id></element-citation></ref>
<ref id="b2-ijo-67-01-05766"><label>2</label><element-citation publication-type="journal"><article-title>Hepatocellular carcinoma</article-title><source>Nat Rev Dis Primers</source><volume>7</volume><fpage>7</fpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41572-021-00245-6</pub-id><pub-id pub-id-type="pmid">33479233</pub-id></element-citation></ref>
<ref id="b3-ijo-67-01-05766"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Zhu</surname><given-names>AX</given-names></name><name><surname>Bernards</surname><given-names>R</given-names></name><name><surname>Qin</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name></person-group><article-title>Evolving therapeutic landscape of advanced hepatocellular carcinoma</article-title><source>Nat Rev Gastroenterol Hepatol</source><volume>20</volume><fpage>203</fpage><lpage>222</lpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41575-022-00704-9</pub-id></element-citation></ref>
<ref id="b4-ijo-67-01-05766"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>S</given-names></name></person-group><article-title>Cancer chemoprevention and chemotherapy: Dietary polyphenols and signalling pathways</article-title><source>Mol Nutr Food Res</source><volume>52</volume><fpage>507</fpage><lpage>526</lpage><year>2008</year><pub-id pub-id-type="doi">10.1002/mnfr.200700326</pub-id><pub-id pub-id-type="pmid">18435439</pub-id></element-citation></ref>
<ref id="b5-ijo-67-01-05766"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garc&#x000ED;a Rodr&#x000ED;guez</surname><given-names>LA</given-names></name><name><surname>Mart&#x000ED;n-P&#x000E9;rez</surname><given-names>M</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Rothwell</surname><given-names>PM</given-names></name><name><surname>Lanas</surname><given-names>A</given-names></name></person-group><article-title>Bleeding risk with long-term Low-dose aspirin: A systematic review of observational studies</article-title><source>PLoS One</source><volume>11</volume><fpage>e0160046</fpage><year>2016</year><pub-id pub-id-type="doi">10.1371/journal.pone.0160046</pub-id><pub-id pub-id-type="pmid">27490468</pub-id><pub-id pub-id-type="pmcid">4973997</pub-id></element-citation></ref>
<ref id="b6-ijo-67-01-05766"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Laidlaw</surname><given-names>TM</given-names></name><name><surname>Cahill</surname><given-names>KN</given-names></name></person-group><article-title>Current knowledge and management of hypersensitivity to aspirin and NSAIDs</article-title><source>J Allergy Clin Immunol Pract</source><volume>5</volume><fpage>537</fpage><lpage>545</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.jaip.2016.10.021</pub-id><pub-id pub-id-type="pmid">28483309</pub-id></element-citation></ref>
<ref id="b7-ijo-67-01-05766"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ren</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name></person-group><article-title>Analysis of adverse reactions of aspirin in prophylaxis medication based on FAERS database</article-title><source>Computational Mathematical Methods Med</source><volume>2022</volume><fpage>7882277</fpage><year>2022</year><pub-id pub-id-type="doi">10.1155/2022/7882277</pub-id></element-citation></ref>
<ref id="b8-ijo-67-01-05766"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anwanwan</surname><given-names>D</given-names></name><name><surname>Singh</surname><given-names>SK</given-names></name><name><surname>Singh</surname><given-names>S</given-names></name><name><surname>Saikam</surname><given-names>V</given-names></name><name><surname>Singh</surname><given-names>R</given-names></name></person-group><article-title>Challenges in liver cancer and possible treatment approaches</article-title><source>Biochim Biophys Acta Rev Cancer</source><volume>1873</volume><fpage>188314</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.bbcan.2019.188314</pub-id><pub-id pub-id-type="pmcid">6981221</pub-id></element-citation></ref>
<ref id="b9-ijo-67-01-05766"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sayiner</surname><given-names>M</given-names></name><name><surname>Golabi</surname><given-names>P</given-names></name><name><surname>Younossi</surname><given-names>ZM</given-names></name></person-group><article-title>Disease burden of hepatocellular carcinoma: A global perspective</article-title><source>Dig Dis Sci</source><volume>64</volume><fpage>910</fpage><lpage>917</lpage><year>2019</year><pub-id pub-id-type="doi">10.1007/s10620-019-05537-2</pub-id><pub-id pub-id-type="pmid">30835028</pub-id></element-citation></ref>
<ref id="b10-ijo-67-01-05766"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chopra</surname><given-names>B</given-names></name><name><surname>Dhingra</surname><given-names>AK</given-names></name></person-group><article-title>Natural products: A lead for drug discovery and development</article-title><source>Phytother Res</source><volume>35</volume><fpage>4660</fpage><lpage>4702</lpage><year>2021</year><pub-id pub-id-type="doi">10.1002/ptr.7099</pub-id><pub-id pub-id-type="pmid">33847440</pub-id></element-citation></ref>
<ref id="b11-ijo-67-01-05766"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>C</given-names></name><name><surname>Zhuo</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Zhao</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Liao</surname><given-names>C</given-names></name><name><surname>Quan</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>Z</given-names></name><name><surname>Bode</surname><given-names>AM</given-names></name><name><surname>Cao</surname><given-names>Y</given-names></name><name><surname>Luo</surname><given-names>X</given-names></name></person-group><article-title>Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer</article-title><source>Int J Biol Sci</source><volume>15</volume><fpage>1654</fpage><lpage>1663</lpage><year>2019</year><pub-id pub-id-type="doi">10.7150/ijbs.33837</pub-id><pub-id pub-id-type="pmid">31360108</pub-id><pub-id pub-id-type="pmcid">6643217</pub-id></element-citation></ref>
<ref id="b12-ijo-67-01-05766"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>DJ</given-names></name><name><surname>Cragg</surname><given-names>GM</given-names></name></person-group><article-title>Natural products as sources of new drugs over the nearly four decades from 01/1981 to 09/2019</article-title><source>J Nat Prod</source><volume>83</volume><fpage>770</fpage><lpage>803</lpage><year>2020</year><pub-id pub-id-type="doi">10.1021/acs.jnatprod.9b01285</pub-id><pub-id pub-id-type="pmid">32162523</pub-id></element-citation></ref>
<ref id="b13-ijo-67-01-05766"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>M</given-names></name><name><surname>Lu</surname><given-names>JJ</given-names></name><name><surname>Huang</surname><given-names>MQ</given-names></name><name><surname>Bao</surname><given-names>JL</given-names></name><name><surname>Chen</surname><given-names>XP</given-names></name><name><surname>Wang</surname><given-names>YT</given-names></name></person-group><article-title>Terpenoids: Natural products for cancer therapy</article-title><source>Expert Opin Investig Drugs</source><volume>21</volume><fpage>1801</fpage><lpage>1818</lpage><year>2012</year><pub-id pub-id-type="doi">10.1517/13543784.2012.727395</pub-id><pub-id pub-id-type="pmid">23092199</pub-id></element-citation></ref>
<ref id="b14-ijo-67-01-05766"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Atanasov</surname><given-names>AG</given-names></name><name><surname>Zotchev</surname><given-names>SB</given-names></name><name><surname>Dirsch</surname><given-names>VM</given-names></name><collab>International Natural Product Sciences Taskforce</collab><name><surname>Supuran</surname><given-names>CT</given-names></name></person-group><article-title>Natural products in drug discovery: Advances and opportunities</article-title><source>Nat Rev Drug Discov</source><volume>20</volume><fpage>200</fpage><lpage>216</lpage><year>2021</year><pub-id pub-id-type="doi">10.1038/s41573-020-00114-z</pub-id><pub-id pub-id-type="pmid">33510482</pub-id><pub-id pub-id-type="pmcid">7841765</pub-id></element-citation></ref>
<ref id="b15-ijo-67-01-05766"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Langhasova</surname><given-names>L</given-names></name><name><surname>Hanusova</surname><given-names>V</given-names></name><name><surname>Rezek</surname><given-names>J</given-names></name><name><surname>Stohanslova</surname><given-names>B</given-names></name><name><surname>Ambroz</surname><given-names>M</given-names></name><name><surname>Kralova</surname><given-names>V</given-names></name><name><surname>Vanek</surname><given-names>T</given-names></name><name><surname>Lou</surname><given-names>JD</given-names></name><name><surname>Yun</surname><given-names>ZL</given-names></name><name><surname>Yang</surname><given-names>J</given-names></name><name><surname>Skalova</surname><given-names>L</given-names></name></person-group><article-title>Essential oil from Myrica rubra leaves inhibits cancer cell proliferation and induces apoptosis in several human intestinal lines</article-title><source>Industrial Crops Products</source><volume>59</volume><fpage>20</fpage><lpage>26</lpage><year>2014</year><pub-id pub-id-type="doi">10.1016/j.indcrop.2014.04.018</pub-id></element-citation></ref>
<ref id="b16-ijo-67-01-05766"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Bai</surname><given-names>Z</given-names></name><name><surname>Chi</surname><given-names>BX</given-names></name><name><surname>Wei</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name></person-group><article-title>Curcumol induces cell cycle arrest in colon cancer cells via reactive oxygen species and Akt/GSK3&#x003B2;/cyclin D1 pathway</article-title><source>J Ethnopharmacol</source><volume>210</volume><fpage>1</fpage><lpage>9</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.jep.2017.06.037</pub-id></element-citation></ref>
<ref id="b17-ijo-67-01-05766"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barcellos Marini</surname><given-names>M</given-names></name><name><surname>Rodrigues de Freitas</surname><given-names>W</given-names></name><name><surname>Lacerda da Silva Machado</surname><given-names>F</given-names></name><name><surname>Correa Ramos Leal</surname><given-names>I</given-names></name><name><surname>Ribeiro Soares</surname><given-names>A</given-names></name><name><surname>Masahiko Kanashiro</surname><given-names>M</given-names></name><name><surname>Fraz&#x000E3;o Muzitano</surname><given-names>M</given-names></name></person-group><article-title>Cytotoxic activity of halogenated sesquiterpenes from Laurencia dendroidea</article-title><source>Phytother Res</source><volume>32</volume><fpage>1119</fpage><lpage>1125</lpage><year>2018</year><pub-id pub-id-type="doi">10.1002/ptr.6052</pub-id><pub-id pub-id-type="pmid">29480520</pub-id></element-citation></ref>
<ref id="b18-ijo-67-01-05766"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname><given-names>SJ</given-names></name><name><surname>Ryoo</surname><given-names>IJ</given-names></name><name><surname>Kim</surname><given-names>KC</given-names></name><name><surname>Na</surname><given-names>M</given-names></name><name><surname>Jang</surname><given-names>JH</given-names></name><name><surname>Ahn</surname><given-names>JS</given-names></name><name><surname>Yoo</surname><given-names>ID</given-names></name></person-group><article-title>Hypo-pigmenting effect of sesquiterpenes from Inula britannica in B16 melanoma cells</article-title><source>Arch Pharm Res</source><volume>37</volume><fpage>567</fpage><lpage>574</lpage><year>2014</year><pub-id pub-id-type="doi">10.1007/s12272-013-0302-4</pub-id></element-citation></ref>
<ref id="b19-ijo-67-01-05766"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Song</surname><given-names>J</given-names></name></person-group><article-title>Parthenolide suppresses pancreatic cell growth by autophagy-mediated apoptosis</article-title><source>Onco Targets Ther</source><volume>10</volume><fpage>453</fpage><lpage>461</lpage><year>2017</year><pub-id pub-id-type="doi">10.2147/OTT.S117250</pub-id><pub-id pub-id-type="pmid">28176967</pub-id><pub-id pub-id-type="pmcid">5271392</pub-id></element-citation></ref>
<ref id="b20-ijo-67-01-05766"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Wu</surname><given-names>Z</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>B</given-names></name><name><surname>Zuo</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Wang</surname><given-names>SL</given-names></name></person-group><article-title>Artesunate suppresses the growth of prostatic cancer cells through inhibiting androgen receptor</article-title><source>Biol Pharm Bull</source><volume>40</volume><fpage>479</fpage><lpage>485</lpage><year>2017</year><pub-id pub-id-type="doi">10.1248/bpb.b16-00908</pub-id><pub-id pub-id-type="pmid">28381803</pub-id></element-citation></ref>
<ref id="b21-ijo-67-01-05766"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitsui</surname><given-names>T</given-names></name><name><surname>Hayashi</surname><given-names>K</given-names></name><name><surname>Kawai</surname><given-names>M</given-names></name><name><surname>Kido</surname><given-names>M</given-names></name><name><surname>Tani</surname><given-names>H</given-names></name><name><surname>Takaoka</surname><given-names>D</given-names></name><name><surname>Matsuura</surname><given-names>N</given-names></name><name><surname>Nozaki</surname><given-names>H</given-names></name></person-group><article-title>Culcitiolides E-J, six new eremophilane-type sesquiterpene derivatives from Senecio culcitioides</article-title><source>Chem Pharm Bull (Tokyo)</source><volume>61</volume><fpage>816</fpage><lpage>822</lpage><year>2013</year><pub-id pub-id-type="doi">10.1248/cpb.c13-00243</pub-id><pub-id pub-id-type="pmid">23902864</pub-id></element-citation></ref>
<ref id="b22-ijo-67-01-05766"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ko</surname><given-names>W</given-names></name><name><surname>Park</surname><given-names>JS</given-names></name><name><surname>Kim</surname><given-names>KW</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><name><surname>Kim</surname><given-names>YC</given-names></name><name><surname>Oh</surname><given-names>H</given-names></name></person-group><article-title>Nardosinone-type sesquiterpenes from the hexane fraction of Nardostachys jatamansi attenuate NF-&#x003BA;B and MAPK signaling pathways in lipopolysaccharide-stimulated BV2 microglial cells</article-title><source>Inflammation</source><volume>41</volume><fpage>1215</fpage><lpage>1228</lpage><year>2018</year><pub-id pub-id-type="doi">10.1007/s10753-018-0768-9</pub-id><pub-id pub-id-type="pmid">29616391</pub-id></element-citation></ref>
<ref id="b23-ijo-67-01-05766"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheikh</surname><given-names>IA</given-names></name><name><surname>El-Baba</surname><given-names>C</given-names></name><name><surname>Youssef</surname><given-names>A</given-names></name><name><surname>Saliba</surname><given-names>NA</given-names></name><name><surname>Ghantous</surname><given-names>A</given-names></name><name><surname>Darwiche</surname><given-names>N</given-names></name></person-group><article-title>Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention</article-title><source>Expert Opin Drug Discov</source><volume>17</volume><fpage>1377</fpage><lpage>1405</lpage><year>2022</year><pub-id pub-id-type="doi">10.1080/17460441.2023.2147920</pub-id><pub-id pub-id-type="pmid">36373806</pub-id></element-citation></ref>
<ref id="b24-ijo-67-01-05766"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matos</surname><given-names>MS</given-names></name><name><surname>Anast&#x000E1;cio</surname><given-names>JD</given-names></name><name><surname>Nunes dos Santos</surname><given-names>C</given-names></name></person-group><article-title>Sesquiterpene lactones: Promising natural compounds to fight inflammation</article-title><source>Pharmaceutics</source><volume>13</volume><fpage>991</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/pharmaceutics13070991</pub-id><pub-id pub-id-type="pmid">34208907</pub-id><pub-id pub-id-type="pmcid">8309091</pub-id></element-citation></ref>
<ref id="b25-ijo-67-01-05766"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Merfort</surname><given-names>I</given-names></name></person-group><article-title>Perspectives on sesquiterpene lactones in inflammation and cancer</article-title><source>Curr Drug Targets</source><volume>12</volume><fpage>1560</fpage><lpage>1573</lpage><year>2011</year><pub-id pub-id-type="doi">10.2174/138945011798109437</pub-id><pub-id pub-id-type="pmid">21561425</pub-id></element-citation></ref>
<ref id="b26-ijo-67-01-05766"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hohmann</surname><given-names>MSN</given-names></name><name><surname>Longhi-Balbinot</surname><given-names>DT</given-names></name><name><surname>Guazelli</surname><given-names>CFS</given-names></name><name><surname>Navarro</surname><given-names>SA</given-names></name><name><surname>Zarpelon</surname><given-names>AC</given-names></name><name><surname>Casagrande</surname><given-names>R</given-names></name><name><surname>Arakawa</surname><given-names>NS</given-names></name><name><surname>Verri</surname><given-names>WA</given-names><suffix>Jr</suffix></name></person-group><article-title>Chapter 7-Sesquiterpene lactones: Structural diversity and perspectives as anti-inflammatory molecules</article-title><source>Studies Natu Products Chemistry</source><volume>49</volume><fpage>243</fpage><lpage>264</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/B978-0-444-63601-0.00007-7</pub-id></element-citation></ref>
<ref id="b27-ijo-67-01-05766"><label>27</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ivanescu</surname><given-names>B</given-names></name><name><surname>Miron</surname><given-names>A</given-names></name><name><surname>Corciova</surname><given-names>A</given-names></name></person-group><article-title>Sesquiterpene lactones from Artemisia Genus: Biological activities and methods of analysis</article-title><source>J Anal Methods Chem</source><volume>2015</volume><fpage>247685</fpage><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/247685</pub-id><pub-id pub-id-type="pmid">26495156</pub-id><pub-id pub-id-type="pmcid">4606394</pub-id></element-citation></ref>
<ref id="b28-ijo-67-01-05766"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ooko</surname><given-names>E</given-names></name><name><surname>Saeed</surname><given-names>MEM</given-names></name><name><surname>Kadioglu</surname><given-names>O</given-names></name><name><surname>Sarvi</surname><given-names>S</given-names></name><name><surname>Colak</surname><given-names>M</given-names></name><name><surname>Elmasaoudi</surname><given-names>K</given-names></name><name><surname>Janah</surname><given-names>R</given-names></name><name><surname>Greten</surname><given-names>HJ</given-names></name><name><surname>Efferth</surname><given-names>T</given-names></name></person-group><article-title>Artemisinin derivatives induce iron-dependent cell death (ferroptosis) in tumor cells</article-title><source>Phytomedicine</source><volume>22</volume><fpage>1045</fpage><lpage>1054</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.phymed.2015.08.002</pub-id><pub-id pub-id-type="pmid">26407947</pub-id></element-citation></ref>
<ref id="b29-ijo-67-01-05766"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efferth</surname><given-names>T</given-names></name></person-group><article-title>Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells</article-title><source>Curr Drug Targets</source><volume>7</volume><fpage>407</fpage><lpage>421</lpage><year>2006</year><pub-id pub-id-type="doi">10.2174/138945006776359412</pub-id><pub-id pub-id-type="pmid">16611029</pub-id></element-citation></ref>
<ref id="b30-ijo-67-01-05766"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jia</surname><given-names>J</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Guo</surname><given-names>C</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Yue</surname><given-names>X</given-names></name><name><surname>Qian</surname><given-names>J</given-names></name></person-group><article-title>Artemisinin inhibits gallbladder cancer cell lines through triggering cell cycle arrest and apoptosis</article-title><source>Mol Med Report</source><volume>13</volume><fpage>4461</fpage><lpage>4468</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/mmr.2016.5073</pub-id></element-citation></ref>
<ref id="b31-ijo-67-01-05766"><label>31</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>De Sanctis</surname><given-names>F</given-names></name><name><surname>Zhu</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>G</given-names></name><name><surname>Cheng</surname><given-names>J</given-names></name><name><surname>Cao</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>J</given-names></name><etal/></person-group><article-title>Targeting inhibition of accumulation and function of Myeloid-derived suppressor cells by artemisinin via PI3K/AKT, mTOR, and MAPK pathways enhances Anti-PD-L1 immunotherapy in melanoma and liver tumors</article-title><source>J Immunol Res</source><volume>2022</volume><fpage>2253436</fpage><year>2022</year><pub-id pub-id-type="pmid">35785030</pub-id><pub-id pub-id-type="pmcid">9247850</pub-id></element-citation></ref>
<ref id="b32-ijo-67-01-05766"><label>32</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tyagi</surname><given-names>N</given-names></name><name><surname>Sharma</surname><given-names>GN</given-names></name><name><surname>Shrivastava</surname><given-names>B</given-names></name><name><surname>Saxena</surname><given-names>P</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name></person-group><article-title>Medicinal plants: Used in Anti-cancer treatment</article-title><source>Int J Res Dev Pharmacy Life Sci</source><volume>6</volume><fpage>2732</fpage><lpage>2739</lpage><year>2017</year></element-citation></ref>
<ref id="b33-ijo-67-01-05766"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>GN</given-names></name><name><surname>Bao</surname><given-names>NR</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Xi</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>TH</given-names></name><name><surname>Chen</surname><given-names>FS</given-names></name></person-group><article-title>Ketamine induces ferroptosis of liver cancer cells by targeting lncRNA PVT1/miR-214-3p/GPX4</article-title><source>Drug Des Devel Ther</source><volume>15</volume><fpage>3965</fpage><lpage>3978</lpage><year>2021</year><pub-id pub-id-type="doi">10.2147/DDDT.S332847</pub-id><pub-id pub-id-type="pmid">34566408</pub-id><pub-id pub-id-type="pmcid">8458041</pub-id></element-citation></ref>
<ref id="b34-ijo-67-01-05766"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>AbouAitah</surname><given-names>K</given-names></name><name><surname>Lojkowski</surname><given-names>W</given-names></name></person-group><article-title>Delivery of natural agents by means of mesoporous silica nanospheres as a promising anticancer strategy</article-title><source>Pharmaceutics</source><volume>13</volume><fpage>143</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/pharmaceutics13020143</pub-id><pub-id pub-id-type="pmid">33499150</pub-id><pub-id pub-id-type="pmcid">7912645</pub-id></element-citation></ref>
<ref id="b35-ijo-67-01-05766"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weifeng</surname><given-names>T</given-names></name><name><surname>Feng</surname><given-names>S</given-names></name><name><surname>Xiangji</surname><given-names>L</given-names></name><name><surname>Changqing</surname><given-names>S</given-names></name><name><surname>Zhiquan</surname><given-names>Q</given-names></name><name><surname>Huazhong</surname><given-names>Z</given-names></name><name><surname>Peining</surname><given-names>Y</given-names></name><name><surname>Yong</surname><given-names>Y</given-names></name><name><surname>Mengchao</surname><given-names>W</given-names></name><name><surname>Xiaoqing</surname><given-names>J</given-names></name><name><surname>Wan-Yee</surname><given-names>L</given-names></name></person-group><article-title>Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells</article-title><source>Phytomedicine</source><volume>18</volume><fpage>158</fpage><lpage>162</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.phymed.2010.07.003</pub-id></element-citation></ref>
<ref id="b36-ijo-67-01-05766"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>CZ</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Yun</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>GG</given-names></name><name><surname>Lai</surname><given-names>PB</given-names></name></person-group><article-title>Dihydroartemisinin exhibits antitumor activity toward hepatocellular carcinoma in vitro and in vivo</article-title><source>Biochem Pharmacol</source><volume>83</volume><fpage>1278</fpage><lpage>1289</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bcp.2012.02.002</pub-id><pub-id pub-id-type="pmid">22342732</pub-id></element-citation></ref>
<ref id="b37-ijo-67-01-05766"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vandewynckel</surname><given-names>YP</given-names></name><name><surname>Laukens</surname><given-names>D</given-names></name><name><surname>Geerts</surname><given-names>A</given-names></name><name><surname>Vanhove</surname><given-names>C</given-names></name><name><surname>Descamps</surname><given-names>B</given-names></name><name><surname>Colle</surname><given-names>I</given-names></name><name><surname>Devisscher</surname><given-names>L</given-names></name><name><surname>Bogaerts</surname><given-names>E</given-names></name><name><surname>Paridaens</surname><given-names>A</given-names></name><name><surname>Verhelst</surname><given-names>X</given-names></name><etal/></person-group><article-title>Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent</article-title><source>Eur J Gastroenterol Hepatol</source><volume>26</volume><fpage>861</fpage><lpage>870</lpage><year>2014</year><pub-id pub-id-type="doi">10.1097/MEG.0000000000000066</pub-id><pub-id pub-id-type="pmid">24987823</pub-id></element-citation></ref>
<ref id="b38-ijo-67-01-05766"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ilamathi</surname><given-names>M</given-names></name><name><surname>Santhosh</surname><given-names>S</given-names></name><name><surname>Sivaramakrishnan</surname><given-names>V</given-names></name></person-group><article-title>Artesunate as an anti-cancer agent targets stat-3 and favorably suppresses hepatocellular carcinoma</article-title><source>Curr Top Med Chem</source><volume>16</volume><fpage>2453</fpage><lpage>2463</lpage><year>2016</year><pub-id pub-id-type="doi">10.2174/1568026616666160212122820</pub-id><pub-id pub-id-type="pmid">26873192</pub-id></element-citation></ref>
<ref id="b39-ijo-67-01-05766"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Xing</surname><given-names>Y</given-names></name><name><surname>Min</surname><given-names>M</given-names></name><name><surname>Runpeng</surname><given-names>Z</given-names></name><name><surname>Jun</surname><given-names>X</given-names></name><name><surname>Dong</surname><given-names>H</given-names></name></person-group><article-title>Artesunate promotes sensitivity to sorafenib in hepatocellular carcinoma</article-title><source>Biochem Biophysical Res Commun</source><volume>519</volume><fpage>41</fpage><lpage>45</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2019.08.115</pub-id></element-citation></ref>
<ref id="b40-ijo-67-01-05766"><label>40</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Li</surname><given-names>FJ</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Geng</surname><given-names>CN</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Guaiane-type sesquiterpenoid dimers from Artemisia zhongdianensis and antihepatoma carcinoma activity via the p38MAPK pathway</article-title><source>Chin J Chemistry</source><volume>41</volume><fpage>2453</fpage><lpage>2468</lpage><year>2023</year><pub-id pub-id-type="doi">10.1002/cjoc.202300166</pub-id></element-citation></ref>
<ref id="b41-ijo-67-01-05766"><label>41</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>Z</given-names></name><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Huang</surname><given-names>XY</given-names></name><name><surname>Geng</surname><given-names>CA</given-names></name><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Artemidubolides A-T, cytotoxic unreported guaiane-type sesquiterpenoid dimers against three hepatoma cell lines from Artemisia dubia</article-title><source>Phytochemistry</source><volume>202</volume><fpage>113299</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2022.113299</pub-id><pub-id pub-id-type="pmid">35809862</pub-id></element-citation></ref>
<ref id="b42-ijo-67-01-05766"><label>42</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Ke</surname><given-names>CQ</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>L</given-names></name><name><surname>Ye</surname><given-names>Y</given-names></name></person-group><article-title>Sesquiterpene lactone dimers from Artemisia lavandulifolia inhibit interleukin-1&#x003B2; production in macrophages through activating autophagy</article-title><source>Bioorg Chem</source><volume>105</volume><fpage>104451</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.bioorg.2020.104451</pub-id></element-citation></ref>
<ref id="b43-ijo-67-01-05766"><label>43</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Geng</surname><given-names>C</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Tang</surname><given-names>S</given-names></name><name><surname>Shen</surname><given-names>C</given-names></name><name><surname>Gao</surname><given-names>Z</given-names></name><etal/></person-group><article-title>New guaiane-type sesquiterpenoid dimers from Artemisia atrovirens and their antihepatoma activity</article-title><source>Acta Pharm Sin B</source><volume>11</volume><fpage>1648</fpage><lpage>1666</lpage><year>2021</year><pub-id pub-id-type="doi">10.1016/j.apsb.2020.12.006</pub-id><pub-id pub-id-type="pmid">34221874</pub-id><pub-id pub-id-type="pmcid">8245908</pub-id></element-citation></ref>
<ref id="b44-ijo-67-01-05766"><label>44</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rasul</surname><given-names>A</given-names></name><name><surname>Di</surname><given-names>J</given-names></name><name><surname>Millimouno</surname><given-names>FM</given-names></name><name><surname>Malhi</surname><given-names>M</given-names></name><name><surname>Tsuji</surname><given-names>I</given-names></name><name><surname>Ali</surname><given-names>M</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Reactive oxygen species mediate isoalantolactone-induced apoptosis in human prostate cancer cells</article-title><source>Molecules</source><volume>18</volume><fpage>9382</fpage><lpage>9396</lpage><year>2013</year><pub-id pub-id-type="doi">10.3390/molecules18089382</pub-id><pub-id pub-id-type="pmid">23921797</pub-id><pub-id pub-id-type="pmcid">6270412</pub-id></element-citation></ref>
<ref id="b45-ijo-67-01-05766"><label>45</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>ZC</given-names></name><name><surname>Hui</surname><given-names>XG</given-names></name><name><surname>Huo</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>DX</given-names></name><name><surname>Peng</surname><given-names>W</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>XB</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>WH</given-names></name><name><surname>Liang</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>ZQ</given-names></name></person-group><article-title>Antiproliferative effects of isoalantolactone in human liver cancer cells are mediated through caspase-dependent apoptosis, ROS generation, suppression of cell migration and invasion and targeting Ras/Raf/MEK signalling pathway</article-title><source>Acta Biochim Pol</source><volume>69</volume><fpage>299</fpage><lpage>304</lpage><year>2022</year><pub-id pub-id-type="pmid">35389600</pub-id></element-citation></ref>
<ref id="b46-ijo-67-01-05766"><label>46</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gu</surname><given-names>W</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>H</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name></person-group><article-title>Dehydrocostus lactone reduced malignancy of HepG2 human hepatocellular carcinoma cells via Down-regulation of the PI3K/AKT signaling pathway</article-title><source>Bull Exp Biol Med</source><volume>174</volume><fpage>360</fpage><lpage>365</lpage><year>2023</year><pub-id pub-id-type="doi">10.1007/s10517-023-05708-2</pub-id><pub-id pub-id-type="pmid">36723745</pub-id></element-citation></ref>
<ref id="b47-ijo-67-01-05766"><label>47</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Si</surname><given-names>H</given-names></name><name><surname>Genna</surname><given-names>B</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Burenbatu</surname><given-names>B</given-names></name><name><surname>Feng</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name></person-group><article-title>DaHuangWan targets EGF signaling to inhibit the proliferation of hepatoma cells</article-title><source>PLoS One</source><volume>15</volume><fpage>e0231466</fpage><year>2020</year><pub-id pub-id-type="doi">10.1371/journal.pone.0231466</pub-id><pub-id pub-id-type="pmid">32298294</pub-id><pub-id pub-id-type="pmcid">7161984</pub-id></element-citation></ref>
<ref id="b48-ijo-67-01-05766"><label>48</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>J</given-names></name><name><surname>Yi</surname><given-names>M</given-names></name><name><surname>Tao</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name></person-group><article-title>Costunolide isolated from Vladimiria souliei inhibits the proliferation and induces the apoptosis of HepG2 cells</article-title><source>Mol Med Rep</source><volume>19</volume><fpage>1372</fpage><lpage>1379</lpage><year>2019</year></element-citation></ref>
<ref id="b49-ijo-67-01-05766"><label>49</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cui</surname><given-names>YQ</given-names></name><name><surname>Liu</surname><given-names>YJ</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name></person-group><article-title>The suppressive effects of Britannin (Bri) on human liver cancer through inducing apoptosis and autophagy via AMPK activation regulated by ROS</article-title><source>Biochem Biophys Res Commun</source><volume>497</volume><fpage>916</fpage><lpage>923</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2017.12.144</pub-id></element-citation></ref>
<ref id="b50-ijo-67-01-05766"><label>50</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Zhou</surname><given-names>TY</given-names></name><name><surname>Nie</surname><given-names>CH</given-names></name><name><surname>Wan</surname><given-names>DL</given-names></name><name><surname>Zheng</surname><given-names>SS</given-names></name></person-group><article-title>Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer</article-title><source>Biochem Biophys Res Commun</source><volume>499</volume><fpage>156</fpage><lpage>163</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2018.03.091</pub-id><pub-id pub-id-type="pmid">29548826</pub-id></element-citation></ref>
<ref id="b51-ijo-67-01-05766"><label>51</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chai</surname><given-names>T</given-names></name><name><surname>Meng</surname><given-names>XH</given-names></name><name><surname>Wang</surname><given-names>CB</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Ma</surname><given-names>LM</given-names></name><name><surname>Shi</surname><given-names>YP</given-names></name><name><surname>Yang</surname><given-names>JL</given-names></name></person-group><article-title>Narjatamolide, an unusual homoguaiane sesquiterpene lactone from Nardostachys jatamansi</article-title><source>J Org Chem</source><volume>86</volume><fpage>11006</fpage><lpage>11010</lpage><year>2020</year><pub-id pub-id-type="doi">10.1021/acs.joc.0c02446</pub-id><pub-id pub-id-type="pmid">33326231</pub-id></element-citation></ref>
<ref id="b52-ijo-67-01-05766"><label>52</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shimizu</surname><given-names>Y</given-names></name><name><surname>Polavarapu</surname><given-names>R</given-names></name><name><surname>Eskla</surname><given-names>KL</given-names></name><name><surname>Nicholson</surname><given-names>CK</given-names></name><name><surname>Koczor</surname><given-names>CA</given-names></name><name><surname>Wang</surname><given-names>R</given-names></name><name><surname>Lewis</surname><given-names>W</given-names></name><name><surname>Shiva</surname><given-names>S</given-names></name><name><surname>Lefer</surname><given-names>DJ</given-names></name><name><surname>Calvert</surname><given-names>JW</given-names></name></person-group><article-title>Hydrogen sulfide regulates cardiac mitochondrial biogenesis via the activation of AMPK</article-title><source>J Mol Cell Cardiol</source><volume>116</volume><fpage>29</fpage><lpage>40</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.yjmcc.2018.01.011</pub-id><pub-id pub-id-type="pmid">29408195</pub-id><pub-id pub-id-type="pmcid">5845802</pub-id></element-citation></ref>
<ref id="b53-ijo-67-01-05766"><label>53</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Ge</surname><given-names>K</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>L</given-names></name></person-group><article-title>ROS-dependent cell death Induced by parthenolide in human hepatoma cell hepG2</article-title><source>Open Access Library J</source><volume>7</volume><fpage>1</fpage><lpage>18</lpage><year>2020</year></element-citation></ref>
<ref id="b54-ijo-67-01-05766"><label>54</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>JD</given-names></name><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Zhang</surname><given-names>HL</given-names></name><name><surname>Lin</surname><given-names>JP</given-names></name><name><surname>Qiu</surname><given-names>CJ</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Biomimetic semisynthesis of arglabin from parthenolide</article-title><source>J Org Chem</source><volume>77</volume><fpage>7103</fpage><lpage>7107</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/jo300888s</pub-id><pub-id pub-id-type="pmid">22849854</pub-id></element-citation></ref>
<ref id="b55-ijo-67-01-05766"><label>55</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Ding</surname><given-names>Y</given-names></name><name><surname>Zhai</surname><given-names>J</given-names></name><name><surname>Ji</surname><given-names>Q</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Yang</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><name><surname>Long</surname><given-names>J</given-names></name><name><surname>Tong</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Guaianolide sesquiterpene lactones, a source to discover agents that selectively inhibit acute myelogenous leukemia stem and progenitor cells</article-title><source>J Med Chem</source><volume>55</volume><fpage>8757</fpage><lpage>8769</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/jm301064b</pub-id><pub-id pub-id-type="pmid">22985027</pub-id></element-citation></ref>
<ref id="b56-ijo-67-01-05766"><label>56</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>Z</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Lu</surname><given-names>Q</given-names></name><name><surname>Li</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>Z</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name><etal/></person-group><article-title>Mecheliolide elicits ROS-mediated ERS driven immunogenic cell death in hepatocellular carcinoma</article-title><source>Redox Biol</source><volume>54</volume><fpage>102351</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.redox.2022.102351</pub-id><pub-id pub-id-type="pmid">35671636</pub-id><pub-id pub-id-type="pmcid">9168183</pub-id></element-citation></ref>
<ref id="b57-ijo-67-01-05766"><label>57</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhong</surname><given-names>J</given-names></name><name><surname>Gong</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Qing</surname><given-names>Y</given-names></name><name><surname>Wu</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>Z</given-names></name><etal/></person-group><article-title>Micheliolide alleviates hepatic steatosis in db/db mice by inhibiting inflammation and promoting autophagy via PPAR-&#x003B3;-mediated NF-&#x0043A;B and AMPK/mTOR signaling</article-title><source>Int Immunopharmacol</source><volume>59</volume><fpage>197</fpage><lpage>208</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.intimp.2018.03.036</pub-id><pub-id pub-id-type="pmid">29656210</pub-id></element-citation></ref>
<ref id="b58-ijo-67-01-05766"><label>58</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>SJ</given-names></name><name><surname>Wang</surname><given-names>JC</given-names></name><name><surname>Niu</surname><given-names>HX</given-names></name><name><surname>Jia</surname><given-names>QQ</given-names></name><name><surname>Chen</surname><given-names>XW</given-names></name><name><surname>Du</surname><given-names>XY</given-names></name><name><surname>Lu</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>B</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Sesquiterpene lactones inhibit advanced oxidation protein product-induced MCP-1 expression in podocytes via an IKK/NF-&#x003BA;B-dependent mechanism</article-title><source>Oxid Med Cell Longev</source><volume>2015</volume><fpage>934058</fpage><year>2015</year><pub-id pub-id-type="doi">10.1155/2015/934058</pub-id></element-citation></ref>
<ref id="b59-ijo-67-01-05766"><label>59</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Chang</surname><given-names>G</given-names></name><name><surname>Lin</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Pang</surname><given-names>T</given-names></name></person-group><article-title>Therapeutic effects of micheliolide on a murine model of rheumatoid arthritis</article-title><source>Mol Med Rep</source><volume>11</volume><fpage>489</fpage><lpage>493</lpage><year>2015</year><pub-id pub-id-type="doi">10.3892/mmr.2014.2767</pub-id></element-citation></ref>
<ref id="b60-ijo-67-01-05766"><label>60</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bian</surname><given-names>M</given-names></name><name><surname>Fan</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Liu</surname><given-names>W</given-names></name></person-group><article-title>Targeting the thioredoxin system as a strategy for cancer therapy: Miniperspective</article-title><source>J Med Chem</source><volume>62</volume><fpage>7309</fpage><lpage>7321</lpage><year>2019</year><pub-id pub-id-type="doi">10.1021/acs.jmedchem.8b01595</pub-id><pub-id pub-id-type="pmid">30963763</pub-id></element-citation></ref>
<ref id="b61-ijo-67-01-05766"><label>61</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>An</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Xu</surname><given-names>C</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Lu</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhai</surname><given-names>J</given-names></name><name><surname>Fan</surname><given-names>H</given-names></name><etal/></person-group><article-title>Micheliolide derivative DMAMCL inhibits glioma cell growth in vitro and in vivo</article-title><source>PLoS One</source><volume>10</volume><fpage>e0116202</fpage><year>2015</year><pub-id pub-id-type="doi">10.1371/journal.pone.0116202</pub-id><pub-id pub-id-type="pmid">25658946</pub-id><pub-id pub-id-type="pmcid">4320118</pub-id></element-citation></ref>
<ref id="b62-ijo-67-01-05766"><label>62</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>S</given-names></name><name><surname>Ye</surname><given-names>J</given-names></name><name><surname>Yin</surname><given-names>M</given-names></name><name><surname>Yu</surname><given-names>R</given-names></name></person-group><article-title>DMAMCL exerts antitumor effects on hepatocellular carcinoma both in vitro and in vivo</article-title><source>Cancer Lett</source><volume>483</volume><fpage>87</fpage><lpage>97</lpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.canlet.2020.04.003</pub-id><pub-id pub-id-type="pmid">32268165</pub-id></element-citation></ref>
<ref id="b63-ijo-67-01-05766"><label>63</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sulistyani</surname><given-names>N</given-names></name></person-group><article-title>Screening of anticancer, hepatoprotective and nephroprotective effects of ethanol extract of Elephantopus scaber L</article-title><source>Pak J Pharm Sci</source><volume>33</volume><fpage>901</fpage><lpage>907</lpage><year>2020</year><pub-id pub-id-type="pmid">33191211</pub-id></element-citation></ref>
<ref id="b64-ijo-67-01-05766"><label>64</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fu</surname><given-names>L</given-names></name><name><surname>Pei</surname><given-names>D</given-names></name><name><surname>Yu</surname><given-names>M</given-names></name><name><surname>Shang</surname><given-names>H</given-names></name><name><surname>Si</surname><given-names>JG</given-names></name><name><surname>Zhang</surname><given-names>HW</given-names></name><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Zou</surname><given-names>ZM</given-names></name></person-group><article-title>New phenolic acids from the whole herb of Elephantopus scaber Linn. and their anti-inflammatory activity</article-title><source>Nat Prod Res</source><volume>35</volume><fpage>3667</fpage><lpage>3674</lpage><year>2021</year><pub-id pub-id-type="doi">10.1080/14786419.2020.1723086</pub-id></element-citation></ref>
<ref id="b65-ijo-67-01-05766"><label>65</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ariesta</surname><given-names>I</given-names></name><name><surname>Sukma</surname><given-names>MG</given-names></name></person-group><article-title>Extract of Elephantopus scaber as therapy for insulin resistance by decreasing damage of heart and Liver in STZ-Na induced diabetic rats (Rattus novergicus)</article-title><source>Am Heart J</source><volume>229</volume><fpage>168</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.ahj.2020.10.028</pub-id></element-citation></ref>
<ref id="b66-ijo-67-01-05766"><label>66</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Divya</surname><given-names>GS</given-names></name><name><surname>Mansoor</surname><given-names>KP</given-names></name><name><surname>Rasheed</surname><given-names>SP</given-names></name><name><surname>Kumar</surname><given-names>A</given-names></name></person-group><article-title>PPAR gamma agonists: An effective strategy for cancer treatment</article-title><source>J Pharm Sci Innov</source><volume>2</volume><fpage>1</fpage><lpage>3</lpage><year>2013</year><pub-id pub-id-type="doi">10.7897/2277-4572.02575</pub-id></element-citation></ref>
<ref id="b67-ijo-67-01-05766"><label>67</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bich Ngoc</surname><given-names>TT</given-names></name><name><surname>Hoai Nga</surname><given-names>NT</given-names></name><name><surname>My Trinh</surname><given-names>NT</given-names></name><name><surname>Thuoc</surname><given-names>TL</given-names></name><name><surname>Phuong Thao</surname><given-names>DT</given-names></name></person-group><article-title>Elephantopus mollis Kunth extracts induce antiproliferation and apoptosis in human lung cancer and myeloid leukemia cells</article-title><source>J Ethnopharmacol</source><volume>263</volume><fpage>113222</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.jep.2020.113222</pub-id><pub-id pub-id-type="pmid">32763415</pub-id></element-citation></ref>
<ref id="b68-ijo-67-01-05766"><label>68</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beeran</surname><given-names>AA</given-names></name><name><surname>Maliyakkal</surname><given-names>N</given-names></name><name><surname>Rao</surname><given-names>CM</given-names></name><name><surname>Udupa</surname><given-names>N</given-names></name></person-group><article-title>The enriched fraction of Elephantopus scaber Triggers apoptosis and inhibits Multi-drug resistance transporters in human epithelial cancer cells</article-title><source>Pharmacogn Mag</source><volume>11</volume><fpage>257</fpage><lpage>268</lpage><year>2015</year><pub-id pub-id-type="doi">10.4103/0973-1296.153077</pub-id><pub-id pub-id-type="pmid">25829763</pub-id><pub-id pub-id-type="pmcid">4378122</pub-id></element-citation></ref>
<ref id="b69-ijo-67-01-05766"><label>69</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehmood</surname><given-names>T</given-names></name><name><surname>Maryam</surname><given-names>A</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name></person-group><article-title>Deoxyelephantopin induces apoptosis in HepG2 cells via oxidative stress, NF-&#x003BA;B inhibition and mitochondrial dysfunction</article-title><source>Biofactors</source><volume>43</volume><fpage>63</fpage><lpage>72</lpage><year>2017</year><pub-id pub-id-type="doi">10.1002/biof.1324</pub-id></element-citation></ref>
<ref id="b70-ijo-67-01-05766"><label>70</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>SH</given-names></name><name><surname>Liu</surname><given-names>QB</given-names></name><name><surname>Yao</surname><given-names>GD</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>XX</given-names></name><name><surname>Song</surname><given-names>SJ</given-names></name></person-group><article-title>Germacranolides from Elephantopus scaber L. and their cytotoxic activities</article-title><source>Phytochemistry</source><volume>178</volume><fpage>112479</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2020.112479</pub-id><pub-id pub-id-type="pmid">32768717</pub-id></element-citation></ref>
<ref id="b71-ijo-67-01-05766"><label>71</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>M</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Dong</surname><given-names>SH</given-names></name><name><surname>Liu</surname><given-names>QB</given-names></name><name><surname>Lin</surname><given-names>B</given-names></name><name><surname>Huang</surname><given-names>XX</given-names></name><name><surname>Yao</surname><given-names>GD</given-names></name><name><surname>Song</surname><given-names>SJ</given-names></name></person-group><article-title>Elephantopinolide AP, germacrane-type sesquiterpene lactones from Elephantopus scaber induce apoptosis, autophagy and G2/M phase arrest in hepatocellular carcinoma cells</article-title><source>Eur J Med Chem</source><volume>198</volume><fpage>112362</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.ejmech.2020.112362</pub-id></element-citation></ref>
<ref id="b72-ijo-67-01-05766"><label>72</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mehmood</surname><given-names>T</given-names></name><name><surname>Maryam</surname><given-names>A</given-names></name><name><surname>Tian</surname><given-names>X</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Ma</surname><given-names>T</given-names></name></person-group><article-title>Santamarine inhibits NF-&#x0043A;B and STAT3 activation and induces apoptosis in HepG2 liver cancer cells via oxidative stress</article-title><source>J Cancer</source><volume>8</volume><fpage>3707</fpage><lpage>3717</lpage><year>2017</year><pub-id pub-id-type="doi">10.7150/jca.20239</pub-id><pub-id pub-id-type="pmcid">5688924</pub-id></element-citation></ref>
<ref id="b73-ijo-67-01-05766"><label>73</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Kim</surname><given-names>EO</given-names></name><name><surname>Lee</surname><given-names>DG</given-names></name><name><surname>Jung</surname><given-names>DH</given-names></name><name><surname>Ki</surname><given-names>SH</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name></person-group><article-title>Hemistepsin A inhibits T0901317-induced lipogenesis in the liver</article-title><source>BMB Rep</source><volume>54</volume><fpage>106</fpage><year>2021</year><pub-id pub-id-type="doi">10.5483/BMBRep.2021.54.2.111</pub-id><pub-id pub-id-type="pmcid">7907741</pub-id></element-citation></ref>
<ref id="b74-ijo-67-01-05766"><label>74</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Han</surname><given-names>NR</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name><name><surname>Jegal</surname><given-names>KH</given-names></name><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Jung</surname><given-names>EH</given-names></name><name><surname>Kim</surname><given-names>EO</given-names></name><name><surname>Kim</surname><given-names>D</given-names></name><name><surname>Jung</surname><given-names>DH</given-names></name><name><surname>Lee</surname><given-names>JR</given-names></name><etal/></person-group><article-title>Hemistepsin A alleviates liver fibrosis by inducing apoptosis of activated hepatic stellate cells via inhibition of nuclear factor-&#x003BA;B and Akt</article-title><source>Food Chem Toxicol</source><volume>135</volume><fpage>111044</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.fct.2019.111044</pub-id></element-citation></ref>
<ref id="b75-ijo-67-01-05766"><label>75</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Kim</surname><given-names>EO</given-names></name><name><surname>Jung</surname><given-names>DH</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name></person-group><article-title>The effects of Hemistepta lyrata Bunge (Bunge) fractionated extract on liver X receptor &#x003B1;-dependent lipogenic genes in hepatocyte-derived cells</article-title><source>Herbal Formula Sci</source><volume>28</volume><fpage>255</fpage><lpage>269</lpage><year>2020</year></element-citation></ref>
<ref id="b76-ijo-67-01-05766"><label>76</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Lee</surname><given-names>JE</given-names></name><name><surname>Jung</surname><given-names>EH</given-names></name><name><surname>Jung</surname><given-names>JY</given-names></name><name><surname>Jung</surname><given-names>DH</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name></person-group><article-title>Hemistepsin A ameliorates acute inflammation in macrophages via inhibition of nuclear factor-&#x003BA;B and activation of nuclear factor erythroid 2-related factor 2</article-title><source>Food Chem Toxicol</source><volume>111</volume><fpage>176</fpage><lpage>188</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.fct.2017.11.014</pub-id></element-citation></ref>
<ref id="b77-ijo-67-01-05766"><label>77</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Baek</surname><given-names>SY</given-names></name><name><surname>Hwang</surname><given-names>UW</given-names></name><name><surname>Suk</surname><given-names>HY</given-names></name><name><surname>Kim</surname><given-names>YW</given-names></name></person-group><article-title>Hemistepsin a inhibits cell proliferation and induces G0/G1-Phase arrest, cellular senescence and apoptosis via the AMPK and p53/p21 signals in human hepatocellular carcinoma</article-title><source>Biomolecules</source><volume>10</volume><fpage>713</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/biom10050713</pub-id><pub-id pub-id-type="pmid">32375410</pub-id><pub-id pub-id-type="pmcid">7277854</pub-id></element-citation></ref>
<ref id="b78-ijo-67-01-05766"><label>78</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>IJ</given-names></name><name><surname>Kim</surname><given-names>JK</given-names></name><name><surname>Kim</surname><given-names>EO</given-names></name><name><surname>Park</surname><given-names>SM</given-names></name><name><surname>Kim</surname><given-names>SC</given-names></name><name><surname>Ki</surname><given-names>SH</given-names></name><name><surname>Ku</surname><given-names>SK</given-names></name></person-group><article-title>Hemistepsin A induces apoptosis of hepatocellular carcinoma cells by downregulating STAT3</article-title><source>Int J Mol Sci</source><volume>22</volume><fpage>4743</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/ijms22094743</pub-id><pub-id pub-id-type="pmid">33947048</pub-id><pub-id pub-id-type="pmcid">8125382</pub-id></element-citation></ref>
<ref id="b79-ijo-67-01-05766"><label>79</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nibret</surname><given-names>E</given-names></name><name><surname>Youns</surname><given-names>M</given-names></name><name><surname>Krauth-Siegel</surname><given-names>RL</given-names></name><name><surname>Wink</surname><given-names>M</given-names></name></person-group><article-title>Biological activities of x1anthatin from Xanthium strumarium leaves</article-title><source>Phytother Res</source><volume>25</volume><fpage>1883</fpage><lpage>1890</lpage><year>2011</year><pub-id pub-id-type="doi">10.1002/ptr.3651</pub-id><pub-id pub-id-type="pmid">21953905</pub-id></element-citation></ref>
<ref id="b80-ijo-67-01-05766"><label>80</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kov&#x000E1;cs</surname><given-names>A</given-names></name><name><surname>Vasas</surname><given-names>A</given-names></name><name><surname>Forgo</surname><given-names>P</given-names></name><name><surname>R&#x000E9;thy</surname><given-names>B</given-names></name><name><surname>Zupk&#x000F3;</surname><given-names>I</given-names></name><name><surname>Hohmann</surname><given-names>J</given-names></name></person-group><article-title>Xanthanolides with antitumour activity from Xanthium italicum</article-title><source>Z Naturforsch C J Biosci</source><volume>64</volume><fpage>343</fpage><lpage>349</lpage><year>2009</year><pub-id pub-id-type="doi">10.1515/znc-2009-5-607</pub-id><pub-id pub-id-type="pmid">19678536</pub-id></element-citation></ref>
<ref id="b81-ijo-67-01-05766"><label>81</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ram&#x000ED;rez-Erosa</surname><given-names>I</given-names></name><name><surname>Huang</surname><given-names>Y</given-names></name><name><surname>Hickie</surname><given-names>RA</given-names></name><name><surname>Sutherland</surname><given-names>RG</given-names></name><name><surname>Barl</surname><given-names>B</given-names></name></person-group><article-title>Xanthatin and xanthinosin from the burs of Xanthium strumarium L. as potential anticancer agents</article-title><source>Can J Physiol Pharmacol</source><volume>85</volume><fpage>1160</fpage><lpage>1172</lpage><year>2007</year><pub-id pub-id-type="doi">10.1139/Y07-104</pub-id><pub-id pub-id-type="pmid">18066118</pub-id></element-citation></ref>
<ref id="b82-ijo-67-01-05766"><label>82</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shi</surname><given-names>T</given-names></name><name><surname>Zhang</surname><given-names>L</given-names></name><name><surname>Cheng</surname><given-names>Q</given-names></name><name><surname>Yu</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Shen</surname><given-names>YJ</given-names></name><name><surname>Feng</surname><given-names>XJ</given-names></name><name><surname>Shen</surname><given-names>YX</given-names></name></person-group><article-title>Xanthatin induces apoptosis by activating endoplasmic reticulum stress in hepatoma cells</article-title><source>Eur J Pharmacol</source><volume>843</volume><fpage>1</fpage><lpage>11</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2018.10.041</pub-id></element-citation></ref>
<ref id="b83-ijo-67-01-05766"><label>83</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuck</surname><given-names>K</given-names></name><name><surname>J&#x000FC;rgenliemk</surname><given-names>G</given-names></name><name><surname>Lipowicz</surname><given-names>B</given-names></name><name><surname>Heilmann</surname><given-names>J</given-names></name></person-group><article-title>Sesquiterpenes from myrrh and their ICAM-1 inhibitory activity in vitro</article-title><source>Molecules</source><volume>26</volume><fpage>42</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/molecules26010042</pub-id><pub-id pub-id-type="pmid">33374825</pub-id><pub-id pub-id-type="pmcid">7796156</pub-id></element-citation></ref>
<ref id="b84-ijo-67-01-05766"><label>84</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>BB</given-names></name><name><surname>Ma</surname><given-names>LS</given-names></name><name><surname>Sun</surname><given-names>X</given-names></name><name><surname>Chang</surname><given-names>JJ</given-names></name><name><surname>Xie</surname><given-names>WD</given-names></name><name><surname>Li</surname><given-names>X</given-names></name></person-group><article-title>Telekin suppresses human hepatocellular carcinoma cells in vitro by inducing G2/M phase arrest via the p38 MAPK signaling pathway</article-title><source>Acta Pharmacol Sin</source><volume>35</volume><fpage>1311</fpage><lpage>1322</lpage><year>2014</year><pub-id pub-id-type="doi">10.1038/aps.2014.74</pub-id><pub-id pub-id-type="pmid">25176399</pub-id><pub-id pub-id-type="pmcid">4186990</pub-id></element-citation></ref>
<ref id="b85-ijo-67-01-05766"><label>85</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>LH</given-names></name><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Geng</surname><given-names>CA</given-names></name><name><surname>Dong</surname><given-names>W</given-names></name><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Zhang</surname><given-names>XM</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Artemiprincepsolides A-F, Novel Germacrane-guaiane and Eudesmane-guaiane Sesquiterpenoid Dimers from Artemisia princeps and Their Antihepatoma Activity</article-title><source>Chin J Chem</source><volume>41</volume><fpage>2648</fpage><lpage>2656</lpage><year>2023</year><pub-id pub-id-type="doi">10.1002/cjoc.202300242</pub-id></element-citation></ref>
<ref id="b86-ijo-67-01-05766"><label>86</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Liu</surname><given-names>TT</given-names></name><name><surname>Qi</surname><given-names>MG</given-names></name><name><surname>Feng</surname><given-names>JC</given-names></name><name><surname>Li</surname><given-names>XY</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name></person-group><article-title>Insecticidal activity of sesquiterpene lactones and monoterpenoid from the fruits of Carpesium abrotanoides</article-title><source>Industrial Crops Products</source><volume>92</volume><fpage>77</fpage><lpage>83</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.indcrop.2016.07.046</pub-id></element-citation></ref>
<ref id="b87-ijo-67-01-05766"><label>87</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Ren</surname><given-names>FC</given-names></name><name><surname>Liu</surname><given-names>JK</given-names></name></person-group><article-title>Sesquiterpene lactones from Carpesium abrotanoides</article-title><source>Fitoterapia</source><volume>80</volume><fpage>21</fpage><lpage>24</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.fitote.2008.09.009</pub-id></element-citation></ref>
<ref id="b88-ijo-67-01-05766"><label>88</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name><name><surname>Min</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Na</surname><given-names>M</given-names></name><name><surname>Kwon</surname><given-names>B</given-names></name><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Kim</surname><given-names>Y</given-names></name><name><surname>Bae</surname><given-names>K</given-names></name></person-group><article-title>Cytotoxic sesquiterpene lactones from Carpesium abrotanoides</article-title><source>Planta Med</source><volume>68</volume><fpage>745</fpage><lpage>747</lpage><year>2002</year><pub-id pub-id-type="doi">10.1055/s-2002-33789</pub-id><pub-id pub-id-type="pmid">12221601</pub-id></element-citation></ref>
<ref id="b89-ijo-67-01-05766"><label>89</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>C</given-names></name><name><surname>Yuan</surname><given-names>C</given-names></name><name><surname>Jia</surname><given-names>Z</given-names></name></person-group><article-title>Xanthanolides, Germacranolides, and Other Constituents from Carpesium longifolium</article-title><source>J Nat Prod</source><volume>66</volume><fpage>1554</fpage><lpage>1557</lpage><year>2003</year><pub-id pub-id-type="doi">10.1021/np030278f</pub-id><pub-id pub-id-type="pmid">14695795</pub-id></element-citation></ref>
<ref id="b90-ijo-67-01-05766"><label>90</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yan</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Peng</surname><given-names>M</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Feng</surname><given-names>E</given-names></name><name><surname>Li</surname><given-names>Q</given-names></name><name><surname>Guo</surname><given-names>B</given-names></name><name><surname>Ding</surname><given-names>X</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Tang</surname><given-names>L</given-names></name></person-group><article-title>Sesquiterpenes from Carpesium faberi triggered ROS-induced apoptosis and protective autophagy in hepatocellular carcinoma cells</article-title><source>Phytochemistry</source><volume>214</volume><fpage>113805</fpage><year>2023</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2023.113805</pub-id><pub-id pub-id-type="pmid">37527743</pub-id></element-citation></ref>
<ref id="b91-ijo-67-01-05766"><label>91</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Cantore</surname><given-names>P</given-names></name><name><surname>Iacobellis</surname><given-names>NS</given-names></name><name><surname>De Marco</surname><given-names>A</given-names></name><name><surname>Capasso</surname><given-names>F</given-names></name><name><surname>Senatore</surname><given-names>F</given-names></name></person-group><article-title>Antibacterial activity of Coriandrum sativum L. and Foeniculum vulgare Miller var. vulgare (Miller) essential oils</article-title><source>J Agric Food Chem</source><volume>52</volume><fpage>7862</fpage><lpage>7866</lpage><year>2004</year><pub-id pub-id-type="doi">10.1021/jf0493122</pub-id><pub-id pub-id-type="pmid">15612768</pub-id></element-citation></ref>
<ref id="b92-ijo-67-01-05766"><label>92</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Emamghoreishi</surname><given-names>M</given-names></name><name><surname>Khasaki</surname><given-names>M</given-names></name><name><surname>Aazam</surname><given-names>MF</given-names></name></person-group><article-title>Coriandrum sativum: Evaluation of its anxiolytic effect in the elevated plus-maze</article-title><source>J Ethnopharmacol</source><volume>96</volume><fpage>365</fpage><lpage>370</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/j.jep.2004.06.022</pub-id></element-citation></ref>
<ref id="b93-ijo-67-01-05766"><label>93</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bickers</surname><given-names>D</given-names></name><name><surname>Calow</surname><given-names>P</given-names></name><name><surname>Greim</surname><given-names>H</given-names></name><name><surname>Hanifin</surname><given-names>JM</given-names></name><name><surname>Rogers</surname><given-names>AE</given-names></name><name><surname>Saurat</surname><given-names>JH</given-names></name><name><surname>Sipes</surname><given-names>IG</given-names></name><name><surname>Smith</surname><given-names>RL</given-names></name><name><surname>Tagami</surname><given-names>H</given-names></name></person-group><article-title>A toxicologic and dermatologic assessment of linalool and related esters when used as fragrance ingredients</article-title><source>Food Chem Toxicol</source><volume>41</volume><fpage>919</fpage><lpage>942</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0278-6915(03)00016-4</pub-id><pub-id pub-id-type="pmid">12804649</pub-id></element-citation></ref>
<ref id="b94-ijo-67-01-05766"><label>94</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usta</surname><given-names>J</given-names></name><name><surname>Kreydiyyeh</surname><given-names>S</given-names></name><name><surname>Knio</surname><given-names>K</given-names></name><name><surname>Barnabe</surname><given-names>P</given-names></name><name><surname>Bou-Moughlabay</surname><given-names>Y</given-names></name><name><surname>Dagher</surname><given-names>S</given-names></name></person-group><article-title>Linalool decreases HepG2 viability by inhibiting mitochondrial complexes I and II, increasing reactive oxygen species and decreasing ATP and GSH levels</article-title><source>Chem Biol Interact</source><volume>180</volume><fpage>39</fpage><lpage>46</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.cbi.2009.02.012</pub-id><pub-id pub-id-type="pmid">19428344</pub-id></element-citation></ref>
<ref id="b95-ijo-67-01-05766"><label>95</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simamora</surname><given-names>A</given-names></name><name><surname>Timotius</surname><given-names>KH</given-names></name><name><surname>Yerer</surname><given-names>MB</given-names></name><name><surname>Setiawan</surname><given-names>H</given-names></name><name><surname>Mun'im</surname><given-names>A</given-names></name></person-group><article-title>Xanthorrhizol, a potential anticancer agent, from Curcuma xanthorrhiza Roxb</article-title><source>Phytomedicine</source><volume>105</volume><fpage>154359</fpage><year>2022</year><pub-id pub-id-type="doi">10.1016/j.phymed.2022.154359</pub-id><pub-id pub-id-type="pmid">35933899</pub-id></element-citation></ref>
<ref id="b96-ijo-67-01-05766"><label>96</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tee</surname><given-names>TT</given-names></name><name><surname>Cheah</surname><given-names>YH</given-names></name><name><surname>Meenakshii</surname><given-names>N</given-names></name><name><surname>Mohd Sharom</surname><given-names>MY</given-names></name><name><surname>Azimahtol Hawariah</surname><given-names>LP</given-names></name></person-group><article-title>Xanthorrhizol induced DNA fragmentation in HepG2 cells involving Bcl-2 family proteins</article-title><source>Biochem Biophys Res Commun</source><volume>420</volume><fpage>834</fpage><lpage>838</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bbrc.2012.03.083</pub-id><pub-id pub-id-type="pmid">22465013</pub-id></element-citation></ref>
<ref id="b97-ijo-67-01-05766"><label>97</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fonseca</surname><given-names>DV</given-names></name><name><surname>Salgado</surname><given-names>PR</given-names></name><name><surname>de Carvalho</surname><given-names>FL</given-names></name><name><surname>Salvadori</surname><given-names>MG</given-names></name><name><surname>Penha</surname><given-names>AR</given-names></name><name><surname>Leite</surname><given-names>FC</given-names></name><name><surname>Borges</surname><given-names>CJ</given-names></name><name><surname>Piuvezam</surname><given-names>MR</given-names></name><name><surname>Pordeus</surname><given-names>LC</given-names></name><name><surname>Sousa</surname><given-names>DP</given-names></name><name><surname>Almeida</surname><given-names>RN</given-names></name></person-group><article-title>Nerolidol exhibits antinociceptive and anti-inflammatory activity: Involvement of the GABAergic system and proinflammatory cytokines</article-title><source>Fundam Clin Pharmacol</source><volume>30</volume><fpage>14</fpage><lpage>22</lpage><year>2016</year><pub-id pub-id-type="doi">10.1111/fcp.12166</pub-id><pub-id pub-id-type="pmid">26791997</pub-id></element-citation></ref>
<ref id="b98-ijo-67-01-05766"><label>98</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krist</surname><given-names>S</given-names></name><name><surname>Banovac</surname><given-names>D</given-names></name><name><surname>Tabanca</surname><given-names>N</given-names></name><name><surname>Wedge</surname><given-names>DE</given-names></name><name><surname>Gochev</surname><given-names>VK</given-names></name><name><surname>Wanner</surname><given-names>J</given-names></name><name><surname>Schmidt</surname><given-names>E</given-names></name><name><surname>Jirovetz</surname><given-names>L</given-names></name></person-group><article-title>Antimicrobial activity of nerolidol and its derivatives against airborne microbes and further biological activities</article-title><source>Nat Prod Commun</source><volume>10</volume><fpage>143</fpage><lpage>148</lpage><year>2015</year><pub-id pub-id-type="pmid">25920237</pub-id></element-citation></ref>
<ref id="b99-ijo-67-01-05766"><label>99</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>WK</given-names></name><name><surname>Tan</surname><given-names>LT</given-names></name><name><surname>Chan</surname><given-names>KG</given-names></name><name><surname>Lee</surname><given-names>LH</given-names></name><name><surname>Goh</surname><given-names>BH</given-names></name></person-group><article-title>Nerolidol: A sesquiterpene alcohol with Multi-faceted pharmacological and biological activities</article-title><source>Molecules</source><volume>21</volume><fpage>529</fpage><year>2016</year><pub-id pub-id-type="doi">10.3390/molecules21050529</pub-id><pub-id pub-id-type="pmid">27136520</pub-id><pub-id pub-id-type="pmcid">6272852</pub-id></element-citation></ref>
<ref id="b100-ijo-67-01-05766"><label>100</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biazi</surname><given-names>BI</given-names></name><name><surname>Zanetti</surname><given-names>TA</given-names></name><name><surname>Baranoski</surname><given-names>A</given-names></name><name><surname>Corveloni</surname><given-names>AC</given-names></name><name><surname>Mantovani</surname><given-names>MS</given-names></name></person-group><article-title>Cis-Nerolidol induces endoplasmic reticulum stress and cell death in human hepatocellular carcinoma cells through extensive CYP2C19 and CYP1A2 oxidation</article-title><source>Basic Clin Pharmacol Toxicol</source><volume>121</volume><fpage>334</fpage><lpage>341</lpage><year>2017</year><pub-id pub-id-type="doi">10.1111/bcpt.12772</pub-id><pub-id pub-id-type="pmid">28256105</pub-id></element-citation></ref>
<ref id="b101-ijo-67-01-05766"><label>101</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sharifi-Rad</surname><given-names>M</given-names></name><name><surname>Nazaruk</surname><given-names>J</given-names></name><name><surname>Polito</surname><given-names>L</given-names></name><name><surname>Morais-Braga</surname><given-names>MFB</given-names></name><name><surname>Rocha</surname><given-names>JE</given-names></name><name><surname>Coutinho</surname><given-names>HDM</given-names></name><name><surname>Salehi</surname><given-names>B</given-names></name><name><surname>Tabanelli</surname><given-names>G</given-names></name><name><surname>Montanari</surname><given-names>C</given-names></name><name><surname>Del Mar Contreras</surname><given-names>M</given-names></name><etal/></person-group><article-title>Matricaria genus as a source of antimicrobial agents: From farm to pharmacy and food applications</article-title><source>Microbiol Res</source><volume>215</volume><fpage>76</fpage><lpage>79</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.micres.2018.06.010</pub-id><pub-id pub-id-type="pmid">30172312</pub-id></element-citation></ref>
<ref id="b102-ijo-67-01-05766"><label>102</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eddin</surname><given-names>LB</given-names></name><name><surname>Jha</surname><given-names>NK</given-names></name><name><surname>Goyal</surname><given-names>SN</given-names></name><name><surname>Agrawal</surname><given-names>YO</given-names></name><name><surname>Subramanya</surname><given-names>SB</given-names></name><name><surname>Bastaki</surname><given-names>SMA</given-names></name><name><surname>Ojha</surname><given-names>S</given-names></name></person-group><article-title>Health benefits, pharmacological effects, molecular mechanisms, and therapeutic potential of &#x003B1;-bisabolol</article-title><source>Nutrients</source><volume>14</volume><fpage>1370</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/nu14071370</pub-id></element-citation></ref>
<ref id="b103-ijo-67-01-05766"><label>103</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kreuger</surname><given-names>MRO</given-names></name><name><surname>Grootjans</surname><given-names>S</given-names></name><name><surname>Biavatti</surname><given-names>MW</given-names></name><name><surname>Vandenabeele</surname><given-names>P</given-names></name><name><surname>D'Herde</surname><given-names>K</given-names></name></person-group><article-title>Sesquiterpene lactones as drugs with multiple targets in cancer treatment: Focus on parthenolide</article-title><source>Anticancer Drugs</source><volume>23</volume><fpage>883</fpage><lpage>896</lpage><year>2012</year><pub-id pub-id-type="doi">10.1097/CAD.0b013e328356cad9</pub-id><pub-id pub-id-type="pmid">22797176</pub-id></element-citation></ref>
<ref id="b104-ijo-67-01-05766"><label>104</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Fang</surname><given-names>B</given-names></name><name><surname>Ma</surname><given-names>F</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Deng</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>G</given-names></name><name><surname>He</surname><given-names>G</given-names></name></person-group><article-title>Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis</article-title><source>Eur J Pharmacol</source><volume>698</volume><fpage>95</fpage><lpage>102</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2012.10.013</pub-id></element-citation></ref>
<ref id="b105-ijo-67-01-05766"><label>105</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>YY</given-names></name><name><surname>Zheng</surname><given-names>Q</given-names></name><name><surname>Fang</surname><given-names>B</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>Ma</surname><given-names>FY</given-names></name><name><surname>Roshan</surname><given-names>S</given-names></name><name><surname>Banafa</surname><given-names>A</given-names></name><name><surname>Chen</surname><given-names>MJ</given-names></name><name><surname>Chang</surname><given-names>JL</given-names></name><name><surname>Deng</surname><given-names>XM</given-names></name><etal/></person-group><article-title>Germacrone induces apoptosis in human hepatoma HepG2 cells through inhibition of the JAK2/STAT3 signalling pathway</article-title><source>Med Sci</source><volume>33</volume><fpage>339</fpage><lpage>345</lpage><year>2013</year></element-citation></ref>
<ref id="b106-ijo-67-01-05766"><label>106</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Na-Bangchang</surname><given-names>K</given-names></name><name><surname>Plengsuriyakam</surname><given-names>T</given-names></name><name><surname>Karbwang</surname><given-names>J</given-names></name></person-group><article-title>Research and development of atractylodes lancea (Thunb) DC. As a promising candidate for cholangiocarcinoma chemotherapeutics</article-title><source>Evid Based Complement Alternat Med</source><volume>2017</volume><fpage>5929234</fpage><year>2017</year><pub-id pub-id-type="doi">10.1155/2017/5929234</pub-id></element-citation></ref>
<ref id="b107-ijo-67-01-05766"><label>107</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Mai</surname><given-names>JY</given-names></name><name><surname>Hou</surname><given-names>TL</given-names></name><name><surname>Ping</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Antiviral activities of atractylon from Atractylodis Rhizoma</article-title><source>Mol Med Rep</source><volume>14</volume><fpage>3704</fpage><lpage>3710</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/mmr.2016.5713</pub-id><pub-id pub-id-type="pmid">27600871</pub-id><pub-id pub-id-type="pmcid">5042776</pub-id></element-citation></ref>
<ref id="b108-ijo-67-01-05766"><label>108</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>H</given-names></name><name><surname>Li</surname><given-names>GY</given-names></name><name><surname>Dai</surname><given-names>RH</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>C</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>J</given-names></name></person-group><article-title>Chemical constituents of Atractylodes chinensis (DC.) koidz</article-title><source>Biochem Syst Ecol</source><volume>38</volume><fpage>1220</fpage><lpage>1223</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.bse.2010.12.023</pub-id></element-citation></ref>
<ref id="b109-ijo-67-01-05766"><label>109</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Chen</surname><given-names>T</given-names></name><name><surname>Yang</surname><given-names>X</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name></person-group><article-title>Atractylon induces apoptosis and suppresses metastasis in hepatic cancer cells and inhibits growth in vivo</article-title><source>Cancer Manag Rese</source><volume>11</volume><fpage>5883</fpage><lpage>5894</lpage><year>2019</year><pub-id pub-id-type="doi">10.2147/CMAR.S194795</pub-id></element-citation></ref>
<ref id="b110-ijo-67-01-05766"><label>110</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Ping</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Zhao</surname><given-names>H</given-names></name><name><surname>Xue</surname><given-names>J</given-names></name></person-group><article-title>Molecular mechanism of atractylon in the invasion and migration of hepatic cancer cells based on high-throughput sequencing</article-title><source>Mol Med Rep</source><volume>25</volume><fpage>112</fpage><year>2022</year><pub-id pub-id-type="doi">10.3892/mmr.2022.12628</pub-id><pub-id pub-id-type="pmcid">8845028</pub-id></element-citation></ref>
<ref id="b111-ijo-67-01-05766"><label>111</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cheng</surname><given-names>SB</given-names></name><name><surname>Wu</surname><given-names>LC</given-names></name><name><surname>Hsieh</surname><given-names>YC</given-names></name><name><surname>Wu</surname><given-names>CH</given-names></name><name><surname>Chan</surname><given-names>YJ</given-names></name><name><surname>Chang</surname><given-names>LH</given-names></name><name><surname>Chang</surname><given-names>CM</given-names></name><name><surname>Hsu</surname><given-names>SL</given-names></name><name><surname>Teng</surname><given-names>CL</given-names></name><name><surname>Wu</surname><given-names>CC</given-names></name></person-group><article-title>Supercritical carbon dioxide extraction of aromatic turmerone from Curcuma longa Linn. Induces apoptosis through reactive oxygen species-triggered intrinsic and extrinsic pathways in human hepatocellular carcinoma HepG2 cells</article-title><source>J Agric Food Chem</source><volume>60</volume><fpage>9620</fpage><lpage>9630</lpage><year>2012</year><pub-id pub-id-type="doi">10.1021/jf301882b</pub-id><pub-id pub-id-type="pmid">22946656</pub-id></element-citation></ref>
<ref id="b112-ijo-67-01-05766"><label>112</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abu-Izneid</surname><given-names>T</given-names></name><name><surname>Rauf</surname><given-names>A</given-names></name><name><surname>Shariati</surname><given-names>MA</given-names></name><name><surname>Khalil</surname><given-names>AA</given-names></name><name><surname>Imran</surname><given-names>M</given-names></name><name><surname>Rebezov</surname><given-names>M</given-names></name><name><surname>Uddin</surname><given-names>MS</given-names></name><name><surname>Mahomoodally</surname><given-names>MF</given-names></name><name><surname>Rengasamy</surname><given-names>KRR</given-names></name></person-group><article-title>Sesquiterpenes and their derivatives-natural anticancer compounds: An update</article-title><source>Pharmacol Res</source><volume>161</volume><fpage>105165</fpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.phrs.2020.105165</pub-id><pub-id pub-id-type="pmid">32835868</pub-id></element-citation></ref>
<ref id="b113-ijo-67-01-05766"><label>113</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fraga</surname><given-names>BM</given-names></name></person-group><article-title>Natural sesquiterpenoids</article-title><source>Nat Prod Rep</source><volume>30</volume><fpage>1226</fpage><lpage>1264</lpage><year>2013</year><pub-id pub-id-type="doi">10.1039/c3np70047j</pub-id><pub-id pub-id-type="pmid">23884176</pub-id></element-citation></ref>
<ref id="b114-ijo-67-01-05766"><label>114</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Kuang</surname><given-names>Y</given-names></name><name><surname>Xing</surname><given-names>Z</given-names></name><name><surname>Deng</surname><given-names>X</given-names></name><name><surname>Luo</surname><given-names>Z</given-names></name></person-group><article-title>Thapsigargin induces apoptosis in adrenocortical carcinoma by activating endoplasmic reticulum stress and the JNK signaling pathway: An in vitro and in vivo study</article-title><source>Drug Des Devel Ther</source><volume>13</volume><fpage>2787</fpage><lpage>2798</lpage><year>2019</year><pub-id pub-id-type="doi">10.2147/DDDT.S209947</pub-id><pub-id pub-id-type="pmid">31496655</pub-id><pub-id pub-id-type="pmcid">6697672</pub-id></element-citation></ref>
<ref id="b115-ijo-67-01-05766"><label>115</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Andersen</surname><given-names>TB</given-names></name><name><surname>L&#x000F3;pez</surname><given-names>CQ</given-names></name><name><surname>Manczak</surname><given-names>T</given-names></name><name><surname>Martinez</surname><given-names>K</given-names></name><name><surname>Simonsen</surname><given-names>HT</given-names></name></person-group><article-title>Thapsigargin-from Thapsia L. to mipsagargin</article-title><source>Molecules</source><volume>20</volume><fpage>6113</fpage><lpage>6127</lpage><year>2015</year><pub-id pub-id-type="doi">10.3390/molecules20046113</pub-id><pub-id pub-id-type="pmid">25856061</pub-id><pub-id pub-id-type="pmcid">6272310</pub-id></element-citation></ref>
<ref id="b116-ijo-67-01-05766"><label>116</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brennen</surname><given-names>WN</given-names></name><name><surname>Rosen</surname><given-names>DM</given-names></name><name><surname>Wang</surname><given-names>H</given-names></name><name><surname>Isaacs</surname><given-names>JT</given-names></name><name><surname>Denmeade</surname><given-names>SR</given-names></name></person-group><article-title>Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug</article-title><source>J Natl Cancer Inst</source><volume>104</volume><fpage>1320</fpage><lpage>1334</lpage><year>2012</year><pub-id pub-id-type="doi">10.1093/jnci/djs336</pub-id><pub-id pub-id-type="pmid">22911669</pub-id><pub-id pub-id-type="pmcid">3529592</pub-id></element-citation></ref>
<ref id="b117-ijo-67-01-05766"><label>117</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Denmeade</surname><given-names>SR</given-names></name><name><surname>Mhaka</surname><given-names>AM</given-names></name><name><surname>Rosen</surname><given-names>DM</given-names></name><name><surname>Brennen</surname><given-names>WN</given-names></name><name><surname>Dalrymple</surname><given-names>S</given-names></name><name><surname>Dach</surname><given-names>I</given-names></name><name><surname>Olesen</surname><given-names>C</given-names></name><name><surname>Gurel</surname><given-names>B</given-names></name><name><surname>Demarzo</surname><given-names>AM</given-names></name><name><surname>Wilding</surname><given-names>G</given-names></name><etal/></person-group><article-title>Engineering a prostate-specific membrane antigen-activated tumor endothelial cell prodrug for cancer therapy</article-title><source>Sci Transl Med</source><volume>4</volume><fpage>140ra86</fpage><year>2012</year><pub-id pub-id-type="doi">10.1126/scitranslmed.3003886</pub-id><pub-id pub-id-type="pmid">22745436</pub-id><pub-id pub-id-type="pmcid">3715055</pub-id></element-citation></ref>
<ref id="b118-ijo-67-01-05766"><label>118</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qu</surname><given-names>Z</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Zhang</surname><given-names>Z</given-names></name><name><surname>Zheng</surname><given-names>P</given-names></name><name><surname>Zhao</surname><given-names>S</given-names></name><name><surname>Hou</surname><given-names>W</given-names></name></person-group><article-title>Phytochemistry and pharmacology of sesquiterpenoids from Atractylodes DC. Genus Rhizomes</article-title><source>Molecules</source><volume>29</volume><fpage>1379</fpage><year>2024</year><pub-id pub-id-type="doi">10.3390/molecules29061379</pub-id><pub-id pub-id-type="pmid">38543015</pub-id><pub-id pub-id-type="pmcid">10975564</pub-id></element-citation></ref>
<ref id="b119-ijo-67-01-05766"><label>119</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tian</surname><given-names>XH</given-names></name><name><surname>Hong</surname><given-names>LL</given-names></name><name><surname>Jiao</surname><given-names>WH</given-names></name><name><surname>Lin</surname><given-names>HW</given-names></name></person-group><article-title>Natural sesquiterpene quinone/quinols: Chemistry, biological activity, and synthesis</article-title><source>Nat Prod Reps</source><volume>40</volume><fpage>718</fpage><lpage>749</lpage><year>2023</year><pub-id pub-id-type="doi">10.1039/D2NP00045H</pub-id></element-citation></ref>
<ref id="b120-ijo-67-01-05766"><label>120</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shulha</surname><given-names>O</given-names></name><name><surname>Zidorn</surname><given-names>C</given-names></name></person-group><article-title>Sesquiterpene lactones and their precursors as chemosystematic markers in the tribe Cichorieae of the Asteraceae revisited: An update (2008-2017)</article-title><source>Phytochemistry</source><volume>163</volume><fpage>149</fpage><lpage>177</lpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2019.02.001</pub-id><pub-id pub-id-type="pmid">30837086</pub-id></element-citation></ref>
<ref id="b121-ijo-67-01-05766"><label>121</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Feng</surname><given-names>ZM</given-names></name><name><surname>Yang</surname><given-names>YN</given-names></name><name><surname>Jiang</surname><given-names>JS</given-names></name><name><surname>Zhang</surname><given-names>PC</given-names></name></person-group><article-title>Eight new eudesmane-and eremophilane-type sesquiterpenoids from Atractylodes lancea</article-title><source>Fitoterapia</source><volume>114</volume><fpage>115</fpage><lpage>121</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.fitote.2016.08.017</pub-id><pub-id pub-id-type="pmid">27592419</pub-id></element-citation></ref>
<ref id="b122-ijo-67-01-05766"><label>122</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ding</surname><given-names>HY</given-names></name><name><surname>Wu</surname><given-names>YC</given-names></name><name><surname>Linc</surname><given-names>HC</given-names></name></person-group><article-title>Phytochemical and pharmacological studies on Chinese changzhu</article-title><source>J Chin Chem Soc</source><volume>47</volume><fpage>561</fpage><lpage>566</lpage><year>2000</year><pub-id pub-id-type="doi">10.1002/jccs.200000075</pub-id></element-citation></ref>
<ref id="b123-ijo-67-01-05766"><label>123</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nakai</surname><given-names>Y</given-names></name><name><surname>Kido</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>K</given-names></name><name><surname>Kase</surname><given-names>Y</given-names></name><name><surname>Sakakibara</surname><given-names>I</given-names></name><name><surname>Higuchi</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>H</given-names></name></person-group><article-title>Effect of the rhizomes of Atractylodes lancea and its constituents on the delay of gastric emptying</article-title><source>J Ethnopharmacol</source><volume>84</volume><fpage>51</fpage><lpage>55</lpage><year>2003</year><pub-id pub-id-type="doi">10.1016/S0378-8741(02)00260-X</pub-id></element-citation></ref>
<ref id="b124-ijo-67-01-05766"><label>124</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Guo</surname><given-names>W</given-names></name><name><surname>XU</surname><given-names>B</given-names></name><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Zheng</surname><given-names>B</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>M</given-names></name><name><surname>Du</surname><given-names>XD</given-names></name></person-group><article-title>Anti-tumor effect of Hinesol on liver cancer via downregulating MEK/ERK and NF-&#x003BA;B pathway in SMMC-7721 and LM3cells</article-title><source>Chin J Pharmacol Toxicol</source><volume>32</volume><fpage>282</fpage><lpage>282</lpage><year>2018</year></element-citation></ref>
<ref id="b125-ijo-67-01-05766"><label>125</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lobo</surname><given-names>R</given-names></name><name><surname>Prabhu</surname><given-names>KS</given-names></name><name><surname>Shirwaikar</surname><given-names>A</given-names></name></person-group><article-title>Curcuma zedoaria Rosc. (White turmeric): A review of its chemical, pharmacological and ethnomedicinal properties</article-title><source>J Pharm Pharmacol</source><volume>61</volume><fpage>13</fpage><lpage>21</lpage><year>2009</year><pub-id pub-id-type="doi">10.1211/jpp.61.01.0003</pub-id><pub-id pub-id-type="pmid">19126292</pub-id></element-citation></ref>
<ref id="b126-ijo-67-01-05766"><label>126</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>Z</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Zhuang</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Peng</surname><given-names>Y</given-names></name></person-group><article-title>Curcumenol targeting YWHAG inhibits the pentose phosphate pathway and enhances antitumor effects of cisplatin</article-title><source>Evid Based Complement Alternat Med</source><volume>2022</volume><fpage>3988916</fpage><year>2022</year><pub-id pub-id-type="doi">10.1155/2022/3988916</pub-id><pub-id pub-id-type="pmid">35795276</pub-id><pub-id pub-id-type="pmcid">9251105</pub-id></element-citation></ref>
<ref id="b127-ijo-67-01-05766"><label>127</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wen</surname><given-names>Y</given-names></name><name><surname>Han</surname><given-names>J</given-names></name><name><surname>Chen</surname><given-names>J</given-names></name><name><surname>Dong</surname><given-names>J</given-names></name><name><surname>Xia</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Dai</surname><given-names>J</given-names></name><name><surname>Lu</surname><given-names>J</given-names></name><name><surname>Jin</surname><given-names>G</given-names></name><etal/></person-group><article-title>Plasma mi RNA s as early biomarkers for detecting hepatocellular carcinoma</article-title><source>Int J Cancer</source><volume>137</volume><fpage>1679</fpage><lpage>1690</lpage><year>2015</year><pub-id pub-id-type="doi">10.1002/ijc.29544</pub-id><pub-id pub-id-type="pmid">25845839</pub-id></element-citation></ref>
<ref id="b128-ijo-67-01-05766"><label>128</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yerukala Sathipati</surname><given-names>S</given-names></name><name><surname>Ho</surname><given-names>SY</given-names></name></person-group><article-title>Novel miRNA signature for predicting the stage of hepatocellular carcinoma</article-title><source>Scie Rep</source><volume>10</volume><fpage>14452</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41598-020-71324-z</pub-id></element-citation></ref>
<ref id="b129-ijo-67-01-05766"><label>129</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sartorius</surname><given-names>K</given-names></name><name><surname>Sartorius</surname><given-names>B</given-names></name><name><surname>Winkler</surname><given-names>C</given-names></name><name><surname>Chuturgoon</surname><given-names>A</given-names></name><name><surname>Makarova</surname><given-names>J</given-names></name></person-group><article-title>The biological and diagnostic role of miRNA's in hepatocellular carcinoma</article-title><source>Front Biosci (Landmark Ed)</source><volume>23</volume><fpage>1701</fpage><lpage>1720</lpage><year>2018</year><pub-id pub-id-type="doi">10.2741/4668</pub-id><pub-id pub-id-type="pmid">29293458</pub-id></element-citation></ref>
<ref id="b130-ijo-67-01-05766"><label>130</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qadir</surname><given-names>MI</given-names></name><name><surname>Rizvi</surname><given-names>SZ</given-names></name></person-group><article-title>miRNA in hepatocellular carcinoma: Pathogenesis and therapeutic approaches</article-title><source>Crit Rev Eukaryot Gene Expr</source><volume>27</volume><fpage>355</fpage><lpage>361</lpage><year>2017</year><pub-id pub-id-type="doi">10.1615/CritRevEukaryotGeneExpr.2017019539</pub-id><pub-id pub-id-type="pmid">29283330</pub-id></element-citation></ref>
<ref id="b131-ijo-67-01-05766"><label>131</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elhefnawi</surname><given-names>M</given-names></name><name><surname>Salah</surname><given-names>Z</given-names></name><name><surname>Soliman</surname><given-names>B</given-names></name></person-group><article-title>The promise of miRNA replacement therapy for hepatocellular carcinoma</article-title><source>Curr Gene Ther</source><volume>19</volume><fpage>290</fpage><lpage>304</lpage><year>2019</year><pub-id pub-id-type="doi">10.2174/1566523219666191023101433</pub-id><pub-id pub-id-type="pmid">31657677</pub-id></element-citation></ref>
<ref id="b132-ijo-67-01-05766"><label>132</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Gao</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>B</given-names></name><name><surname>Xie</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>G</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name></person-group><article-title>Identification of prognostic markers for hepatocellular carcinoma based on miRNA expression profiles</article-title><source>Life Sci</source><volume>232</volume><fpage>116596</fpage><year>2019</year><pub-id pub-id-type="doi">10.1016/j.lfs.2019.116596</pub-id><pub-id pub-id-type="pmid">31233760</pub-id></element-citation></ref>
<ref id="b133-ijo-67-01-05766"><label>133</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>D</given-names></name><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>J</given-names></name></person-group><article-title>Role of miRNA sponges in hepatocellular carcinoma</article-title><source>Clin Chim Acta</source><volume>500</volume><fpage>10</fpage><lpage>19</lpage><year>2020</year><pub-id pub-id-type="doi">10.1016/j.cca.2019.09.013</pub-id></element-citation></ref>
<ref id="b134-ijo-67-01-05766"><label>134</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nagy</surname><given-names>&#x000C1;</given-names></name><name><surname>L&#x000E1;nczky</surname><given-names>A</given-names></name><name><surname>Menyh&#x000E1;rt</surname><given-names>O</given-names></name><name><surname>Gy&#x00151;rffy</surname><given-names>B</given-names></name></person-group><article-title>Validation of miRNA prognostic power in hepatocellular carcinoma using expression data of independent datasets</article-title><source>Sci Rep</source><volume>8</volume><fpage>9227</fpage><year>2018</year><pub-id pub-id-type="doi">10.1038/s41598-018-27521-y</pub-id><pub-id pub-id-type="pmid">29907753</pub-id><pub-id pub-id-type="pmcid">6003936</pub-id></element-citation></ref>
<ref id="b135-ijo-67-01-05766"><label>135</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>R</given-names></name><name><surname>Zhong</surname><given-names>L</given-names></name><name><surname>Sun</surname><given-names>K</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Mao</surname><given-names>D</given-names></name><name><surname>Fang</surname><given-names>G</given-names></name><name><surname>Long</surname><given-names>F</given-names></name></person-group><article-title>A study on curcumol influencing proliferation and apoptosis of hepatocellular carcinoma cells through DJ-1/PTEN/PI3K/AKT Pathway</article-title><source>Biomed Res Int</source><volume>2022</volume><fpage>9912776</fpage><year>2022</year><pub-id pub-id-type="doi">10.1155/2022/9912776</pub-id><pub-id pub-id-type="pmid">35647179</pub-id><pub-id pub-id-type="pmcid">9142276</pub-id></element-citation></ref>
<ref id="b136-ijo-67-01-05766"><label>136</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirana</surname><given-names>C</given-names></name><name><surname>McIntosh</surname><given-names>GH</given-names></name><name><surname>Record</surname><given-names>IR</given-names></name><name><surname>Jones</surname><given-names>GP</given-names></name></person-group><article-title>Antitumor activity of extract of Zingiber aromaticum and its bioactive sesquiterpenoid zerumbone</article-title><source>Nutr Cancer</source><volume>45</volume><fpage>218</fpage><lpage>225</lpage><year>2003</year><pub-id pub-id-type="doi">10.1207/S15327914NC4502_12</pub-id><pub-id pub-id-type="pmid">12881017</pub-id></element-citation></ref>
<ref id="b137-ijo-67-01-05766"><label>137</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wani</surname><given-names>NA</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Teng</surname><given-names>K</given-names></name><name><surname>Barajas</surname><given-names>JM</given-names></name><name><surname>Motiwala</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>P</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Br&#x000FC;schweiler</surname><given-names>R</given-names></name><name><surname>Ghoshal</surname><given-names>K</given-names></name><name><surname>Jacob</surname><given-names>ST</given-names></name></person-group><article-title>Reprogramming of glucose metabolism by zerumbone suppresses hepatocarcinogenesis</article-title><source>Mol Cancer Res</source><volume>16</volume><fpage>256</fpage><lpage>268</lpage><year>2018</year><pub-id pub-id-type="doi">10.1158/1541-7786.MCR-17-0304</pub-id></element-citation></ref>
<ref id="b138-ijo-67-01-05766"><label>138</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Samad</surname><given-names>NA</given-names></name><name><surname>Abdul</surname><given-names>AB</given-names></name><name><surname>Rahman</surname><given-names>HS</given-names></name><name><surname>Rasedee</surname><given-names>A</given-names></name><name><surname>Tengku Ibrahim</surname><given-names>TA</given-names></name><name><surname>Keon</surname><given-names>YS</given-names></name></person-group><article-title>Zerumbone suppresses angiogenesis in HepG2 cells through inhibition of matrix metalloproteinase-9, vascular endothelial growth factor, and vascular endothelial growth factor receptor expressions</article-title><source>Pharmacogn Mag</source><volume>13</volume><issue>Suppl 4</issue><fpage>S731</fpage><lpage>S736</lpage><year>2017</year></element-citation></ref>
<ref id="b139-ijo-67-01-05766"><label>139</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdul</surname><given-names>ABH</given-names></name><name><surname>Al-Zubairi</surname><given-names>AS</given-names></name><name><surname>Tallan</surname><given-names>ND</given-names></name><name><surname>Wahab</surname><given-names>SIA</given-names></name><name><surname>Zain</surname><given-names>ZNM</given-names></name><name><surname>Ruslay</surname><given-names>S</given-names></name><name><surname>Syam</surname><given-names>MM</given-names></name></person-group><article-title>Anticancer activity of natural compound (zerumbone) extracted from Zingiber zerumbet in human HeLa cervical cancer cells</article-title><source>Int J Pharmacol</source><volume>4</volume><fpage>160</fpage><year>2008</year><pub-id pub-id-type="doi">10.3923/ijp.2008.160.168</pub-id></element-citation></ref>
<ref id="b140-ijo-67-01-05766"><label>140</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sakinah</surname><given-names>SA</given-names></name><name><surname>Handayani</surname><given-names>ST</given-names></name><name><surname>Hawariah</surname><given-names>LP</given-names></name></person-group><article-title>Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio</article-title><source>Cancer Cell Int</source><volume>7</volume><fpage>4</fpage><year>2007</year><pub-id pub-id-type="doi">10.1186/1475-2867-7-4</pub-id><pub-id pub-id-type="pmid">17407577</pub-id><pub-id pub-id-type="pmcid">1852295</pub-id></element-citation></ref>
<ref id="b141-ijo-67-01-05766"><label>141</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Taha</surname><given-names>MME</given-names></name><name><surname>Abdul</surname><given-names>AB</given-names></name><name><surname>Abdullah</surname><given-names>R</given-names></name><name><surname>Ibrahim</surname><given-names>TA</given-names></name><name><surname>Abdelwahab</surname><given-names>SI</given-names></name><name><surname>Mohan</surname><given-names>S</given-names></name></person-group><article-title>Potential chemoprevention of diethylnitrosamine-initiated and 2-acetylaminofluorene-promoted hepatocarcinogenesis by zerumbone from the rhizomes of the subtropical ginger (Zingiber zerumbet)</article-title><source>Chem Biol Interact</source><volume>186</volume><fpage>295</fpage><lpage>305</lpage><year>2010</year><pub-id pub-id-type="doi">10.1016/j.cbi.2010.04.029</pub-id><pub-id pub-id-type="pmid">20452335</pub-id></element-citation></ref>
<ref id="b142-ijo-67-01-05766"><label>142</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bora</surname><given-names>KS</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name></person-group><article-title>Phytochemical and pharmacological potential of Medicago sativa: A review</article-title><source>Pharm Biol</source><volume>49</volume><fpage>211</fpage><lpage>220</lpage><year>2011</year><pub-id pub-id-type="doi">10.3109/13880209.2010.504732</pub-id></element-citation></ref>
<ref id="b143-ijo-67-01-05766"><label>143</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rustaiyan</surname><given-names>A</given-names></name><name><surname>Masoudi</surname><given-names>S</given-names></name></person-group><article-title>Chemical constituents and biological activities of Iranian Artemisia species</article-title><source>Phytochemistry Lett</source><volume>4</volume><fpage>440</fpage><lpage>447</lpage><year>2011</year><pub-id pub-id-type="doi">10.1016/j.phytol.2011.07.003</pub-id></element-citation></ref>
<ref id="b144-ijo-67-01-05766"><label>144</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>ZZ</given-names></name><name><surname>Yan</surname><given-names>JF</given-names></name><name><surname>Song</surname><given-names>ZJ</given-names></name><name><surname>Ye</surname><given-names>F</given-names></name><name><surname>Liao</surname><given-names>X</given-names></name><name><surname>Peng</surname><given-names>SL</given-names></name><name><surname>Ding</surname><given-names>LS</given-names></name></person-group><article-title>Chemical constituents from the aerial parts of Artemisia minor</article-title><source>J Nat Prod</source><volume>72</volume><fpage>1198</fpage><lpage>1201</lpage><year>2009</year><pub-id pub-id-type="doi">10.1021/np800643n</pub-id><pub-id pub-id-type="pmid">19476336</pub-id></element-citation></ref>
<ref id="b145-ijo-67-01-05766"><label>145</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mart&#x000ED;nez</surname><given-names>MJA</given-names></name><name><surname>Del Olmo</surname><given-names>LMB</given-names></name><name><surname>Ticona</surname><given-names>LA</given-names></name><name><surname>Benito</surname><given-names>PB</given-names></name></person-group><article-title>The Artemisia L. genus: A review of bioactive sesquiterpene lactones</article-title><source>Stud Natu Products Chem</source><volume>37</volume><fpage>43</fpage><lpage>65</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/B978-0-444-59514-0.00002-X</pub-id></element-citation></ref>
<ref id="b146-ijo-67-01-05766"><label>146</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suresh</surname><given-names>J</given-names></name><name><surname>Mahesh</surname><given-names>NM</given-names></name><name><surname>Ahuja</surname><given-names>J</given-names></name><name><surname>Santilna</surname><given-names>KS</given-names></name></person-group><article-title>Review on Artemisia nilagirica (Clarke) pamp</article-title><source>J Biol Active Products Nat</source><volume>1</volume><fpage>97</fpage><lpage>104</lpage><year>2011</year></element-citation></ref>
<ref id="b147-ijo-67-01-05766"><label>147</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>X</given-names></name><name><surname>Ma</surname><given-names>W</given-names></name><name><surname>Hu</surname><given-names>J</given-names></name><name><surname>Li</surname><given-names>T</given-names></name><name><surname>Geng</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>M</given-names></name><name><surname>Yang</surname><given-names>K</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Diverse structures and antihepatoma effect of sesquiterpenoid dimers from Artemisia eriopoda by AKT/STAT signaling pathway</article-title><source>Signal Transduct Target Ther</source><volume>8</volume><fpage>64</fpage><year>2023</year><pub-id pub-id-type="doi">10.1038/s41392-022-01267-6</pub-id><pub-id pub-id-type="pmid">36788208</pub-id><pub-id pub-id-type="pmcid">9929101</pub-id></element-citation></ref>
<ref id="b148-ijo-67-01-05766"><label>148</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>J</given-names></name><name><surname>Lai</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>M</given-names></name><name><surname>Zhen</surname><given-names>T</given-names></name><name><surname>Hu</surname><given-names>H</given-names></name><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Wong</surname><given-names>AST</given-names></name><name><surname>Zeng</surname><given-names>JZ</given-names></name></person-group><article-title>Orphan nuclear receptor Nur77 mediates the lethal endoplasmic reticulum stress and therapeutic efficacy of cryptomeridiol in hepatocellular carcinoma</article-title><source>Cells</source><volume>11</volume><fpage>3870</fpage><year>2022</year><pub-id pub-id-type="doi">10.3390/cells11233870</pub-id><pub-id pub-id-type="pmid">36497127</pub-id><pub-id pub-id-type="pmcid">9737475</pub-id></element-citation></ref>
<ref id="b149-ijo-67-01-05766"><label>149</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>FQ</given-names></name><name><surname>Li</surname><given-names>SP</given-names></name><name><surname>Gao</surname><given-names>JL</given-names></name><name><surname>Hu</surname><given-names>G</given-names></name><name><surname>Lao</surname><given-names>SC</given-names></name><name><surname>Concei&#x000E7;&#x000E3;o</surname><given-names>EL</given-names></name><name><surname>Fung</surname><given-names>KP</given-names></name><name><surname>Wangl</surname><given-names>YT</given-names></name><name><surname>Lee</surname><given-names>SM</given-names></name></person-group><article-title>Furanodiene induces G2/M cell cycle arrest and apoptosis through MAPK signaling and mitochondria-caspase pathway in human hepatocellular carcinoma cells</article-title><source>Cancer Biol Ther</source><volume>6</volume><fpage>1044</fpage><lpage>1050</lpage><year>2014</year></element-citation></ref>
<ref id="b150-ijo-67-01-05766"><label>150</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>WD</given-names></name><name><surname>Deng</surname><given-names>R</given-names></name><name><surname>Li</surname><given-names>DD</given-names></name><name><surname>Wu</surname><given-names>KW</given-names></name><name><surname>Feng</surname><given-names>GK</given-names></name><name><surname>Li</surname><given-names>HJ</given-names></name><name><surname>Zhu</surname><given-names>XF</given-names></name></person-group><article-title>Hirsutanol A induces apoptosis and autophagy via reactive oxygen species accumulation in breast cancer MCF-7 cells</article-title><source>J Pharmacol Sci</source><volume>119</volume><fpage>214</fpage><lpage>220</lpage><year>2012</year><pub-id pub-id-type="doi">10.1254/jphs.11235FP</pub-id><pub-id pub-id-type="pmid">22786562</pub-id></element-citation></ref>
<ref id="b151-ijo-67-01-05766"><label>151</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Chen</surname><given-names>WD</given-names></name><name><surname>Deng</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>H</given-names></name><name><surname>Tang</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>KW</given-names></name><name><surname>Li</surname><given-names>DD</given-names></name><name><surname>Feng</surname><given-names>GK</given-names></name><name><surname>Lan</surname><given-names>WJ</given-names></name><name><surname>Li</surname><given-names>HJ</given-names></name><name><surname>Zhu</surname><given-names>XF</given-names></name></person-group><article-title>Hirsutanol A, a novel sesquiterpene compound from fungus Chondrostereum sp., induces apoptosis and inhibits tumor growth through mitochondrial-independent ROS production: Hirsutanol A inhibits tumor growth through ROS production</article-title><source>J Transl Med</source><volume>11</volume><fpage>32</fpage><year>2013</year><pub-id pub-id-type="doi">10.1186/1479-5876-11-32</pub-id><pub-id pub-id-type="pmid">23394457</pub-id><pub-id pub-id-type="pmcid">3637523</pub-id></element-citation></ref>
<ref id="b152-ijo-67-01-05766"><label>152</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Mao</surname><given-names>Y</given-names></name><name><surname>Hou</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>X</given-names></name></person-group><article-title>The effect of beta-elemene on alpha-tubulin polymerization in human hepatoma HepG2 cells</article-title><source>Chin J Cancer Res</source><volume>25</volume><fpage>770</fpage><lpage>776</lpage><year>2013</year></element-citation></ref>
<ref id="b153-ijo-67-01-05766"><label>153</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name><name><surname>Liang</surname><given-names>X</given-names></name><name><surname>Wu</surname><given-names>L</given-names></name><name><surname>Cui</surname><given-names>S</given-names></name><name><surname>Guo</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Assessing the quality of RCTs on the effect of beta-elemene, one ingredient of a Chinese herb, against malignant tumors</article-title><source>Contemp Clin Trials</source><volume>27</volume><fpage>70</fpage><lpage>82</lpage><year>2006</year><pub-id pub-id-type="doi">10.1016/j.cct.2005.07.002</pub-id></element-citation></ref>
<ref id="b154-ijo-67-01-05766"><label>154</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>G</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>H</given-names></name><name><surname>Ren</surname><given-names>Y</given-names></name><name><surname>Shen</surname><given-names>YM</given-names></name></person-group><article-title>Synthesis and in vitro anti-proliferative activity of &#x003B2;-elemene monosubstituted derivatives in HeLa cells mediated through arrest of cell cycle at the G1 phase</article-title><source>Bioorg Med Chem</source><volume>17</volume><fpage>1118</fpage><lpage>1124</lpage><year>2009</year><pub-id pub-id-type="doi">10.1016/j.bmc.2008.12.040</pub-id><pub-id pub-id-type="pmid">19128976</pub-id></element-citation></ref>
<ref id="b155-ijo-67-01-05766"><label>155</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>B</given-names></name><name><surname>Jiang</surname><given-names>Y</given-names></name><name><surname>Zhu</surname><given-names>F</given-names></name><name><surname>Sun</surname><given-names>D</given-names></name><name><surname>Huang</surname><given-names>H</given-names></name></person-group><article-title>Demethylation effects of elemene on the GSTP1 gene in HCC cell line QGY7703</article-title><source>Oncol Lett</source><volume>11</volume><fpage>2545</fpage><lpage>2551</lpage><year>2016</year><pub-id pub-id-type="doi">10.3892/ol.2016.4243</pub-id><pub-id pub-id-type="pmid">27073515</pub-id><pub-id pub-id-type="pmcid">4812123</pub-id></element-citation></ref>
<ref id="b156-ijo-67-01-05766"><label>156</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Guo</surname><given-names>Y</given-names></name><name><surname>Wei</surname><given-names>W</given-names></name><name><surname>Wang</surname><given-names>B</given-names></name><name><surname>Jin</surname><given-names>H</given-names></name><name><surname>Sun</surname><given-names>J</given-names></name><name><surname>Qi</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>S</given-names></name><name><surname>Zuo</surname><given-names>Y</given-names></name></person-group><article-title>Anti-tumor effect of &#x003B2;-elemene in murine hepatocellular carcinoma cell line H22 depends on the level of c-Met downregulation</article-title><source>Biomedicine Preventive Nutr</source><volume>2</volume><fpage>91</fpage><lpage>98</lpage><year>2012</year><pub-id pub-id-type="doi">10.1016/j.bionut.2012.01.005</pub-id></element-citation></ref>
<ref id="b157-ijo-67-01-05766"><label>157</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ni</surname><given-names>G</given-names></name><name><surname>Shi</surname><given-names>GR</given-names></name><name><surname>Zhang</surname><given-names>D</given-names></name><name><surname>Fu</surname><given-names>NJ</given-names></name><name><surname>Yang</surname><given-names>HZ</given-names></name><name><surname>Chen</surname><given-names>XG</given-names></name><name><surname>Yu</surname><given-names>DQ</given-names></name></person-group><article-title>Cytotoxic Lignans and Sesquiterpenoids from the Rhizomes of Acorus tatarinowii</article-title><source>Planta Medica</source><volume>82</volume><fpage>632</fpage><lpage>638</lpage><year>2016</year><pub-id pub-id-type="doi">10.1055/s-0035-1568248</pub-id><pub-id pub-id-type="pmid">26848706</pub-id></element-citation></ref>
<ref id="b158-ijo-67-01-05766"><label>158</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Wei</surname><given-names>HB</given-names></name><name><surname>Xu</surname><given-names>YZ</given-names></name><name><surname>Hu</surname><given-names>SC</given-names></name><name><surname>Gao</surname><given-names>K</given-names></name></person-group><article-title>Senedensiscins A-F: Six new eudesmane sesquiterpenoid glucosides from Senecio densiserratus</article-title><source>Tetrahedron</source><volume>69</volume><fpage>10598</fpage><lpage>10603</lpage><year>2013</year><pub-id pub-id-type="doi">10.1016/j.tet.2013.10.047</pub-id></element-citation></ref>
<ref id="b159-ijo-67-01-05766"><label>159</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>ML</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name><name><surname>Wei</surname><given-names>HB</given-names></name><name><surname>Gao</surname><given-names>K</given-names></name></person-group><article-title>Cytotoxic sesquiterpenoids from Senecio densiserratus</article-title><source>Phytochemistry Lett</source><volume>16</volume><fpage>236</fpage><lpage>240</lpage><year>2016</year><pub-id pub-id-type="doi">10.1016/j.phytol.2016.04.017</pub-id></element-citation></ref>
<ref id="b160-ijo-67-01-05766"><label>160</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tsevegsuren</surname><given-names>N</given-names></name><name><surname>Edrada</surname><given-names>RA</given-names></name><name><surname>Lin</surname><given-names>W</given-names></name><name><surname>Ebel</surname><given-names>R</given-names></name><name><surname>Torre</surname><given-names>C</given-names></name><name><surname>Ortlepp</surname><given-names>S</given-names></name><name><surname>Wray</surname><given-names>V</given-names></name><name><surname>Proksch</surname><given-names>P</given-names></name></person-group><article-title>Biologically active natural products from Mongolian medicinal plants Scorzonera divaricata and Scorzonera pseudodivaricata</article-title><source>J Nat Prod</source><volume>70</volume><fpage>962</fpage><lpage>967</lpage><year>2007</year><pub-id pub-id-type="doi">10.1021/np070013r</pub-id><pub-id pub-id-type="pmid">17542634</pub-id></element-citation></ref>
<ref id="b161-ijo-67-01-05766"><label>161</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Q</given-names></name><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Jiang</surname><given-names>CX</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Shi</surname><given-names>ZN</given-names></name><name><surname>Li</surname><given-names>HF</given-names></name><name><surname>Zhu</surname><given-names>Y</given-names></name></person-group><article-title>Two novel bioactive sulfated guaiane sesquiterpenoid salt alkaloids from the aerial parts of Scorzonera divaricata</article-title><source>Fitoterapia</source><volume>124</volume><fpage>113</fpage><lpage>119</lpage><year>2018</year><pub-id pub-id-type="doi">10.1016/j.fitote.2017.10.011</pub-id></element-citation></ref>
<ref id="b162-ijo-67-01-05766"><label>162</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shang</surname><given-names>C</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Artemongolins A-K, undescribed germacrane-guaiane sesquiterpenoid dimers from Artemisia mongolica and their antihepatoma activities</article-title><source>Arch Pharm Res</source><volume>46</volume><fpage>782</fpage><lpage>794</lpage><year>2023</year><pub-id pub-id-type="doi">10.1007/s12272-023-01466-x</pub-id><pub-id pub-id-type="pmid">37770811</pub-id></element-citation></ref>
<ref id="b163-ijo-67-01-05766"><label>163</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>MF</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Wang</surname><given-names>YC</given-names></name><name><surname>Li</surname><given-names>FJ</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Artemyriantholides A-K, guaiane-type sesquiterpenoid dimers from Artemisia myriantha var. pleiocephala and their antihepatoma activity</article-title><source>Phytochemistry</source><volume>222</volume><fpage>114100</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2024.114100</pub-id><pub-id pub-id-type="pmid">38636688</pub-id></element-citation></ref>
<ref id="b164-ijo-67-01-05766"><label>164</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>He</surname><given-names>XF</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Highly oxygenated guaiane-type sesquiterpene lactones from Artemisia sacrorum and their antihepatoma activity</article-title><source>Phytochemistry</source><volume>217</volume><fpage>113930</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.phytochem.2023.113930</pub-id></element-citation></ref>
<ref id="b165-ijo-67-01-05766"><label>165</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Li</surname><given-names>TZ</given-names></name><name><surname>Ma</surname><given-names>YB</given-names></name><name><surname>Ma</surname><given-names>WJ</given-names></name><name><surname>Xue</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>JJ</given-names></name></person-group><article-title>Synthesis and antihepatoma activity of guaianolide dimers derived from lavandiolide I</article-title><source>Bioorg Med Chem Lett</source><volume>104</volume><fpage>129708</fpage><year>2024</year><pub-id pub-id-type="doi">10.1016/j.bmcl.2024.129708</pub-id><pub-id pub-id-type="pmid">38521176</pub-id></element-citation></ref>
<ref id="b166-ijo-67-01-05766"><label>166</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fang</surname><given-names>JY</given-names></name><name><surname>Richardson</surname><given-names>BC</given-names></name></person-group><article-title>The MAPK signalling pathways and colorectal cancer</article-title><source>Lancet Oncol</source><volume>6</volume><fpage>322</fpage><lpage>327</lpage><year>2005</year><pub-id pub-id-type="doi">10.1016/S1470-2045(05)70168-6</pub-id><pub-id pub-id-type="pmid">15863380</pub-id></element-citation></ref>
<ref id="b167-ijo-67-01-05766"><label>167</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meloche</surname><given-names>S</given-names></name><name><surname>Pouyss&#x000E9;gur</surname><given-names>J</given-names></name></person-group><article-title>The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1-to S-phase transition</article-title><source>Oncogene</source><volume>26</volume><fpage>3227</fpage><lpage>3239</lpage><year>2007</year><pub-id pub-id-type="doi">10.1038/sj.onc.1210414</pub-id><pub-id pub-id-type="pmid">17496918</pub-id></element-citation></ref>
<ref id="b168-ijo-67-01-05766"><label>168</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yang</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Wang</surname><given-names>D</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Bai</surname><given-names>X</given-names></name></person-group><article-title>Hydroxysafflor yellow A inhibits angiogenesis of hepatocellular carcinoma via blocking ERK/MAPK and NF-&#x003BA;B signaling pathway in H22 tumor-bearing mice</article-title><source>Eur J Pharmacol</source><volume>754</volume><fpage>105</fpage><lpage>114</lpage><year>2015</year><pub-id pub-id-type="doi">10.1016/j.ejphar.2015.02.015</pub-id><pub-id pub-id-type="pmid">25720342</pub-id></element-citation></ref>
<ref id="b169-ijo-67-01-05766"><label>169</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cusimano</surname><given-names>A</given-names></name><name><surname>Foder&#x000E0;</surname><given-names>D</given-names></name><name><surname>D'Alessandro</surname><given-names>N</given-names></name><name><surname>Lampiasi</surname><given-names>N</given-names></name><name><surname>Azzolina</surname><given-names>A</given-names></name><name><surname>Montalto</surname><given-names>G</given-names></name><name><surname>Cervello</surname><given-names>M</given-names></name></person-group><article-title>Potentiation of the antitumor effects of both selective cyclooxygenase-1 and cyclooxygenase-2 inhibitors in human hepatic cancer cells by inhibition of the MEK/ERK pathway</article-title><source>Cancer Biol Ther</source><volume>6</volume><fpage>1457</fpage><lpage>1464</lpage><year>2007</year><pub-id pub-id-type="doi">10.4161/cbt.6.9.4629</pub-id></element-citation></ref>
<ref id="b170-ijo-67-01-05766"><label>170</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>XD</given-names></name><name><surname>Meng</surname><given-names>FC</given-names></name><name><surname>Mao</surname><given-names>JX</given-names></name></person-group><article-title>Progress of natural sesquiterpenoids in the treatment of hepatocellular carcinoma</article-title><source>Front Oncol</source><volume>14</volume><fpage>1445222</fpage><year>2024</year><pub-id pub-id-type="doi">10.3389/fonc.2024.1445222</pub-id><pub-id pub-id-type="pmid">39081717</pub-id><pub-id pub-id-type="pmcid">11286475</pub-id></element-citation></ref>
<ref id="b171-ijo-67-01-05766"><label>171</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>T</given-names></name><name><surname>Sun</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Fu</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Li</surname><given-names>C</given-names></name></person-group><article-title>p53-mediated PI3K/AKT/mTOR pathway played a role in Ptox<sup>Dpt</sup>-induced EMT inhibition in liver cancer cell lines</article-title><source>Oxid Med Cell Longev</source><volume>2019</volume><fpage>2531493</fpage><year>2019</year></element-citation></ref>
<ref id="b172-ijo-67-01-05766"><label>172</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kahraman</surname><given-names>DC</given-names></name><name><surname>Kahraman</surname><given-names>T</given-names></name><name><surname>Cetin-Atalay</surname><given-names>R</given-names></name></person-group><article-title>Targeting PI3K/Akt/mTOR pathway identifies differential expression and functional role of IL8 in liver cancer stem cell enrichment</article-title><source>Mol Cancer Ther</source><volume>18</volume><fpage>2146</fpage><lpage>2157</lpage><year>2019</year><pub-id pub-id-type="doi">10.1158/1535-7163.MCT-19-0004</pub-id><pub-id pub-id-type="pmid">31439713</pub-id></element-citation></ref>
<ref id="b173-ijo-67-01-05766"><label>173</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Luedde</surname><given-names>T</given-names></name><name><surname>Schwabe</surname><given-names>RF</given-names></name></person-group><article-title>NF-&#x003BA;B in the liver-linking injury, fibrosis and hepatocellular carcinoma</article-title><source>Nat Rev Gastroenterol Hepatol</source><volume>8</volume><fpage>108</fpage><lpage>118</lpage><year>2011</year><pub-id pub-id-type="doi">10.1038/nrgastro.2010.213</pub-id><pub-id pub-id-type="pmid">21293511</pub-id><pub-id pub-id-type="pmcid">3295539</pub-id></element-citation></ref>
<ref id="b174-ijo-67-01-05766"><label>174</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>CL</given-names></name><name><surname>Jurk</surname><given-names>D</given-names></name><name><surname>Fullard</surname><given-names>N</given-names></name><name><surname>Banks</surname><given-names>P</given-names></name><name><surname>Page</surname><given-names>A</given-names></name><name><surname>Luli</surname><given-names>S</given-names></name><name><surname>Elsharkawy</surname><given-names>AM</given-names></name><name><surname>Gieling</surname><given-names>RG</given-names></name><name><surname>Chakraborty</surname><given-names>JB</given-names></name><name><surname>Fox</surname><given-names>C</given-names></name><etal/></person-group><article-title>NF&#x003BA;B1 is a suppressor of neutrophil-driven hepatocellular carcinoma</article-title><source>Nat Commun</source><volume>6</volume><fpage>6818</fpage><year>2015</year><pub-id pub-id-type="doi">10.1038/ncomms7818</pub-id></element-citation></ref>
<ref id="b175-ijo-67-01-05766"><label>175</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>C</given-names></name><name><surname>Cheung</surname><given-names>ST</given-names></name></person-group><article-title>STAT3: An emerging therapeutic target for hepatocellular carcinoma</article-title><source>Cancers</source><volume>11</volume><fpage>1646</fpage><year>2019</year><pub-id pub-id-type="doi">10.3390/cancers11111646</pub-id><pub-id pub-id-type="pmid">31731457</pub-id><pub-id pub-id-type="pmcid">6895841</pub-id></element-citation></ref>
<ref id="b176-ijo-67-01-05766"><label>176</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boland</surname><given-names>ML</given-names></name><name><surname>Chourasis</surname><given-names>AH</given-names></name><name><surname>Macleod</surname><given-names>KF</given-names></name></person-group><article-title>Mitochondrial dysfunction in cancer</article-title><source>Front Oncol</source><volume>3</volume><fpage>292</fpage><year>2013</year><pub-id pub-id-type="doi">10.3389/fonc.2013.00292</pub-id><pub-id pub-id-type="pmid">24350057</pub-id><pub-id pub-id-type="pmcid">3844930</pub-id></element-citation></ref>
<ref id="b177-ijo-67-01-05766"><label>177</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>KH</given-names></name><name><surname>Huang</surname><given-names>ES</given-names></name><name><surname>Piantadosi</surname><given-names>C</given-names></name><name><surname>Pagano</surname><given-names>JS</given-names></name><name><surname>Geissman</surname><given-names>TA</given-names></name></person-group><article-title>Cytotoxicity of sesquiterpene lactones</article-title><source>Cancer Res</source><volume>31</volume><fpage>1649</fpage><lpage>1654</lpage><year>1971</year><pub-id pub-id-type="pmid">4330633</pub-id></element-citation></ref>
<ref id="b178-ijo-67-01-05766"><label>178</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lopez-Anton</surname><given-names>N</given-names></name><name><surname>Hermann</surname><given-names>C</given-names></name><name><surname>Murillo</surname><given-names>R</given-names></name><name><surname>Merfort</surname><given-names>I</given-names></name><name><surname>Wanner</surname><given-names>G</given-names></name><name><surname>Vollmar</surname><given-names>AM</given-names></name><name><surname>Dirsch</surname><given-names>VM</given-names></name></person-group><article-title>Sesquiterpene lactones induce distinct forms of cell death that modulate human Monocyte-derived macrophage responses</article-title><source>Apoptosis</source><volume>12</volume><fpage>141</fpage><lpage>153</lpage><year>2007</year><pub-id pub-id-type="doi">10.1007/s10495-006-0331-2</pub-id></element-citation></ref>
<ref id="b179-ijo-67-01-05766"><label>179</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bai</surname><given-names>Z</given-names></name><name><surname>Yao</surname><given-names>C</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><name><surname>Xie</surname><given-names>Y</given-names></name><name><surname>Ye</surname><given-names>XY</given-names></name><name><surname>Bai</surname><given-names>R</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name></person-group><article-title>Anti-tumor drug discovery based on natural product &#x003B2;-elemene: Anti-tumor mechanisms and structural modification</article-title><source>Molecules</source><volume>26</volume><fpage>1499</fpage><year>2021</year><pub-id pub-id-type="doi">10.3390/molecules26061499</pub-id></element-citation></ref>
<ref id="b180-ijo-67-01-05766"><label>180</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Li</surname><given-names>CL</given-names></name><name><surname>Wang</surname><given-names>SL</given-names></name></person-group><article-title>Basic research progress of natural anticancer target drugs of elemene liposomes series</article-title><source>Zhongguo Zhong Xi Yi Jie He Za Zhi</source><volume>34</volume><fpage>507</fpage><lpage>512</lpage><year>2014</year><comment>In Chinese</comment><pub-id pub-id-type="pmid">24812915</pub-id></element-citation></ref>
<ref id="b181-ijo-67-01-05766"><label>181</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhai</surname><given-names>B</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>Zeng</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>N</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Zeng</surname><given-names>Y</given-names></name><name><surname>You</surname><given-names>Y</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Sui</surname><given-names>X</given-names></name><name><surname>Xie</surname><given-names>T</given-names></name></person-group><article-title>Drug delivery systems for elemene, its main active ingredient &#x003B2;-elemene, and its derivatives in cancer therapy</article-title><source>Int J Nanomedicine</source><volume>13</volume><fpage>6279</fpage><lpage>6296</lpage><year>2018</year><pub-id pub-id-type="doi">10.2147/IJN.S174527</pub-id><pub-id pub-id-type="pmcid">6186893</pub-id></element-citation></ref>
<ref id="b182-ijo-67-01-05766"><label>182</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>T</given-names></name><name><surname>Cl</surname><given-names>L</given-names></name><name><surname>Wang</surname><given-names>SL</given-names></name><name><surname>Zeng</surname><given-names>ZW</given-names></name><name><surname>Wang</surname><given-names>F</given-names></name><name><surname>Zhao</surname><given-names>R</given-names></name></person-group><article-title>Advances in the research of Elemene Liposome series targeted anticancer natural drugs</article-title><source>Chin J Integr Trad West Med</source><volume>34</volume><fpage>507</fpage><lpage>512</lpage><year>2014</year></element-citation></ref>
<ref id="b183-ijo-67-01-05766"><label>183</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Xu</surname><given-names>K</given-names></name><name><surname>Pian</surname><given-names>G</given-names></name><name><surname>Sun</surname><given-names>S</given-names></name></person-group><article-title>Artesunate and sorafenib: Combinatorial inhibition of liver cancer cell growth</article-title><source>Oncol Lett</source><volume>18</volume><fpage>4735</fpage><lpage>4743</lpage><year>2019</year><pub-id pub-id-type="pmid">31611983</pub-id><pub-id pub-id-type="pmcid">6781774</pub-id></element-citation></ref>
<ref id="b184-ijo-67-01-05766"><label>184</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yao</surname><given-names>X</given-names></name><name><surname>Zhao</surname><given-names>CR</given-names></name><name><surname>Yin</surname><given-names>H</given-names></name><name><surname>Wang</surname><given-names>K</given-names></name><name><surname>Gao</surname><given-names>JJ</given-names></name></person-group><article-title>Synergistic antitumor activity of sorafenib and artesunate in hepatocellular carinoma cells</article-title><source>Acta Pharmacol Sin</source><volume>41</volume><fpage>1609</fpage><lpage>1620</lpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41401-020-0395-5</pub-id><pub-id pub-id-type="pmid">32300243</pub-id><pub-id pub-id-type="pmcid">7921114</pub-id></element-citation></ref>
<ref id="b185-ijo-67-01-05766"><label>185</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alven</surname><given-names>S</given-names></name><name><surname>Aderibigbe</surname><given-names>BA</given-names></name></person-group><article-title>Nanoparticles formulations of artemisinin and derivatives as potential therapeutics for the treatment of cancer, leishmaniasis and malaria</article-title><source>Pharmaceutics</source><volume>12</volume><fpage>748</fpage><year>2020</year><pub-id pub-id-type="doi">10.3390/pharmaceutics12080748</pub-id><pub-id pub-id-type="pmid">32784933</pub-id><pub-id pub-id-type="pmcid">7466127</pub-id></element-citation></ref>
<ref id="b186-ijo-67-01-05766"><label>186</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pan</surname><given-names>XW</given-names></name><name><surname>Huang</surname><given-names>JS</given-names></name><name><surname>Liu</surname><given-names>SR</given-names></name><name><surname>Shao</surname><given-names>YD</given-names></name><name><surname>Xi</surname><given-names>JJ</given-names></name><name><surname>He</surname><given-names>RY</given-names></name><name><surname>Shi</surname><given-names>TT</given-names></name><name><surname>Zhuang</surname><given-names>RX</given-names></name><name><surname>Bao</surname><given-names>JF</given-names></name></person-group><article-title>Evaluation of the liver targeting and anti-liver cancer activity of artesunate-loaded and glycyrrhetinic acid-coated nanoparticles</article-title><source>Exp Ther Med</source><volume>26</volume><fpage>516</fpage><year>2023</year><pub-id pub-id-type="doi">10.3892/etm.2023.12215</pub-id></element-citation></ref>
<ref id="b187-ijo-67-01-05766"><label>187</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hermida</surname><given-names>MA</given-names></name><name><surname>Kumar</surname><given-names>JD</given-names></name><name><surname>Leslie</surname><given-names>NR</given-names></name></person-group><article-title>GSK3 and its interactions with the PI3K/AKT/mTOR signalling network</article-title><source>Adv Biol Regul</source><volume>65</volume><fpage>5</fpage><lpage>15</lpage><year>2017</year><pub-id pub-id-type="doi">10.1016/j.jbior.2017.06.003</pub-id><pub-id pub-id-type="pmid">28712664</pub-id></element-citation></ref>
<ref id="b188-ijo-67-01-05766"><label>188</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tang</surname><given-names>W</given-names></name><name><surname>Chen</surname><given-names>Z</given-names></name><name><surname>Zhang</surname><given-names>W</given-names></name><name><surname>Cheng</surname><given-names>Y</given-names></name><name><surname>Zhang</surname><given-names>B</given-names></name><name><surname>Wu</surname><given-names>F</given-names></name><name><surname>Wang</surname><given-names>Q</given-names></name><name><surname>Wang</surname><given-names>S</given-names></name><name><surname>Rong</surname><given-names>D</given-names></name><name><surname>Reiter</surname><given-names>FP</given-names></name><etal/></person-group><article-title>The mechanisms of sorafenib resistance in hepatocellular carcinoma: Theoretical basis and therapeutic aspects</article-title><source>Signal Transduct Target Ther</source><volume>5</volume><fpage>87</fpage><year>2020</year><pub-id pub-id-type="doi">10.1038/s41392-020-0187-x</pub-id><pub-id pub-id-type="pmid">32532960</pub-id><pub-id pub-id-type="pmcid">7292831</pub-id></element-citation></ref></ref-list></back>
<floats-group>
<fig id="f1-ijo-67-01-05766" position="float">
<label>Figure 1</label>
<caption>
<p>Chemical structures of sesquiterpenoids.</p></caption>
<graphic xlink:href="ijo-67-01-05766-g00.tif"/></fig>
<fig id="f2-ijo-67-01-05766" position="float">
<label>Figure 2</label>
<caption>
<p>Mechanistic pathways of sesquiterpenoids in hepatocellular carcinoma. (A) Gingerone, (B) Santamarine, (C) Germacenone and (D) Linalool (figure was drawn with Figdraw). PDK1, protein kinase domain containing 1; PI3K, phosphatidylinositol 3-kinase; PIP2, phosphatidylinositol(<xref rid="b4-ijo-67-01-05766" ref-type="bibr">4</xref>,<xref rid="b5-ijo-67-01-05766" ref-type="bibr">5</xref>)bisphosphate; PIP3, phosphatidylinositol 3,4,5-triphosphate; mTORC2, mammalian target of rapamycin complex 2; AKT(PKB), protein kinase B; MDM2, mdm2 proto-oncogene. TNF-&#x003B1;, tumor necrosis factor-&#x003B1;. TRADD, tumor necrosis factor receptor 1-associated death domain protein; TRAF2/5, tumor necrosis factor receptor-associated factor 2/5; RIP1, receptor interacting serine/threonine-protein kinase 1; TAK1, thymidine kinase 1; IKK&#x003B2;, inhibitor of &#x003BA;B kinase &#x003B2;; I&#x003BA;B-&#x003B1;, inhibitor of nuclear factor &#x003BA;B &#x003B1;; IL-1&#x003B2;, interleukin-1&#x003B2;; NF-&#x003BA;B, nuclear factor-&#x003BA;B; Bcl-2, B-cell lymphoma-2; ROS, reactive oxygen species; ERK, extracellular signal-regulated kinase; MAPK, mitogen-activated protein kinases; AMPK, adenosinemonophosphate-activated protein kinase; RAF, rapidly accelerated fibrosarcoma; MEK, mitogen-activated protein kinase kinase; GSH, glutathione; NADH, nicotinamide adenine dinucleotide; ADP, adenosine diphosphate; ATP, adenosine triphosphate; NAD<sup>+</sup>, nicotinamide adenine dinucleotide; RTS, radiation therapy simulation.</p></caption>
<graphic xlink:href="ijo-67-01-05766-g01.tif"/></fig>
<fig id="f3-ijo-67-01-05766" position="float">
<label>Figure 3</label>
<caption>
<p>Mechanistic pathways of sesquiterpenoids in hepatocellular carcinoma. (A) Hinesol, (B) Ar-turmerone, (C) Xanthatin and (D) &#x003B1;-bisabolol (figure was drawn with Figdraw). GRB2, growth factor receptor-bound protein 2; SOS, suppressor of tumorigenicity 1; RAS, rat sarcoma; GTR, G-protein coupled receptors; GDP, GDP-D-mannose pyrophosphorylase; RAF, rapidly accelerated fibrosarcoma; MEK/MAPKK, MAPK kinase; ERK, extracellular signal-regulated kinase; MAPKKK, MAPK kinase kinase; MAPK, mitogen-activated protein kinases; NF-&#x003BA;B, nuclear factor-&#x003BA;B; MSK1/2, mitogen- and stress-activated protein kinases; Erk1/2, extracellular signal-regulated kinase; ASK1, apoptosis signal-regulating kinase 1; MT, metallothionein; MKK4/7, MAPK kinase 4/7; JNK, c-Jun N-terminal kinase; ER, endoplasmic reticulum; BIP, binding immunoglobulin protein; CHOP, C/EBP homologous protein; ATF4, activating transcription factor 4; PERK, protein kinase R-like endoplasmic reticulum kinase; eIF2&#x003B1;, eukaryotic translation initiation factor 2&#x003B1;; FADD, fas-associating protein with a novel death domain; Bid, BH3-interacting domain death agonist; Bax, BCL2-associated X; Bcl-2, B-cell lymphoma-2; Cyt c, cytochrome C; Caspase-3, cysteinyl aspartate-specific proteinase-3.</p></caption>
<graphic xlink:href="ijo-67-01-05766-g02.tif"/></fig>
<table-wrap id="tI-ijo-67-01-05766" position="float">
<label>Table I</label>
<caption>
<p>Basic information on various natural sesquiterpenoids.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Name of compound</th>
<th valign="top" align="center">Molecular formula</th>
<th valign="top" align="center">Relative molecular mass</th>
<th valign="top" align="center">Source</th>
<th valign="top" align="center">(Refs.)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Acorusin E</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>22</sub>O<sub>5</sub></td>
<td valign="top" align="center">282</td>
<td valign="top" align="left"><italic>Acori tatarinowii</italic> rhizoma</td>
<td valign="top" align="center">(<xref rid="b150-ijo-67-01-05766" ref-type="bibr">150</xref>)</td></tr>
<tr>
<td valign="top" align="left">Ar-turmerone</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O</td>
<td valign="top" align="center">236</td>
<td valign="top" align="left">Turmeric</td>
<td valign="top" align="center">(<xref rid="b104-ijo-67-01-05766" ref-type="bibr">104</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemeriopodin G7</td>
<td valign="top" align="left">C<sub>29</sub>H<sub>36</sub>O<sub>6</sub></td>
<td valign="top" align="center">516</td>
<td valign="top" align="left"><italic>Artemisia australis</italic></td>
<td valign="top" align="center">(<xref rid="b135-ijo-67-01-05766" ref-type="bibr">135</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemiprincepsolides A</td>
<td valign="top" align="left">C<sub>30</sub>H<sub>38</sub>O<sub>6</sub></td>
<td valign="top" align="center">539</td>
<td valign="top" align="left"><italic>Artemisia princeps</italic></td>
<td valign="top" align="center">(<xref rid="b78-ijo-67-01-05766" ref-type="bibr">78</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemongolins E</td>
<td valign="top" align="left">C<sub>31</sub>H<sub>39</sub>O<sub>8</sub></td>
<td valign="top" align="center">539</td>
<td valign="top" align="left"><italic>Artemisia mongolica</italic></td>
<td valign="top" align="center">(<xref rid="b155-ijo-67-01-05766" ref-type="bibr">155</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemisacrolide B</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>24</sub>O<sub>5</sub></td>
<td valign="top" align="center">377</td>
<td valign="top" align="left"><italic>Artemisia sacrorum</italic></td>
<td valign="top" align="center">(<xref rid="b157-ijo-67-01-05766" ref-type="bibr">157</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemisinin</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>22</sub>O<sub>5</sub></td>
<td valign="top" align="center">284</td>
<td valign="top" align="left"><italic>Artemisia apiacea</italic></td>
<td valign="top" align="center">(<xref rid="b27-ijo-67-01-05766" ref-type="bibr">27</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemyriantholide E</td>
<td valign="top" align="left">C<sub>30</sub>H<sub>33</sub>O<sub>6</sub>Cl</td>
<td valign="top" align="center">523</td>
<td valign="top" align="left"><italic>Artemisia lactiflora</italic></td>
<td valign="top" align="center">(<xref rid="b156-ijo-67-01-05766" ref-type="bibr">156</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artesunate</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>28</sub>O<sub>8</sub></td>
<td valign="top" align="center">380</td>
<td valign="top" align="left"><italic>Artemisia apiacea</italic></td>
<td valign="top" align="center">(<xref rid="b30-ijo-67-01-05766" ref-type="bibr">30</xref>)</td></tr>
<tr>
<td valign="top" align="left">Atractylon</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O</td>
<td valign="top" align="center">236</td>
<td valign="top" align="left">Rhizoma atractylodis</td>
<td valign="top" align="center">(<xref rid="b99-ijo-67-01-05766" ref-type="bibr">99</xref>)</td></tr>
<tr>
<td valign="top" align="left">Bigelovin</td>
<td valign="top" align="left">C<sub>17</sub>H<sub>20</sub>O<sub>5</sub></td>
<td valign="top" align="center">324</td>
<td valign="top" align="left">Inula flower</td>
<td valign="top" align="center">(<xref rid="b43-ijo-67-01-05766" ref-type="bibr">43</xref>)</td></tr>
<tr>
<td valign="top" align="left">Britanin</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>26</sub>O<sub>7</sub></td>
<td valign="top" align="center">366</td>
<td valign="top" align="left">Inula flower</td>
<td valign="top" align="center">(<xref rid="b42-ijo-67-01-05766" ref-type="bibr">42</xref>)</td></tr>
<tr>
<td valign="top" align="left">Carpespene A</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>18</sub>O<sub>3</sub></td>
<td valign="top" align="center">264</td>
<td valign="top" align="left"><italic>Carpesium faberi</italic>, Guizhou</td>
<td valign="top" align="center">(<xref rid="b79-ijo-67-01-05766" ref-type="bibr">79</xref>)</td></tr>
<tr>
<td valign="top" align="left">Cis-Nerolidol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>26</sub>O</td>
<td valign="top" align="center">222</td>
<td valign="top" align="left">Natural products found in essential oils such as bitter neroli oil and Peruvian balm oil</td>
<td valign="top" align="center">(<xref rid="b90-ijo-67-01-05766" ref-type="bibr">90</xref>)</td></tr>
<tr>
<td valign="top" align="left">Costunolide</td>
<td valign="top" align="left">C<sub>12</sub>H<sub>20</sub>O<sub>2</sub></td>
<td valign="top" align="center">216</td>
<td valign="top" align="left">Costustoot</td>
<td valign="top" align="center">(<xref rid="b40-ijo-67-01-05766" ref-type="bibr">40</xref>)</td></tr>
<tr>
<td valign="top" align="left">Cryptomeridiol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>28</sub>O<sub>2</sub></td>
<td valign="top" align="center">260</td>
<td valign="top" align="left"><italic>Mangnolia officinalis</italic></td>
<td valign="top" align="center">(<xref rid="b142-ijo-67-01-05766" ref-type="bibr">142</xref>)</td></tr>
<tr>
<td valign="top" align="left">Curcumenol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>24</sub>O<sub>2</sub></td>
<td valign="top" align="center">260</td>
<td valign="top" align="left"><italic>Curcuma zedoary</italic></td>
<td valign="top" align="center">(<xref rid="b119-ijo-67-01-05766" ref-type="bibr">119</xref>)</td></tr>
<tr>
<td valign="top" align="left">Dehydrocostus lactone</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>18</sub>O<sub>2</sub></td>
<td valign="top" align="center">248</td>
<td valign="top" align="left"><italic>Inula racemosa</italic></td>
<td valign="top" align="center">(<xref rid="b39-ijo-67-01-05766" ref-type="bibr">39</xref>)</td></tr>
<tr>
<td valign="top" align="left">Deoxyelephantopin</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>20</sub>O<sub>6</sub></td>
<td valign="top" align="center">364</td>
<td valign="top" align="left"><italic>Elephantopus scaber</italic></td>
<td valign="top" align="center">(<xref rid="b59-ijo-67-01-05766" ref-type="bibr">59</xref>)</td></tr>
<tr>
<td valign="top" align="left">Dihydroartemisinin</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>24</sub>O<sub>5</sub></td>
<td valign="top" align="center">288</td>
<td valign="top" align="left"><italic>Artemisia apiacea</italic></td>
<td valign="top" align="center">(<xref rid="b28-ijo-67-01-05766" ref-type="bibr">28</xref>)</td></tr>
<tr>
<td valign="top" align="left">Dimethylaminomicheliolide</td>
<td valign="top" align="left">C<sub>17</sub>H<sub>28</sub>ClNO<sub>3</sub></td>
<td valign="top" align="center">339</td>
<td valign="top" align="left"><italic>Michelia L.</italic></td>
<td valign="top" align="center">(<xref rid="b50-ijo-67-01-05766" ref-type="bibr">50</xref>)</td></tr>
<tr>
<td valign="top" align="left">Elemene</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>24</sub></td>
<td valign="top" align="center">228</td>
<td valign="top" align="left"><italic>Curcuma zedoary</italic></td>
<td valign="top" align="center">(<xref rid="b146-ijo-67-01-05766" ref-type="bibr">146</xref>)</td></tr>
<tr>
<td valign="top" align="left">Furanodiene</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O</td>
<td valign="top" align="center">232</td>
<td valign="top" align="left"><italic>Curcuma zedoary</italic></td>
<td valign="top" align="center">(<xref rid="b143-ijo-67-01-05766" ref-type="bibr">143</xref>)</td></tr>
<tr>
<td valign="top" align="left">Germacrone</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>22</sub>O</td>
<td valign="top" align="center">236</td>
<td valign="top" align="left"><italic>Curcuma zedoary</italic></td>
<td valign="top" align="center">(<xref rid="b97-ijo-67-01-05766" ref-type="bibr">97</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hemistepsin A</td>
<td valign="top" align="left">C<sub>18</sub>H<sub>20</sub>O<sub>6</sub></td>
<td valign="top" align="center">352</td>
<td valign="top" align="left"><italic>Hemistepta lyrata</italic></td>
<td valign="top" align="center">(<xref rid="b66-ijo-67-01-05766" ref-type="bibr">66</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hinesol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>26</sub>O</td>
<td valign="top" align="center">244</td>
<td valign="top" align="left">Rhizoma atractylodis</td>
<td valign="top" align="center">(<xref rid="b115-ijo-67-01-05766" ref-type="bibr">115</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hirsutanol A</td>
<td valign="top" align="left">C<sub>14</sub>H<sub>18</sub>O<sub>3</sub></td>
<td valign="top" align="center">252</td>
<td valign="top" align="left">Endophytic bacteria of soft corals</td>
<td valign="top" align="center">(<xref rid="b144-ijo-67-01-05766" ref-type="bibr">144</xref>)</td></tr>
<tr>
<td valign="top" align="left">Isoalantolactone</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O<sub>2</sub></td>
<td valign="top" align="center">252</td>
<td valign="top" align="left"><italic>Elecampane</italic></td>
<td valign="top" align="center">(<xref rid="b37-ijo-67-01-05766" ref-type="bibr">37</xref>)</td></tr>
<tr>
<td valign="top" align="left">Lavandiolide H</td>
<td valign="top" align="left">C<sub>30</sub>H<sub>38</sub>O<sub>6</sub></td>
<td valign="top" align="center">494</td>
<td valign="top" align="left"><italic>Artemisia atrovirens</italic></td>
<td valign="top" align="center">(<xref rid="b33-ijo-67-01-05766" ref-type="bibr">33</xref>)</td></tr>
<tr>
<td valign="top" align="left">Lavandiolide I</td>
<td valign="top" align="left">C<sub>30</sub>H<sub>36</sub>O<sub>6</sub></td>
<td valign="top" align="center">492</td>
<td valign="top" align="left"><italic>Artemisia</italic></td>
<td valign="top" align="center">(<xref rid="b158-ijo-67-01-05766" ref-type="bibr">158</xref>)</td></tr>
<tr>
<td valign="top" align="left">Linalool</td>
<td valign="top" align="left">C<sub>10</sub>H<sub>18</sub>O</td>
<td valign="top" align="center">172</td>
<td valign="top" align="left"><italic>Coriandrum sativum L.</italic></td>
<td valign="top" align="center">(<xref rid="b84-ijo-67-01-05766" ref-type="bibr">84</xref>)</td></tr>
<tr>
<td valign="top" align="left">Micheliolide</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td valign="top" align="center">268</td>
<td valign="top" align="left"><italic>Michelia L.</italic></td>
<td valign="top" align="center">(<xref rid="b47-ijo-67-01-05766" ref-type="bibr">47</xref>)</td></tr>
<tr>
<td valign="top" align="left">Narjatamolide</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>24</sub>O<sub>4</sub></td>
<td valign="top" align="center">316</td>
<td valign="top" align="left">Rhizome of <italic>Pinus officinalis</italic></td>
<td valign="top" align="center">(<xref rid="b44-ijo-67-01-05766" ref-type="bibr">44</xref>)</td></tr>
<tr>
<td valign="top" align="left">Parthenolide</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td valign="top" align="center">268</td>
<td valign="top" align="left">White daisy</td>
<td valign="top" align="center">(<xref rid="b45-ijo-67-01-05766" ref-type="bibr">45</xref>)</td></tr>
<tr>
<td valign="top" align="left">Santamarine</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td valign="top" align="center">268</td>
<td valign="top" align="left"><italic>Aplotaxis auriculata</italic></td>
<td valign="top" align="center">(<xref rid="b65-ijo-67-01-05766" ref-type="bibr">65</xref>)</td></tr>
<tr>
<td valign="top" align="left">Scabertopinolide G</td>
<td valign="top" align="left">C<sub>20</sub>H<sub>22</sub>O<sub>7</sub></td>
<td valign="top" align="center">397</td>
<td valign="top" align="left"><italic>Elephantopus scaber</italic></td>
<td valign="top" align="center">(<xref rid="b63-ijo-67-01-05766" ref-type="bibr">63</xref>)</td></tr>
<tr>
<td valign="top" align="left">Senedensiscin G</td>
<td valign="top" align="left">C<sub>28</sub>H<sub>46</sub>O<sub>10</sub></td>
<td valign="top" align="center">542</td>
<td valign="top" align="left">Senedensiscin</td>
<td valign="top" align="center">(<xref rid="b152-ijo-67-01-05766" ref-type="bibr">152</xref>)</td></tr>
<tr>
<td valign="top" align="left">Sulfoscorzonin E</td>
<td valign="top" align="left">C<sub>19</sub>H<sub>27</sub>O<sub>6</sub>NS</td>
<td valign="top" align="center">397</td>
<td valign="top" align="left"><italic>Scorzonera divaricata</italic></td>
<td valign="top" align="center">(<xref rid="b153-ijo-67-01-05766" ref-type="bibr">153</xref>)</td></tr>
<tr>
<td valign="top" align="left">Thapsigargin</td>
<td valign="top" align="left">C<sub>34</sub>H<sub>50</sub>O<sub>12</sub></td>
<td valign="top" align="center">652</td>
<td valign="top" align="left"><italic>Thapsia garganica</italic></td>
<td valign="top" align="center">(<xref rid="b105-ijo-67-01-05766" ref-type="bibr">105</xref>)</td></tr>
<tr>
<td valign="top" align="left">Telekin</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>20</sub>O<sub>3</sub></td>
<td valign="top" align="center">268</td>
<td valign="top" align="left"><italic>Carpesium divaricatum</italic></td>
<td valign="top" align="center">(<xref rid="b77-ijo-67-01-05766" ref-type="bibr">77</xref>)</td></tr>
<tr>
<td valign="top" align="left">Xanthatin</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>18</sub>O<sub>3</sub></td>
<td valign="top" align="center">264</td>
<td valign="top" align="left">Xanthium</td>
<td valign="top" align="center">(<xref rid="b72-ijo-67-01-05766" ref-type="bibr">72</xref>)</td></tr>
<tr>
<td valign="top" align="left">Xanthorrhizol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>22</sub>O</td>
<td valign="top" align="center">236</td>
<td valign="top" align="left">Turmeric</td>
<td valign="top" align="center">(<xref rid="b88-ijo-67-01-05766" ref-type="bibr">88</xref>)</td></tr>
<tr>
<td valign="top" align="left">Zerumbone</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>22</sub>O</td>
<td valign="top" align="center">236</td>
<td valign="top" align="left"><italic>Zingiber zerumbet</italic></td>
<td valign="top" align="center">(<xref rid="b129-ijo-67-01-05766" ref-type="bibr">129</xref>)</td></tr>
<tr>
<td valign="top" align="left">(2S,7R,10S)-3-hydroxypseudotigerone 11-O-&#x003B2;-D-glucopyranoside</td>
<td valign="top" align="left">C<sub>21</sub>H<sub>34</sub>O<sub>8</sub></td>
<td valign="top" align="center">416</td>
<td valign="top" align="left"><italic>Atractylis lancea</italic> rhizome</td>
<td valign="top" align="center">(<xref rid="b111-ijo-67-01-05766" ref-type="bibr">111</xref>)</td></tr>
<tr>
<td valign="top" align="left">&#x003B2;-elemene</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>24</sub></td>
<td valign="top" align="center">228</td>
<td valign="top" align="left"><italic>Curcuma zedoary</italic></td>
<td valign="top" align="center">(<xref rid="b149-ijo-67-01-05766" ref-type="bibr">149</xref>)</td></tr>
<tr>
<td valign="top" align="left">&#x003B1;-bisabolol</td>
<td valign="top" align="left">C<sub>15</sub>H<sub>26</sub>O</td>
<td valign="top" align="center">222</td>
<td valign="top" align="left">Chamomile</td>
<td valign="top" align="center">(<xref rid="b94-ijo-67-01-05766" ref-type="bibr">94</xref>)</td></tr></tbody></table></table-wrap>
<table-wrap id="tII-ijo-67-01-05766" position="float">
<label>Table II</label>
<caption>
<p>Mechanisms of action of sesquiterpenoids against hepatocellular carcinoma.</p></caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th valign="top" align="left">Sesquiterpene compound</th>
<th valign="top" align="center">IC<sub>50</sub></th>
<th valign="top" align="center">Effective dose</th>
<th valign="top" align="center">Pathways</th>
<th valign="top" align="center">Observed effects</th>
<th valign="top" align="center">(Refs.)</th></tr></thead>
<tbody>
<tr>
<td valign="top" align="left">Artemisinin</td>
<td valign="top" align="center">250 <italic>&#x003BC;</italic>M (HepG2), 290 <italic>&#x003BC;</italic>M (SMMC-7721)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via TIMP2 protein&#x02191; and matrix metalloproteinase 2 protein&#x02193;</td>
<td valign="top" align="left">Inhibited the migration and invasion of HepG2 and SMMC-7721 cells</td>
<td valign="top" align="center">(<xref rid="b35-ijo-67-01-05766" ref-type="bibr">35</xref>)</td></tr>
<tr>
<td valign="top" align="left">Dihydroartemisinin</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">20 and 40 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via inhibition of cyclin B and cdc25c, G<sub>2</sub>/M phase arrest</td>
<td valign="top" align="left">Apoptosis of HepG2 and Hep3B cells was induced</td>
<td valign="top" align="center">(<xref rid="b36-ijo-67-01-05766" ref-type="bibr">36</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artesunate</td>
<td valign="top" align="center">20 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via STAT3, PI3K/AKT/mTOR pathway</td>
<td valign="top" align="left">The activity of HepG2 cells was inhibited</td>
<td valign="top" align="center">(<xref rid="b39-ijo-67-01-05766" ref-type="bibr">39</xref>)</td></tr>
<tr>
<td valign="top" align="left">Lavandiolide H</td>
<td valign="top" align="center">3.8 <italic>&#x003BC;</italic>M (HepG2), 4.6 <italic>&#x003BC;</italic>M (SMMC-7721), 4.5 <italic>&#x003BC;</italic>M (Huh7)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Bcl-2 protein&#x02193; and PARP-1&#x02191;</td>
<td valign="top" align="left">Inhibited the proliferation of HepG2, SMMC-7721 and Huh7 cells</td>
<td valign="top" align="center">(<xref rid="b43-ijo-67-01-05766" ref-type="bibr">43</xref>)</td></tr>
<tr>
<td valign="top" align="left">Isoalantolactone</td>
<td valign="top" align="center">71.2 <italic>&#x003BC;</italic>M (12 h), 53.4 <italic>&#x003BC;</italic>M (24 h)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via Ras/Raf/MEK</td>
<td valign="top" align="left">Inhibition of HepG2 cell proliferation</td>
<td valign="top" align="center">(<xref rid="b45-ijo-67-01-05766" ref-type="bibr">45</xref>)</td></tr>
<tr>
<td valign="top" align="left">Dehydrocostus lactone</td>
<td valign="top" align="center">20.33 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via PI3K/AKT</td>
<td valign="top" align="left">Inhibition of HepG2 cell proliferation</td>
<td valign="top" align="center">(<xref rid="b46-ijo-67-01-05766" ref-type="bibr">46</xref>)</td></tr>
<tr>
<td valign="top" align="left">Costunolide</td>
<td valign="top" align="center">18.09&#x000B1;1.74 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Bax protein&#x02191;, caspase-3&#x02191;, caspase-8&#x02191;, caspase-9&#x02191; and Bcl-2 protein&#x02193;</td>
<td valign="top" align="left">Promoted HepG2 cell apoptosis</td>
<td valign="top" align="center">(<xref rid="b48-ijo-67-01-05766" ref-type="bibr">48</xref>)</td></tr>
<tr>
<td valign="top" align="left">Britanin</td>
<td valign="top" align="center">27.86&#x000B1;1.35 <italic>&#x003BC;</italic>M (HepG2), 28.92&#x000B1;1.09 <italic>&#x003BC;</italic>M (SMMC-7721), 15.69&#x000B1;1.58 <italic>&#x003BC;</italic>M (Huh7)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via AMPK was regulated by activation of ROS</td>
<td valign="top" align="left">Induced apoptosis and autophagy in HepG2, SMMC-7721 and Huh7 cells</td>
<td valign="top" align="center">(<xref rid="b49-ijo-67-01-05766" ref-type="bibr">49</xref>)</td></tr>
<tr>
<td valign="top" align="left">Bigelovin</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">5 and 10 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">Caspase-3&#x02191; and PARP-1&#x02191;</td>
<td valign="top" align="left">Induced apoptosis of HepG2 and SMMC-7721 cells</td>
<td valign="top" align="center">(<xref rid="b50-ijo-67-01-05766" ref-type="bibr">50</xref>)</td></tr>
<tr>
<td valign="top" align="left">Narjatamolide</td>
<td valign="top" align="center">5.67&#x000B1;1.43 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via induced cell cycle arrest at G2/M phase</td>
<td valign="top" align="left">Inhibition of BEL-7402 cell proliferation</td>
<td valign="top" align="center">(<xref rid="b51-ijo-67-01-05766" ref-type="bibr">51</xref>)</td></tr>
<tr>
<td valign="top" align="left">Parthenolide</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">ROS is generated, resulting in blocking of the cell cycle</td>
<td valign="top" align="left">Apoptosis and autophagy in HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b53-ijo-67-01-05766" ref-type="bibr">53</xref>)</td></tr>
<tr>
<td valign="top" align="left">Micheliolide</td>
<td valign="top" align="center">31.46&#x000B1;5.33 <italic>&#x003BC;</italic>M (24 h), 13.4&#x000B1;1.39 <italic>&#x003BC;</italic>M (48 h), 8.13&#x000B1;1.29 <italic>&#x003BC;</italic>M (72 h)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">ROS inhibition normalized MCL-induced ERS</td>
<td valign="top" align="left">inhibited the development of hepatoma organoids</td>
<td valign="top" align="center">(<xref rid="b56-ijo-67-01-05766" ref-type="bibr">56</xref>)</td></tr>
<tr>
<td valign="top" align="left">DMAMCL</td>
<td valign="top" align="center">12.74&#x000B1;0.72 <italic>&#x003BC;</italic>M (HepG2), 13.82&#x000B1;0.54 <italic>&#x003BC;</italic>M (Hep3B), 12.91&#x000B1;0.83 <italic>&#x003BC;</italic>M (Huh7), 17.21&#x000B1;0.68 <italic>&#x003BC;</italic>M (SMMC-7221)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via PI3K/AKT</td>
<td valign="top" align="left">Apoptosis of HepG2, SMMC-7721, Hep3B and Huh7 cell lines</td>
<td valign="top" align="center">(<xref rid="b62-ijo-67-01-05766" ref-type="bibr">62</xref>)</td></tr>
<tr>
<td valign="top" align="left">Deoxyelephantopin</td>
<td valign="top" align="center">40 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via NF-&#x003BA;B</td>
<td valign="top" align="left">Inhibition of HepG2 cell proliferation and induction of apoptosis</td>
<td valign="top" align="center">(<xref rid="b69-ijo-67-01-05766" ref-type="bibr">69</xref>)</td></tr>
<tr>
<td valign="top" align="left">Scabertopinolide G</td>
<td valign="top" align="center">7.0-10.3 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via increased ROS production and decreased MMP</td>
<td valign="top" align="left">Autophagy was induced in Hep3B and HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b70-ijo-67-01-05766" ref-type="bibr">70</xref>)</td></tr>
<tr>
<td valign="top" align="left">Santamarine</td>
<td valign="top" align="center">70 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via NF-&#x003BA;B</td>
<td valign="top" align="left">Inhibition of HepG2 cell proliferation and induction of apoptosis</td>
<td valign="top" align="center">(<xref rid="b72-ijo-67-01-05766" ref-type="bibr">72</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hemistepsin A</td>
<td valign="top" align="center">15.27&#x000B1;1.84 <italic>&#x003BC;</italic>M (Huh7), 26.5&#x000B1;6.07 <italic>&#x003BC;</italic>M (HepG2)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via AMP/AMPK, STAT3</td>
<td valign="top" align="left">Slowed down the cell cycle progression of Huh7 and HepG2 cells and induced apoptosis</td>
<td valign="top" align="center">(<xref rid="b77-ijo-67-01-05766" ref-type="bibr">77</xref>)</td></tr>
<tr>
<td valign="top" align="left">Xanthatin</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">20 and 40 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via PERK-eIF2&#x003B1;-ATF4 signaling pathway and target CHOP</td>
<td valign="top" align="left">Apoptosis of HepG2, Bel-7402 and SMMC-7721 hepatoma cells</td>
<td valign="top" align="center">(<xref rid="b82-ijo-67-01-05766" ref-type="bibr">82</xref>)</td></tr>
<tr>
<td valign="top" align="left">Telekin</td>
<td valign="top" align="center">3.75-30 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via activation of p38 and MAPKAPK-2 pathways</td>
<td valign="top" align="left">Inhibition of HepG2 cell viability and induction of apoptosis</td>
<td valign="top" align="center">(<xref rid="b84-ijo-67-01-05766" ref-type="bibr">84</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemiprincepsolides A</td>
<td valign="top" align="center">9.9 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Bc1-2 protein&#x02193; and Bax protein&#x02191;</td>
<td valign="top" align="left">Induced apoptosis of HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b85-ijo-67-01-05766" ref-type="bibr">85</xref>)</td></tr>
<tr>
<td valign="top" align="left">Carpespene A</td>
<td valign="top" align="center">5.17 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via triggering excess ROS</td>
<td valign="top" align="left">Apoptosis of HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b90-ijo-67-01-05766" ref-type="bibr">90</xref>)</td></tr>
<tr>
<td valign="top" align="left">Linalool</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">2 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via inhibition of mitochondrial complex I and II activity</td>
<td valign="top" align="left">The viability of HepG2 cells was reduced</td>
<td valign="top" align="center">(<xref rid="b94-ijo-67-01-05766" ref-type="bibr">94</xref>)</td></tr>
<tr>
<td valign="top" align="left">Xanthorrhizol</td>
<td valign="top" align="center">4.17 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Promoted the proteolytic cleavage of PARP and ICAD, Bcl-2 and Bcl-xl protein&#x02193;</td>
<td valign="top" align="left">Induced apoptosis of HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b96-ijo-67-01-05766" ref-type="bibr">96</xref>)</td></tr>
<tr>
<td valign="top" align="left">Cis-Nerolidol</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">150 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via mitochondrial membrane potential by arresting the cell cycle in G1 phase</td>
<td valign="top" align="left">Cell death was induced in HepG2/C3A cells</td>
<td valign="top" align="center">(<xref rid="b100-ijo-67-01-05766" ref-type="bibr">100</xref>)</td></tr>
<tr>
<td valign="top" align="left">&#x003B1;-bisabolol</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via NF-&#x003BA;B</td>
<td valign="top" align="left">Apoptosis of HepG2 cancer cells</td>
<td valign="top" align="center">(<xref rid="b102-ijo-67-01-05766" ref-type="bibr">102</xref>)</td></tr>
<tr>
<td valign="top" align="left">Germacrone</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">240 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via STAT3 and JAK2</td>
<td valign="top" align="left">Induced apoptosis of HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b105-ijo-67-01-05766" ref-type="bibr">105</xref>)</td></tr>
<tr>
<td valign="top" align="left">Atractylon</td>
<td valign="top" align="center">26.19 <italic>&#x003BC;</italic>M (HepG2), 22.32 <italic>&#x003BC;</italic>M (SMCC7721), 34.14 <italic>&#x003BC;</italic>M (MHCC97H)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via mitochondrial apoptosis pathway</td>
<td valign="top" align="left">Induced apoptosis of HepG2, SMCC7721 and MHCC9H cells</td>
<td valign="top" align="center">(<xref rid="b109-ijo-67-01-05766" ref-type="bibr">109</xref>)</td></tr>
<tr>
<td valign="top" align="left">Ar-turmerone</td>
<td valign="top" align="center">64.8&#x000B1;7.1 <italic>&#x003BC;</italic>g/ml (HepG2), 102.5&#x000B1;11.5 <italic>&#x003BC;</italic>g/ml (Huh-7), 122.2&#x000B1;7.6 <italic>&#x003BC;</italic>g/ml (Hep3B)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via ERK/JNK</td>
<td valign="top" align="left">Apoptosis of HepG2, Huh-7 and Hep3B cells</td>
<td valign="top" align="center">(<xref rid="b111-ijo-67-01-05766" ref-type="bibr">111</xref>)</td></tr>
<tr>
<td valign="top" align="left">Thapsigargin</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">1, 2, 4, 8 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via inhibition of SERCA-ATPase in hepatoma cells and depletion of intracellular Ca<sup>2+</sup> pool</td>
<td valign="top" align="left">Apoptosis of hepatoma cells</td>
<td valign="top" align="center">(<xref rid="b115-ijo-67-01-05766" ref-type="bibr">115</xref>)</td></tr>
<tr>
<td valign="top" align="left">(2S,7R,10S)-3-hydroxypseudotigerone-11-O-&#x003B2;-D-glucopyranoside</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">10 <italic>&#x003BC;</italic>mol/l</td>
<td valign="top" align="left">-</td>
<td valign="top" align="left">Significant protective effect on HepG2 cell injury induced by N-acetyl-p-aminophenol</td>
<td valign="top" align="center">(<xref rid="b121-ijo-67-01-05766" ref-type="bibr">121</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hinesol</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via MAPK and ERK; NF-&#x003BA;B</td>
<td valign="top" align="left">Inhibition of proliferation and induction of apoptosis in SMMC-7721 and LM3 cells</td>
<td valign="top" align="center">(<xref rid="b124-ijo-67-01-05766" ref-type="bibr">124</xref>)</td></tr>
<tr>
<td valign="top" align="left">Curcumenol</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via DJ-1, PTEN, PI3K/AKT signal transduction pathway</td>
<td valign="top" align="left">Inhibition of the proliferation of HepG2 hepatoma cells</td>
<td valign="top" align="center">(<xref rid="b137-ijo-67-01-05766" ref-type="bibr">137</xref>)</td></tr>
<tr>
<td valign="top" align="left">Zerumbone</td>
<td valign="top" align="center">6.20&#x000B1;0.7 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">12.5 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="left">MMP-9, VEGF and VEGF receptor proteins&#x02193;</td>
<td valign="top" align="left">Induced apoptosis of HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b138-ijo-67-01-05766" ref-type="bibr">138</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemeriopodin G7</td>
<td valign="top" align="center">16.0 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">CDC2 and p-CDC2 protein expression&#x02193;, it targets PDGFRA, affects AKT/STAT signaling and induces G<sub>2</sub>/M cell cycle arrest</td>
<td valign="top" align="left">Inhibition of HepG2 cell migration and invasion, and induction of apoptosis</td>
<td valign="top" align="center">(<xref rid="b147-ijo-67-01-05766" ref-type="bibr">147</xref>)</td></tr>
<tr>
<td valign="top" align="left">Cryptomeridiol</td>
<td valign="top" align="center">&gt;50 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via IRE1&#x003B1;-ASK1-JNK, resulting in loss of MMP</td>
<td valign="top" align="left">The viability of HepG2, Hep3B and Huh-7 cells was reduced</td>
<td valign="top" align="center">(<xref rid="b148-ijo-67-01-05766" ref-type="bibr">148</xref>)</td></tr>
<tr>
<td valign="top" align="left">Furanodiene</td>
<td valign="top" align="center">70 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">300 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="left">via mitochondrial caspase apoptosis and ERK/MAPK signals</td>
<td valign="top" align="left">Inhibition of HepG2 cell growth and induction apoptosis</td>
<td valign="top" align="center">(<xref rid="b149-ijo-67-01-05766" ref-type="bibr">149</xref>)</td></tr>
<tr>
<td valign="top" align="left">Hirsutanol A</td>
<td valign="top" align="center">14.54 (24 h), 6.71 (48 h), 3.59 (72 h) <italic>&#x003BC;</italic>mol/l</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">via activated ROS</td>
<td valign="top" align="left">Autophagic cell death was induced in Hep3B hepatoma cells</td>
<td valign="top" align="center">(<xref rid="b150-ijo-67-01-05766" ref-type="bibr">150</xref>, <xref rid="b151-ijo-67-01-05766" ref-type="bibr">151</xref>)</td></tr>
<tr>
<td valign="top" align="left">Elemene</td>
<td valign="top" align="center">63&#x000B1;2.1 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">GSTP1 gene methylation was reversed and cell cycle was inhibited</td>
<td valign="top" align="left">Induced apoptosis of QGY7703 cells</td>
<td valign="top" align="center">(<xref rid="b155-ijo-67-01-05766" ref-type="bibr">155</xref>)</td></tr>
<tr>
<td valign="top" align="left">&#x003B2;-elemene</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">100 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="left">Downregulation of c-Met expression</td>
<td valign="top" align="left">Inhibited the growth of H22 hepatoma cells</td>
<td valign="top" align="center">(<xref rid="b156-ijo-67-01-05766" ref-type="bibr">156</xref>)</td></tr>
<tr>
<td valign="top" align="left">Acorusin E</td>
<td valign="top" align="center">2.11-7.99 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Apoptosis of SMMC-7721 cells</td>
<td valign="top" align="center">(<xref rid="b157-ijo-67-01-05766" ref-type="bibr">157</xref>)</td></tr>
<tr>
<td valign="top" align="left">Senedensiscin G</td>
<td valign="top" align="center">9.5-11.5 <italic>&#x003BC;</italic>M</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Showed inhibitory activity on SMMC-7721 cells</td>
<td valign="top" align="center">(<xref rid="b159-ijo-67-01-05766" ref-type="bibr">159</xref>)</td></tr>
<tr>
<td valign="top" align="left">Sulfoscorzonin E</td>
<td valign="top" align="center">4.21&#x000B1;0.56 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Moderate cytotoxic activity on HepG2 cells</td>
<td valign="top" align="center">(<xref rid="b161-ijo-67-01-05766" ref-type="bibr">161</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemongolins E</td>
<td valign="top" align="center">88.6 <italic>&#x003BC;</italic>M (HepG2), 59.1 <italic>&#x003BC;</italic>M (Huh7), 67.5 <italic>&#x003BC;</italic>M (SK-Hep-1)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">The inhibitory effect on HepG2, Huh7 and SK-Hep-1 cells was significant</td>
<td valign="top" align="center">(<xref rid="b162-ijo-67-01-05766" ref-type="bibr">162</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemyriantholide E</td>
<td valign="top" align="center">14.2 <italic>&#x003BC;</italic>M (HepG2), 9.0 <italic>&#x003BC;</italic>M (Huh7), 8.8 <italic>&#x003BC;</italic>M (SK-Hep-1)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">MAP2K2 may be a core gene</td>
<td valign="top" align="left">Good inhibitory activity against HepG2, Huh7 and SK-Hep-1 cells</td>
<td valign="top" align="center">(<xref rid="b163-ijo-67-01-05766" ref-type="bibr">163</xref>)</td></tr>
<tr>
<td valign="top" align="left">Artemisacrolide B</td>
<td valign="top" align="center">21.9 <italic>&#x003BC;</italic>M (HepG2), 8.2 <italic>&#x003BC;</italic>M (Huh7), 16.9 <italic>&#x003BC;</italic>M (SK-Hep-1)</td>
<td valign="top" align="center">200 <italic>&#x003BC;</italic>g/ml</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Marked anti-liver cancer activity against HepG2, Huh7 and SK-Hep-1 cells</td>
<td valign="top" align="center">(<xref rid="b164-ijo-67-01-05766" ref-type="bibr">164</xref>)</td></tr>
<tr>
<td valign="top" align="left">Lavandiolide I</td>
<td valign="top" align="center">12.1 <italic>&#x003BC;</italic>M (HepG2) 18.4 <italic>&#x003BC;</italic>M (Huh7), 17.6 <italic>&#x003BC;</italic>M (SK-Hep-1)</td>
<td valign="top" align="center">-</td>
<td valign="top" align="center">-</td>
<td valign="top" align="left">Marked anti-liver cancer activity against HepG2, Huh7 and SK-Hep-1 cells</td>
<td valign="top" align="center">(<xref rid="b165-ijo-67-01-05766" ref-type="bibr">165</xref>)</td></tr></tbody></table>
<table-wrap-foot>
<fn id="tfn1-ijo-67-01-05766">
<p>&#x02191;, upregulation; &#x02193;, downregulation; ROS, reactive oxygen species; TIMP2, tissue inhibitors of metalloproteinase 2; STAT3, signal transducers and activators of transcription; PI3K, phosphatidylinositol-3-hydroxykinase; AKT, protein kinase B; mTOR, mammalian target of rapamycin; Bcl-2, B-cell lymphoma/leukemia-2; PARP-1, polymerase 1; Ras, rat sarcoma; Raf, rapidly accelerated fibrosarcoma; MEK, MAPK kinase; Bax, Bcl-2-associated X-protein; caspase-3, procysteinyl aspartate-specific proteinase-3; AMPK, adenosine monophosphate-activated protein kinase; ERS, endoplasmic reticulum stress; NF-&#x003BA;B, nuclear factor-&#x003BA;B; MMP, mitochondrial membrane potential; AMP, adenosine monophosphate; PERK, protein kinase r-like endoplasmic reticulum kinase; eIF2&#x003B1;, eukaryotic translation initiation factor 2&#x003B1;; ATF4, activating transcription factor 4; CHOP, C/EBP homologous protein; MAPKAPK-2, MAPK activated protein kinase 2; PARP, poly(adenosine diphosphate-ribose) polymerase; ICAD, inhibitor of caspase-activated deoxyribonuclease; JAK2, Janus kinase 2; SERCA-ATPase, sarcoplasmic reticulum calcium pumps; MAPK, mitogen-activated protein kinases; ERK, extracellular signal-regulated kinase; PTEN, phosphatase and tensin homolog; DJ-1, Parkinson disease protein DJ-1; VEGF, vascular endothelial growth factor; PDGFRA, platelet-derived growth factor receptor A; IRE1&#x003B1;, inositol-requiring enzyme 1&#x003B1;; ASK1, apoptosis signal-regulating kinase 1; JNK, c-Jun N-terminal kinase; GSTP1, glutathione S-transferase Pi 1; MAP2K2, MAPK kinase 2.</p></fn></table-wrap-foot></table-wrap></floats-group></article>
